fluorodeoxyglucose f18 has been researched along with Disease Exacerbation in 684 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (0.73) | 18.2507 |
| 2000's | 162 (23.68) | 29.6817 |
| 2010's | 429 (62.72) | 24.3611 |
| 2020's | 88 (12.87) | 2.80 |
| Authors | Studies |
|---|---|
| Arahata, Y; Bundo, M; Ikenuma, H; Ito, K; Iwata, K; Kato, T; Kimura, Y; Nakamura, A; Nihashi, T; Okamura, N; Sakurai, K; Sakurai, T; Suzuki, K; Takeda, A; Washimi, Y; Yamaoka, A; Yanai, K | 1 |
| Abdolalizadeh, A; Ashraf-Ganjouei, A; Faghani, S; Fatehi, F; Khomeijani-Farahani, M; Moradi, K | 1 |
| Alberts, I; Han, Y; Initiative, FTADN; Jiang, J; Li, T; Rominger, A; Shi, K; Sun, X; Wang, M; Zuo, C | 1 |
| Agosti, R; Antonacci, F; Castellucci, P; Fanti, S; Farolfi, A; Morigi, JJ; Mosconi, C; Nanni, C; Solli, P; Telo, S | 1 |
| Ahlman, MA; Alessi, HD; Grayson, PC; Luo, Y; Novakovich, E; Quinn, KA; Saboury, B | 1 |
| Albensi, BC; Beheshti, I; Geddert, N; Gupta, V; Ko, JH; Perron, J | 1 |
| Chen, Y; Cheng, J; Liu, F; Wang, H; Wei, S | 1 |
| Hou, J; Jin, H; Peng, J; Qin, X; Shu, Z; Song, Q; Wang, W; Wei, Y; Yuan, Z | 1 |
| Deng, Y; He, L; Xie, H; Zhang, W | 1 |
| Devanand, DP; Masurkar, AV; Wisniewski, T | 1 |
| Hassan, A; Muzaffar, M | 1 |
| Borrie, MJ; Camicioli, R; Chekouo, T; Forkert, ND; Ganesh, A; Hogan, DB; Hsiung, GR; Ismail, Z; Masellis, M; Moorhouse, P; Sajobi, TT; Seitz, DP; Smith, EE; Tartaglia, MC; Wang, M | 1 |
| Eidelberg, D; Namías, M; Perovnik, M; Tang, CC | 1 |
| Huang, L; Liu, J; Shi, A; Su, Y; Wang, J; Xie, L; Yu, X; Zha, J | 1 |
| Meguro, K; Meguro, M; Takahashi, K; Tashiro, M; Yamaguchi, S | 1 |
| Burger, IA; Ghafoor, S; Vargas, AH | 1 |
| Abe, S; Ikeda, N; Masuno, R; Ohira, T; Shimada, Y; Yamamichi, T; Yoshimura, A | 1 |
| Andrews, JP; Dweck, MR; Tzolos, E | 1 |
| Bos, SA; Bredella, MA; Chu, K; Gill, CM; Torriani, M | 1 |
| Bauckneht, M; Capello, E; Dottorini, ME; Eusebi, P; Farotti, L; Massa, F; Morbelli, S; Nobili, F; Parnetti, L; Tranfaglia, C | 1 |
| Ahlström, H; Hansen, T; Kuzniar, M; Mani, K; Tegler, G; Wanhainen, A | 1 |
| Aide, N; Prigent, K | 1 |
| Huo, L; Wang, J; Wang, X; Yang, X; Zhao, H | 1 |
| Alavi, A; Bassetti, M; Cadeo, B; Carnelutti, A; Di Gregorio, F; Melchioretto, G; Merelli, M; Muser, D; Righi, E | 1 |
| Ju, S; Li, Y; Liang, Y; Xu, Y; Yan, J; Yang, P; Zhang, N; Zhu, X; Zhu, Y | 1 |
| Jiang, J; Wang, M; Yan, Z | 1 |
| Fujiwara, Y; Ishibashi, K; Ishii, K; Onishi, A; Wagatsuma, K | 1 |
| Cook, SA; Pourghiasian, M; Tinker, AV; Wilson, D | 1 |
| Landgren, CO; Ulaner, GA | 1 |
| Zhu, X; Zou, S | 1 |
| Allegri, R; Barthélemy, NR; Bateman, RJ; Benzinger, TLS; Berman, SB; Buckles, V; Chhatwal, J; Fagan, AM; Farlow, M; Fox, NC; Gabelle, A; Goate, AM; Gordon, BA; Graff-Radford, NR; Hassenstab, J; Ikeuchi, T; Joseph-Mathurin, N; Jucker, M; Karch, CM; Lehmann, S; Levin, J; Li, Y; Martins, RN; Masters, CL; McDade, E; Mendez, PC; Mori, H; Morris, JC; Noble, J; O'Connor, A; Perrin, RJ; Salloway, S; Sato, C; Schofield, PR; Shimada, H; Shoji, M; Suzuki, K; Xiong, C | 1 |
| Aryal, SR; Bajaj, NS; Bansal, NC; Bhambhvani, P; Hage, FG; McConathy, JE | 1 |
| Aoki, S; Araya, M; Komiyama, T; Kuriyama, K; Maehata, Y; Marino, K; Matsumoto, Y; Miyakawa, A; Miyawaki, D; Nishimura, Y; Nonaka, H; Onishi, H; Saito, M; Saito, R; Sano, N; Sasaki, R; Shibamoto, Y; Shioyama, Y; Suzuki, G; Tominaga, L; Yamada, S | 1 |
| Basler, L; Bogowicz, M; Dummer, R; Förster, R; Gabryś, HS; Guckenberger, M; Hogan, SA; Huellner, MW; Kudura, K; Levesque, MP; Pavic, M; Tanadini-Lang, S; Vuong, D | 1 |
| Hu, B; Hu, T; Li, Y; Teng, L; Yao, Z; Zhang, Z; Zhao, Y | 1 |
| Alberts, I; Ge, J; Jiang, J; Rominger, A; Shi, K; Wang, M; Yan, Z; Yu, J; Zhang, H; Zuo, C | 1 |
| Agosta, F; Caminiti, SP; Caso, F; Cecchetti, G; Filippi, M; Magnani, G; Martinelli, V; Masserini, F; Passerini, G; Perani, D; Pinto, P; Sala, A; Santangelo, R | 1 |
| Berger, H; Dejust, S; Lalire, P; Morland, D; Zizi, G | 1 |
| Artiko, VM; Beatovic, S; Grozdic Milojevic, I; Nikitovic, M; Paripovic, L; Saponjski, J; Saranovic, D; Sobic Saranovic, DP | 1 |
| Buck, A; Delso, G; Huellner, M; Kaushik, S; Kemp, B; Sekine, T; Ter Voert, EEGW; Veit-Haibach, P; Warnock, G; Wiesinger, F | 1 |
| Cho, SY; Jadvar, H; Kim, CK; Potvin, K; Winquist, E; Zukotynski, KA | 1 |
| Freedland, SJ; Gan, H; Hu, S; Liu, C; Ma, X; Meng, J; Pan, J; Song, S; Wan, F; Wang, B; Wei, Y; Xu, X; Ye, D; Zhang, Y; Zhu, Y | 1 |
| Chino, S; Higashigawa, T; Hirano, K; Ichikawa, Y; Kato, H; Kato, N; Nakajima, K; Ouchi, T; Sakuma, H; Tokui, T | 1 |
| Bejanin, A; Boeve, BF; Boxer, AL; Cobigo, Y; Dickerson, BC; Gorno-Tempini, M; Iaccarino, L; Jagust, WJ; Knopman, DS; Kornak, J; Marx, G; Miller, BL; Rabinovici, GD; Rosen, HJ; Staffaroni, AM; Tammewar, G | 1 |
| Matiello, M; O'Hare, M; Schmahmann, JD; Young, MJ | 1 |
| Cheriyan, J; Fisk, M; Lee, S; Vass, L; Wilkinson, I; Wilson, FJ | 1 |
| Kang, L; Su, T; Wang, H; Wang, S; Yang, L | 1 |
| Bešlić, N; Bešlija, S; Cerić, Š; Cerić, T; Pašić, A; Sefić-Pašić, I; Sokolović, E; Vegar-Zubović, S | 1 |
| Lan, X; Qin, C; Shao, F | 1 |
| Ae, R; Hamaguchi, T; Harada, M; Iwasaki, Y; Mizusawa, H; Murai, H; Murayama, S; Nakamura, Y; Sakai, K; Sanjo, N; Satoh, K; Takao, M; Tsukamoto, T; Yamada, M | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Aquino-Parsons, C; Bénard, F; Brown, MJ; Connors, JM; Farinha, P; Freeman, CL; Gerrie, AS; Lo, A; Morris, J; Pickles, T; Savage, KJ; Scott, DW; Sehn, LH; Skinnider, B; Slack, GW; Srour, L; Tonseth, P; Villa, DR; Wilson, DC | 1 |
| Adel, M; Fossati, C; Gaidon, T; Guedj, E; Pan, X; Phan, TL; Wojak, J | 1 |
| Jiang, J; Wang, M; Xiao, SY; Yan, Z; Zuo, C | 1 |
| Balaji, R | 1 |
| Chen, QY; Guo, SS; Jia, GD; Liu, LT; Liu, SL; Luo, DH; Mai, HQ; Sun, R; Sun, XS; Tang, LQ; Xie, HJ; Yu, YF | 1 |
| Handa, Y; Kagimoto, A; Mimae, T; Miyata, Y; Okada, M; Tsutani, Y | 1 |
| Bettendorff, L; Chen, H; Chen, Z; Cirio, R; Flowers, SA; Fonzetti, P; Franchino-Elder, J; Gerber, LM; Gibson, GE; Grandville, T; Habeck, C; Hirsch, JA; Jordan, B; Luchsinger, JA; Schupf, N; Stern, Y; Xu, H | 1 |
| Aghayev, A; Bay, CP; Campia, U; DiCarli, M; Docken, WP; Gerhard-Herman, M; Mitchell, RN; Monach, PA; Steigner, ML; Tedeschi, S | 1 |
| Choi, JY; Han, S | 1 |
| Akuta, N; Arase, Y; Fujiyama, S; Hashimoto, M; Hosaka, T; Ikeda, K; Iritani, S; Kajiwara, A; Kawamura, Y; Kobayashi, M; Kobayashi, Y; Kumada, H; Muraishi, N; Okubo, S; Saitoh, S; Sezaki, H; Shindoh, J; Suzuki, F; Suzuki, Y; Yamashige, D | 1 |
| Chiang, GC; Ebani, EJ; Meng, A; Strauss, SB | 1 |
| Bonnefoy, PB; Goutte, J; Habouzit, V; Jacquet-Francillon, N; Prevot, N | 1 |
| Feng, X; Fu, X; Han, X; Li, L; Li, X; Ma, X; Sun, Z; Wang, X; Wen, X; Wu, J; Xie, X; Yu, H; Zhang, L; Zhang, M; Zhang, X | 1 |
| Bartenstein, P; Di Gioia, D; Fabritius, MP; Holzgreve, A; Knösel, T; Lindner, LH; Renz, BW; Rübenthaler, J; Tiling, R | 1 |
| Albano, D; Bertagna, F; Camoni, L; Giubbini, R; Rodella, C | 1 |
| Benedet, AL; Chan, YH; Gauthier, S; Greenwood, CMT; Jiang, L; Kandiah, N; Mathotaarachchi, S; Ng, KP; Pascoal, TA; Rosa-Neto, P; Shin, M; Therriault, J | 1 |
| Blazhenets, G; Eidelberg, D; Frings, L; Ma, Y; Meyer, PT; Sörensen, A; Wiltfang, J | 1 |
| Borrego Dorado, I; Fernández López, R; Fernández-Rodríguez, P; Piñero González de la Peña, P; Tamayo Carabaño, D | 1 |
| Han, S; Kim, TH; Kim, YI; Ryu, JS; Woo, S | 1 |
| Bodet, D; García-Patos, V; González-Cruz, C; Muñoz-Couselo, E | 1 |
| Andreev, DN; Bellaye, PS; Bonniaud, P; Bouchard, A; Cochet, A; Collin, B; Frenay, J; Goirand, F; Guillemin, M; Helbling, A; Kucheryavy, YA; Mayev, IV; Moreau, M; Mothes, C; Oudot, A; Tanguy, J | 1 |
| Antelmi, L; Berckel, BV; Bosco, P; Didic, M; Drzezga, A; Frisoni, GB; Garibotto, V; Giannakopoulos, P; Gold, G; Guedj, E; Morbelli, S; Nobili, F; Ossenkoppele, R; Perneczky, R; Rager, O; Ratib, O; Redolfi, A; Tabouret-Viaud, C; Trombella, S | 1 |
| Aaløkken, TM; Aukrust, P; Durheim, MT; Fevang, B; Fraz, MSA; Jørgensen, SF; Macpherson, ME; Moe, N; Nordøy, I; Revheim, ME; Stavrinou, ML | 1 |
| Lu, Y; Xu, G | 1 |
| Avery, R; Cao, J; Cooper, LT; Lomasney, JW; Narang, A; Okwuosa, IS; Passman, RS; Schwartz, YY; Vorovich, E | 1 |
| Bartlett, PF; Jiang, T; Liu, B; Liu, Y; Zhang, Y; Zhou, X; Zhuo, J | 1 |
| Choi, KH; Hong, JH; Kim, MS; Kim, YS; Lee, YS; Park, EY; Song, JH; Sun, DI; Yoo, IR | 1 |
| Creytens, D; Kruse, V; Ost, P; Spaas, M; Van den Broeck, B | 1 |
| Aigner, C; Christoph, DC; Eberhardt, W; Faehling, M; Fendler, WP; Ferdinandus, J; Grünwald, V; Herrmann, K; Karl, KO; Kessler, L; Metzenmacher, M; Umutlu, L | 1 |
| Buck, A; Fassnacht, M; Fröhling, S; Fuss, CT; Germer, CT; Hübschmann, D; Kickuth, R; Kircher, S; Kroiss, M; Lenschow, C; Reibetanz, J; Schlegel, N; Stenzinger, A; Wiegering, A | 1 |
| Adachi, S; Enomoto, T; Haino, K; Ishiguro, T; Ishii, S; Nishikawa, N; Soeda, S; Watanabe, T; Yamaguchi, M; Yoshihara, K | 1 |
| Gold, O; Groshar, D; Guindy, M; Harari, SF; Hod, K; Shpilberg, O; Tavor, S; Tova, Y | 1 |
| Ali, T; Bathini, VG; Edmiston, KL; Gerber, JM; McIntosh, LJ; Mittal, K; Rosen, MP; Walsh, WV; Whalen, GF | 1 |
| Ali, F; Baker, M; Bigio, EH; Botha, H; Buciuc, M; Clark, HM; DeTure, MA; Dickson, DW; Duffy, JR; Ertekin-Taner, N; Fernandez De Castro, CH; Jack, CR; Josephs, KA; Lowe, VJ; Machulda, MM; Martin, PR; Pham, NTT; Polley, EJ; Rademakers, R; Reichard, RR; Reid, RI; Ross, OA; Schwarz, CG; Senjem, ML; Spychalla, AJ; Stierwalt, J; Strand, EA; Utianski, RL; Whitwell, JL | 1 |
| Bhatia, SN; Fleming, HE; Gertler, FB; Hao, L; Kelada, OJ; Ko, H; Mak, H; Pulver, EM; Rohani, N; Zhao, RT | 1 |
| Bonvillain, A; Carrasquillo, JA; Degrange, P; Di Mascio, M; Dodd, L; Hammoud, DA; Schreiber-Stainthorp, W; Shah, S; Sinharay, S; Srinivasula, S; Wang, J | 1 |
| Assi, HA; Hornbacker, K; Kunz, PL; Shaheen, S; Silberman, R; Wittenberg, T | 1 |
| Bejanin, A; Horng, A; Jagust, WJ; Landau, SM; Lockhart, SN; Schreiber, F; Schreiber, S | 1 |
| Jeon, S; Lee, JW; Lee, SM; Mun, ST | 1 |
| Abrunhosa, A; Castelo-Branco, M; Chichorro, N; Donato, P; Ferreira, MJ; Gomes, A; Gonçalves, L; Oliveira-Santos, M; Pedroso de Lima, J; Pego, M; Silva, R | 1 |
| Li, J; Ma, J; Wang, Y; Wang, Z; Wu, X | 1 |
| Chan, ATC; Chan, CML; Ho, WM; King, AD; Leung, L; Ma, B; Mo, F; Poon, A; Wang, K; Wong, SCC | 1 |
| Abramson, JS; Advani, R; Ansell, S; Aurer, I; Bollard, C; Coiffier, B; de Vos, S; Dreyling, M; Elsayed, YA; Engert, A; Federico, M; Fisher, RI; Fortpied, C; Fowler, N; Gopal, A; Goy, A; Gribben, J; Hagenbeek, A; Hilden, P; Hutchings, M; Kaminski, MS; Kelly, K; Kloos, I; Kuruvilla, J; Leonard, JP; Little, RF; Meignan, M; Morschhauser, F; Pfreunschuh, M; Rademaker, J; Rule, S; Salles, G; Schoder, H; Schuster, SJ; Schwartz, LH; Sehn, LH; Seshan, VE; Seymour, JF; Smith, M; Takeshita, K; Thieblemont, C; Tobinai, K; Trneny, M; Valente, N; Van Oers, MHJ; Wilson, W; Witzig, TE; Younes, A; Zelenetz, AD; Zinzani, PL | 1 |
| Dhawan, V; Eidelberg, D; Grmek, M; Jensterle, L; Ma, Y; Peng, S; Pirtošek, Z; Tomše, P; Trošt, M; Zaletel, K | 1 |
| Chang, YC; Chen, JL; Chen, YC; Hsu, FM; Huang, JY; Huang, YS; Jaw, FS; Ko, WC; Yen, RF | 1 |
| Almkvist, O; Antoni, G; Chiotis, K; Jonasson, M; Leuzy, A; Lubberink, M; Nordberg, A; Rodriguez-Vieitez, E; Saint-Aubert, L; Savitcheva, I; Wall, A | 1 |
| Bible, KC; Jasim, S; Nathan, MA | 1 |
| Almquist, H; Bläckberg, M; Cwikiel, M; Gudjonsson, S; Kollberg, P; Liedberg, F; Lyttkens, K; Patschan, O | 1 |
| Kim, JH; Kim, YM; Kim, YT; Lee, HJ; Lee, JJ; Nam, JH; Park, JY | 1 |
| Nation, DA; Yew, B | 1 |
| Geng, L; Wang, T; Wang, W; Yan, S; Ye, YF; Yu, J; Yu, SF; Zheng, SS | 1 |
| Lu, Y; Sanan, P | 1 |
| Almkvist, O; Alongi, P; Bettinardi, V; Cerami, C; Chiotis, K; Gianolli, L; Iaccarino, L; Nordberg, A; Perani, D; Wall, A | 1 |
| Badve, C; Faulhaber, P; Garg, V; Hojjati, M; Rogers, L; Ros, PR; Sloan, A; Tatsuoka, C; Wolansky, LJ | 1 |
| Bao, B; Delaney, J; Groves, K; Ho, G; Kossodo, S; Morin, J; Narayanan, N; Peterson, JD; Rajopadhye, M; Tseng, JC; Zhang, J | 1 |
| Brunken, R; Cerqueira, MD; Culver, DA; Hachamovitch, R; Javed, O; Oldan, JD; Sperry, BW; Tamarappoo, BK | 1 |
| Chang-Halpenny, C; Diehn, M; Eclov, NCW; Gensheimer, MF; Graves, EE; Hara, WY; Hong, JC; Le, QT; Loo, BW; Maxim, PG; Murphy, JD; Neal, JW; Olson, MR; Quon, A; To, J; Wakelee, HA; Zhu, H | 1 |
| Dubois, B; Epelbaum, S; Hampel, H; Levy Nogueira, M; Lista, S; Samri, D; Spies, L; Suppa, P; Teichmann, M | 1 |
| Cho, J; Furumoto, S; Ido, T; Jeong, HJ; Kang, H; Kang, JM; Lee, H; Lee, KM; Lee, SY; Lee, YB; Na, DL; Noh, Y; Okamura, N; Park, KH; Seo, S; Seong, JK; Shin, DH; Villemagne, VL; Woo, SH; Yanai, K; Yeon, BK | 1 |
| Inui, Y; Ito, K; Kato, T | 1 |
| Arnaldi, D; De Carli, F; Dessi, B; Jonsson, C; Leenders, KL; Meles, SK; Morbelli, S; Nobili, F; Pagani, M; Sambuceti, G | 1 |
| Chen, X; Gutknecht, J; Hu, B; Majoe, D; Xie, Y; Yao, Z | 1 |
| Devanand, DP; Kumar, D; Lan, MJ; Mann, JJ; Miller, JM; Ogden, RT; Parsey, RV; Pelton, GH; Pradhaban, G; Rubin-Falcone, H; Stern, Y; Zanderigo, F | 1 |
| Barker, RA; Foltynie, T; Lao-Kaim, NP; Li, W; Loane, C; Martín-Bastida, A; Paul, G; Piccini, P; Politis, M; Roussakis, AA; Valle-Guzman, N; Widner, H | 1 |
| Cook, R; Dey, AK; Eder, L; Gladman, DD; Joshi, AA; Mehta, NN; Siegel, EL | 1 |
| Amthauer, H; Denecke, T; Dreyling, MH; Franzius, C; Kneba, M; Reinke, P; Riess, H; Subklewe, M; Trappe, RU; Zimmermann, H | 1 |
| Braybrooke, JP; Darby, M; Hall, DO; Harvey, JE; Hooper, CE; Lyburn, ID; Masani, V; Maskell, NA; Searle, J; White, P | 1 |
| Barrière, DA; Beaudet, N; Belleville, K; Carpentier, AC; Geraldes, P; Kessai, A; Kirby, K; Lizotte, F; Longpré, JM; Noll, C; Roussy, G; Sarret, P | 1 |
| Barry, CE; Coussens, AK; Esmail, H; Graham, CM; Horswell, S; Lai, RP; Lesosky, M; O'Garra, A; Wilkinson, KA; Wilkinson, RJ | 1 |
| Ballarini, T; Caminiti, SP; Cerami, C; Fallanca, F; Gianolli, L; Iannaccone, S; Magnani, G; Perani, D; Presotto, L; Sala, A; Santangelo, R; Vanoli, EG | 1 |
| Benedet, AL; Gauthier, S; Kang, MS; Massarweh, G; Mathotaarachchi, S; Mohades, S; Park, AY; Pascoal, TA; Rosa-Neto, P; Shin, M; Soucy, JP | 1 |
| Dawson, ET; Drubach, DA; Townley, RA | 1 |
| Ben Bouallègue, F; Mariano-Goulart, D; Payoux, P | 1 |
| Benedet, AL; Gauthier, S; Kang, MS; Mathotaarachchi, S; Nair, V; Ng, KP; Pascoal, TA; Rosa-Neto, P; Shin, M; Struyfs, H; Therriault, J; Walpola, IC | 1 |
| Bersano, E; Cantello, R; Corrado, L; D'alfonso, S; De Marchi, F; Mazzini, L; Sacchetti, GM; Sarnelli, MF; Solara, V; Stecco, A | 1 |
| Alberici, A; Borroni, B; Padovani, A; Paghera, B; Paola Caminiti, S; Perani, D; Pilotto, A; Premi, E; Presotto, L; Turrone, R | 1 |
| Murata, H; Nagashima, Y; Ohtake, M; Tateishi, K; Yamamoto, T; Yamanaka, S | 1 |
| Arnemann, KL; Jagust, WJ; Narayan, S; Rabinovici, GD; Stöber, F | 1 |
| Chan, AT; Chan, CM; Chan, KCA; Hui, EP; Kam, MK; King, A; Leung, SF; Li, L; Lo, YMD; Loong, H; Ma, B; Mo, F; Wang, K; Wong, A; Wong, SCC | 1 |
| Arnaldi, D; Bauckneht, M; Chincarini, A; Efeturk, H; Girtler, N; Grazzini, M; Massa, F; Morbelli, S; Nobili, F; Pagani, M; Pardini, M; Piva, R; Sambuceti, G | 1 |
| Alexander, GE; Bauer, RJ; Caselli, RJ; Chen, K; Chen, Y; Lee, W; Locke, DEC; Reiman, EM; Savage, CR; Sharieff, S; Stonnington, CM; Thiyyagura, P | 1 |
| Liang, X; Liu, Y; Ran, P; Tang, M; Xu, C; Zhu, Y | 1 |
| Abe, T; Bekki, M; Fujimoto, K; Fukumoto, Y; Honda, A; Igata, S; Kurata, S; Nakamura, T; Suda, K; Sugiyama, Y; Sun, J; Tahara, A; Tahara, N; Tanaka, H | 1 |
| Nie, MX; Yan, YF; Zhang, XH; Zhao, QM | 1 |
| Bailly, C; Bodet-Milin, C; Carlier, T; Jamet, B; Kraeber-Bodéré, F; Moreau, P; Planche, L; Touzeau, C | 1 |
| Abdollahi, A; Adeberg, S; Afshar-Oromieh, A; Bendszus, M; Bougatf, N; Debus, C; Debus, J; Floca, R; Haberkorn, U; Heiland, S; Knoll, M; Rieken, S; Waltenberger, M; Wick, W | 1 |
| Gadi, VK; Gralow, J; Jenkins, I; Kinahan, P; Lee, JH; Linden, HM; Mankoff, D; Montgomery, S; Muzi, M; Novakova-Jiresova, A; O'Sullivan, J; Peterson, LM; Shields, A; Specht, JM; Wu, QV | 1 |
| Behen, ME; Chugani, HT; Govil-Dalela, T; Juhász, C; Kumar, A | 1 |
| Belichenko, NP; Chin, FT; Condon, C; James, ML; Kuan, J; Longo, FM; Miao, Z; Semaan, S; Shuhendler, AJ; Simmons, DA | 1 |
| Cai, L; Gao, S; Ji, Y; Li, Y; Shi, Z; Wang, Y; Xing, X; Yang, H; Yao, S; Zhang, N | 1 |
| Bengel, FM; Ross, TL | 1 |
| Baech, J; Cheah, CY; El-Galaly, TC; Gormsen, LC; Lo, A; Villa, D | 1 |
| Brayne, C; Hyde, C; Kelly, S; Lafortune, L; Smailagic, N | 1 |
| Barbour, AP; Burmeister, BH; Burmeister, E; Effeney, R; Harvey, J; Mai, GT; Pryor, DI; Shaw, T; Smithers, BM; Thomas, J | 1 |
| Ambrosini, V; Ardizzoni, A; Comito, F; Melotti, B; Sperandi, F | 1 |
| Kim, HJ; Kim, WC; Koom, WS; Lee, J; Lee, M | 1 |
| Garip-Kuebler, A; Hintschich, C; Klingenstein, A; Mueller-Lisse, UG | 1 |
| Andrews, RD; Cedarbaum, JM; Evans, KC; Even-Sapir, E; Giladi, N; Lerman, H; Lukic, A; Matthews, DC; Mirelman, A; Strother, SC; Wernick, MN | 1 |
| Hu, B; Li, Y; Yao, Z; Zhang, H | 1 |
| Hsiao, IT; Hsu, JL; Huang, SY; Lin, KJ; Liu, HL; Wey, SP | 1 |
| Alessi, S; Bellomi, M; Colleoni, MA; Iorfida, M; Petralia, G; Pricolo, P; Ruju, F; Zugni, F | 1 |
| Biddinger, P; Figueroa, R; Groves, MW; Pucar, D; Williams, HT | 1 |
| Tamam, C; Tamam, M | 1 |
| Blankstein, R; Bravo, PE; Di Carli, MF; Singh, A | 1 |
| Hirota, S; Kadoya, M; Koyama, H; Kurajoh, M; Miyoshi, A; Moriwaki, Y; Nakamoto, Y; Shoji, T; Terada, T; Tsukamoto, Y | 1 |
| Ahn, BC; Jeong, SY; Kim, SJ; Lee, J; Lee, SW; Pak, K | 1 |
| Blazhenets, G; Frings, L; Meyer, PT; Rücker, G; Schiller, F; Sörensen, A | 1 |
| Bauman, JE; Behnia, F; Eaton, KD; Goulart, BHL; Kell, E; Martins, RG; Mulligan, MS; Patel, SA; Romine, PE; Vesselle, HJ; Wallace, SG; Wood, DE | 1 |
| Broski, SM; DeVries, AH; Howe, BM; Spinner, RJ | 1 |
| Arnaldi, D; Bauckneht, M; Brugnolo, A; Chincarini, A; De Carli, F; Didic, M; Dottorini, ME; Drzezga, A; Frisoni, GB; Galluzzi, S; Grazzini, M; Guedj, E; Jonsson, C; Massa, F; Mecocci, P; Morbelli, S; Nobili, F; Ossenkoppele, R; Pagani, M; Pardini, M; Perneczky, R; Sambuceti, G; van Berckel, BNM | 1 |
| Chiang, GC; Fine, HA; Kovanlikaya, I; Magge, R; Naeger, DM; Pisapia, DJ; Seligman, L | 1 |
| Arcolin, M; Bertoldo, A; Dipasquale, O; Expert, P; Fisher, PM; Howes, O; Khan, W; Moro, L; Rizzo, G; Svarer, C; Turkheimer, FE; Veronese, M | 1 |
| Alavi, A; Gerke, O; Høilund-Carlsen, PF; Moghbel, MC | 1 |
| Aiello, M; Chow, K; Cuocolo, A; Dell'Aversana, S; Diomiaiuti, CT; Esposito, R; Galderisi, M; Greiser, A; Imbriaco, M; Losi, M; Nappi, C; Nicolai, E; Pisani, A; Ponsiglione, A; Riccio, E; Spinelli, L | 1 |
| Brice, P; Casasnovas, O; Chen, A; Dercle, L; Ghesquières, H; Houot, R; Manson, G; Mokrane, FZ; Morschhauser, F; Schiano de Colella, JM; Stamatoullas, A | 1 |
| Fujimori, Y; Kashiwagi, T; Kitajima, K; Okada, M; Sawada, A; Tokugawa, T; Yamakado, K; Yoshihara, K; Yoshihara, S | 1 |
| Aikawa, T; Anzai, T; Koyanagawa, K; Oyama-Manabe, N | 1 |
| Cheon, GJ; Chung, JK; Kang, KW; Kim, EE; Koh, Y; Lee, DS; Shagera, QA; Yoo, MY; Yoon, SS | 1 |
| Andreasson, U; Blennow, K; Cullen, NC; Mattsson, N; Zetterberg, H | 1 |
| Doll, C; Duimering, A; Fairchild, A; Ghosh, S; Joseph, K; MacEwan, R; Mulder, K; Nijjar, T; Nijjar, Y; Riauka, T; Schiller, D; Severin, D; Tankel, K; Usmani, N; Warkentin, H; Wong, C | 1 |
| Bennink, RJ; Bijlsma, MF; Creemers, A; Ebbing, EA; Hulshof, MCCM; Jibodh, RA; Krishnadath, KK; Medema, JP; Meijer, SL; Punt, CJA; Steins, A; van Delden, OM; van der Zalm, AP; van Laarhoven, HWM; Waasdorp, C | 1 |
| Bootsma, G; de Booij, M; De Ruysscher, D; Dingemans, AM; Hendriks, LEL; Hofman, P; Houben, R; Schoenmaekers, J; Schreurs, W; Westenend, M | 1 |
| Iaccarino, L; Perani, D; Sala, A | 1 |
| Bakardjian, H; Corsi, MC; De Vico Fallani, F; Diego Sitt, J; Dubois, B; Epelbaum, S; Gagliardi, G; Gaubert, S; Habert, MO; Hermann, B; Houot, M; Naccache, L; Oudiette, D; Raimondo, F | 1 |
| Chen, KL; Cui, M; Dong, Q; Guo, Y; Huang, YY; Li, JQ; Ou, YN; Tan, L; Xu, W; Yu, JT | 1 |
| Bastianello, M; Biafore, F; Depetris, TS; Peralta, C | 1 |
| Altomare, D; Barkhof, F; Caroli, A; Carter, SF; Choo, ILH; Drzezga, A; Ferrari, C; Frisoni, GB; Galluzzi, S; Grimmer, T; Nordberg, A; Ossenkoppele, R; Prestia, A; Redolfi, A; Scheltens, P; Schöll, M; Teunissen, CE; Van Berckel, B; van der Flier, WM; Wall, A | 1 |
| Gambhir, S; Ora, M; Parashar, A; Rangan B K, K; Suraj, AS | 1 |
| Agrawal, A; Mathew, B; Purandare, NC; Puranik, A; Rangarajan, V; Shah, S | 1 |
| Dong, ZR; Li, T; Zhi, XT | 1 |
| Suzawa, N; Taguchi, O; Takao, M; Takeda, K; Yamada, T; Yamakado, K | 1 |
| Bae, SH; Choi, JI; Choi, JY; Chun, HJ; Kim, HY; Lee, HG; Lee, SW; Lee, YJ; Song, DS; Song, MJ; Yoo, IeR; Yoon, SK | 1 |
| Blank, CU; Haanen, JB; Stokkel, MP; van der Hiel, B | 1 |
| Du, Y; Guo, J; Hao, G; Mohan, C; Oz, OK; Sun, X; Zhou, XJ | 1 |
| Laymon, CM; Lieberman, FS; Mountz, JM; Oborski, MJ | 1 |
| Andrade, BB; Cole, S; Hanna, D; Kim, P; Maeurer, M; Schito, M; Wallis, RS; Zumla, A | 1 |
| Goadsby, PJ; Maniyar, FH | 1 |
| Ballet, S; Bini, J; Corot, C; Dickson, SD; Fayad, ZA; Izquierdo-Garcia, D; Klink, A; Lancelot, E; Mateo de Castro, J; Millon, A; Robert, P | 1 |
| Adaszewski, S; Draganski, B; Dukart, J; Frackowiak, RS; Kherif, F; Mueller, K; Schroeter, ML | 1 |
| Ahn, JS; Ahn, MJ; Cho, SH; Choi, JY; Ji, JH; Moon, SH; Park, K; Park, LC; Sun, JM | 1 |
| Chen, W; Dilsizian, V | 1 |
| Hornick, JL; Jagannathan, JP; Ramaiya, NH; Tirumani, SH | 1 |
| Chew, J; Silverman, DH | 1 |
| Buriánková, E; Flodr, P; Formánek, R; Henzlová, L; Indrák, K; Jarošová, M; Kapitáňová, Z; Mysliveček, M; Papajík, T; Procházka, V; Turcsányi, P; Urbanová, R | 1 |
| Bergamini, A; Di Pietro, B; Giurato, L; Masala, S; Meloni, M; Ruotolo, V; Schillaci, O; Uccioli, L | 1 |
| Biermann, M; Bindoff, LA; Gjerde, IO; Haugen, M; Schwarzlmüller, T; Storstein, A; Tran, GT; Tzoulis, C; Vedeler, C | 1 |
| Hickeson, M; Holcroft, C; Makis, W; Nahal, A; Rakheja, R; Skamene, S; Tulbah, R; Turcotte, R | 1 |
| Fioole-Bruining, A; Horenblas, S; Mertens, LS; van Rhijn, BW; Vegt, E; Vogel, WV | 1 |
| Hatashita, S; Yamasaki, H | 1 |
| Brück, A; Helenius, H; Helin, S; Koikkalainen, J; Koivunen, J; Någren, K; Parkkola, R; Rinne, JO; Scheinin, NM; Viitanen, M; Virta, JR | 1 |
| Abdelbaky, A; Brady, TJ; Corsini, E; Ferencik, M; Figueroa, AL; Fontanez, S; Hoffmann, U; Subramanian, S; Tawakol, A | 1 |
| Bai, J; Cao, X; Dai, Z; He, W; Li, Y; Liu, F; Liu, S; Luo, J; Shan, B; Song, J; Zhang, B | 1 |
| Choi, ES; Ha, JH; Ha, SG; Han, I; Kim, HS; Paeng, JC | 1 |
| Case, M; Hake, A; Hochstetler, H; Schuh, K; Sun, J; Trzepacz, PT; Witte, MM; Yu, P | 1 |
| Bille, A; Chicklore, S; Cook, GJ; Landau, D; Lang-Lazdunski, L; Okiror, L; Spicer, J | 1 |
| Baker, M; Bouchard-Kerr, P; Dinelle, K; Feldman, HH; Gonzalez, M; Hsiung, GY; Jacova, C; Lee, H; Mackenzie, IR; McCormick, S; Rademakers, R; Sengdy, P; Sossi, V; Stoessl, AJ; Tawankanjanachot, I | 1 |
| Endo, M; Isaka, M; Kondo, H; Maniwa, T; Nakagawa, K; Ohde, Y; Okumura, T | 1 |
| Ahlskog, JE; Clark, HM; Duffy, JR; Josephs, KA; Sorenson, EJ; Whitwell, JL | 1 |
| Alfieri, RR; Ardizzoni, A; Bartolotti, M; Bordonaro, R; Bortesi, B; Bruzzi, P; Caffarra, C; Cavazzoni, A; Cosentino, S; Fumarola, C; Ippolito, M; Latteri, F; Petronini, PG; Ruffini, L; Scarlattei, M; Soto Parra, HJ; Spadaro, P; Tiseo, M | 1 |
| Alonso-Farto, JC; de Vega, VM; Fayad, ZA; Fernández-Friera, L; Fernández-Ortiz, A; Fuster, V; García, L; Guallar, E; Ibañez, B; Jiménez-Borreguero, LJ; Laclaustra, M; López-Melgar, B; Mendiguren, JM; Mocoroa, A; Molina, J; Ordovás, JM; Peñalvo, JL; Rudd, JH; Sanz, G; Sillesen, H | 1 |
| Abdelbaky, A; Brady, TJ; Corsini, E; Figueroa, AL; Grinspoon, SK; Hoffmann, U; Lavender, ZR; Lawler, MA; MacNabb, MH; Nasir, K; Tawakol, A; Truong, QA | 1 |
| Bartenstein, P; Brendel, M; Ewers, M; Rizk-Jackson, A; Rominger, A; Schuff, N; Weiner, MW | 1 |
| Eom, HS; Kang, SH; Kim, SK; Kim, TS; Kim, YI; Lee, H; Park, WS; Yun, T | 1 |
| MacRae, R; Nair, VJ; Pantarotto, JR; Sirisegaram, A | 1 |
| Bode, M; Hänninen, T; Kaivorinne, AL; Moilanen, V; Remes, AM; Suhonen, NM; Takalo, R | 1 |
| Beale, T; Bomanji, J; Dileo, P; Frezza, AM; Jay, A; Kalavrezos, N; Strauss, SJ; Whelan, J | 1 |
| Fung, SL; Ho, JC; Lee, EY; Wong, CS; Yan, PK | 1 |
| Hagihara, M; Hattori, Y; Ishigatsubo, Y; Ishii, Y; Ishiyama, Y; Tateishi, U; Tomita, N; Yamamoto, E; Yamazaki, E | 1 |
| Babicky, ML; French, RP; Hoh, CK; Jaquish, DV; Leonard, SY; Lowy, AM; Mose, ES; Peterson, M; Schwab, R; Sicklick, JK; Tang, CM | 1 |
| Boon, NA; Chin, CW; Cowie, WJ; Dweck, MR; Fletcher, A; Jenkins, WS; Malley, TS; Newby, DE; Pessotto, R; Pringle, MA; Richardson, H; Rudd, JH; Tsampasian, V; van Beek, EJ; Vesey, AT; Wallace, WA | 1 |
| Arai, H; Chiba, Y; Fujishiro, H; Iseki, E; Kasanuki, K; Manabe, Y; Murayama, N; Ota, K; Sato, K | 1 |
| Agu, O; Brookes, J; Ganeshan, B; Groves, AM; Kotze, CW; Menezes, LJ; Rudd, JHF; Yusuf, SW | 1 |
| Apostolova, I; Brenner, W; Buchert, R; Derlin, T; Hofheinz, F; Köhler, C; Marnitz, S; Michel, R; Prasad, V; Rosner, C; Steffen, IG | 1 |
| Cao, Q; Chen, W; Dilsizian, V; Goloubeva, O; Hersl, J; Jenkins, J; Jones, L; La, H; Smith, M; Tkaczuk, K | 1 |
| Arnold, SE; Chen, K; Da, X; Davatzikos, C; Jack, C; Jagust, W; Reiman, EM; Shaw, LM; Toledo, JB; Trojanowski, JQ; Weiner, MW; Wolk, DA | 1 |
| Lv, WF; Wang, SC; Xie, Q | 1 |
| Assié, G; Libé, R | 1 |
| Conejero-Goldberg, C; Davies, P; Goldberg, TE; Gomar, JJ | 1 |
| Camp, A; Delpassand, ES; Erion, JL; Espenan, GD; Hamiditabar, M; Krenning, EP; Kvols, LK; Mojtahedi, A; O'Dorisio, TM; Samarghandi, A; Simon, J; Wolfangel, R; Wolin, EM; Zamanian, S | 1 |
| Bluemel, C; Buck, AK; Germer, CT; Herrmann, K; Wiegering, A | 1 |
| Coleman, MT; Fillmore, D; Frye, LJ; Janssen, C; Klein, E; Lin, PL; Maiello, P; Tomko, J | 1 |
| Arzu, I; Dabaja, BS; Fayad, LE; Hagemeister, FB; Hess, K; Kedir, A; Mawlawi, O; Medeiros, LJ; Oki, Y; Podoloff, DA; Reed, VK; Rodriguez, A; Shihadeh, F; Wogan, CF | 1 |
| Herben-Dekker, M; Jurgens, CK; Kremer, HP; Leenders, KL; Roos, RA; Spikman, JM; van Oostrom, JC; Witjes-Ané, MN | 1 |
| Ball, DL; Binns, D; Callahan, J; Collins, M; Everitt, SJ; Herschtal, A; Hicks, RJ; Kron, T; MacManus, M; Plumridge, N; Schneider, M | 1 |
| Chetaille, B; Colavolpe, C; Coso, D; Ebbo, M; Franques, J; Gastaud, L; Guedj, E; Khibri, H; Ouvrier, MJ; Schleinitz, N; Trousse, D | 1 |
| Aftimos, P; Awada, A; Charette, N; Deleporte, A; Engelholm, JL; Flamen, P; Garcia, C; Hendlisz, A; Hoerner, F; Lemort, M; Machiels, G; Paesmans, M; Piccart, M; Vandeputte, C | 1 |
| Becker, JA; Johnson, KA; Locascio, JJ; Lorius, N; Marshall, GA; Pepin, LC; Philiossaint, M; Rentz, DM; Roy, K; Sperling, RA | 1 |
| Doran, MG; Fareedy, SB; Gavane, S; Osborne, JR; Spratt, DE; Tarlinton, L; Zelefsky, MJ | 1 |
| Hendel, HW; Høgdall, EV; Jensen, BV; Johannesen, HH; Nielsen, D; Schou, JV; Skougaard, K | 1 |
| Boutoleau-Bretonnière, C; Camus, V; Delrieu, J; Desmidt, T; Lebouvier, T; Mullin, E; Payoux, P; Sourdet, S; Vellas, B | 1 |
| Belsack, D; Buls, N; de Mey, J; Everaert, H; Ilsen, B; Ros, PR; Vandemeulebroucke, J; Vandenbroucke, F; Verdries, D | 1 |
| Chaudhari, AJ; Datta-Mitra, A; Kundu-Raychaudhuri, S; Mitra, A; Raychaudhuri, SP | 1 |
| Albin, RL; Dodge, HH; Harvey, D; Kaye, JA; Koeppe, RA; Saito, N; Silbert, LC; Zhu, J | 1 |
| Bergquist, A; Karlson, BM; Rasmussen, I; Rorsman, F; Sangfelt, P; Sundin, A; Wanders, A | 1 |
| Duffy, JR; Gunter, JL; Jack, CR; Josephs, KA; Lowe, VJ; Machulda, MM; Reid, RI; Schwarz, CG; Senjem, ML; Spychalla, AJ; Strand, EA; Whitwell, JL | 1 |
| Bertens, D; Knol, DL; Scheltens, P; Visser, PJ | 1 |
| Jung, KH; Lee, JH; Lee, KH; Lee, SJ; Paik, JY; Park, JW; Thien Quach, CH | 1 |
| Kollias, SS; Maggio, EM; Purohit, B; Winder, T | 1 |
| Hatanaka, KC; Hirotani, M; Kano, T; Matsushima, M; Minami, N; Nakamichi, K; Nonaka, T; Saijo, M; Sasaki, H; Sasamori, T; Sato, K; Shiga, T; Shimizu, Y; Shirai, S; Takahashi, I; Tanaka, S; Yabe, I | 1 |
| Bahri, H; Boucher, E; Clement, B; Cuggia, M; Devillers, A; Edeline, J; Garin, E; Laurence, L; Leghzali, H; Mesbah, H; Raoul, JL | 1 |
| Beech, P; Cherk, MH; Kalff, V; Patil, S | 1 |
| Bhojwani, D; Choi, JK; Davidoff, AM; Gold, R; Inaba, H; McCarville, MB; Metzger, ML; Sandlund, JT; Sawyer, J; Shulkin, BL | 1 |
| Hagiwara, S; Hirai, R; Inoue, T; Ishiwata, K; Ito, K; Kubota, K; Minamimoto, R; Miwa, A; Miyata, Y; Morooka, M; Okasaki, M; Toyohara, J | 1 |
| Backes, H; Endepols, H; Graf, R; Himmelreich, U; Mertgens, H; Mies, G; Neumaier, B | 1 |
| Bodner, WR; Garg, MK; Gucalp, R; Guha, C; Keller, SM; Ohri, N; Perez-Soler, R; Piperdi, B | 1 |
| Almkvist, O; Kadir, A; Nordberg, A | 1 |
| Abdelbaky, A; Corsini, E; Emami, H; Figueroa, AL; Fontanez, S; Hoffmann, U; Narula, J; Subramanian, S; Tawakol, A | 1 |
| Carrió, I; Domenech, A; Escalera, S; Sampedro, F | 1 |
| Baruch, A; Emami, H; Fayad, ZA; Figueroa, AL; Fredrickson, J; Hoffmann, U; Korsgren, M; Lavender, Z; Lehrer-Graiwer, J; MacNabb, M; Min, JK; Nahrendorf, M; Nasir, K; Rubin, B; Rudd, JH; Singh, P; Tawakol, A; Truong, QA; Vucic, E | 1 |
| Djaldetti, R; Lotan, I; Luckman, J; Siegal, T; Steiner, I | 1 |
| Arahata, Y; Fujiwara, K; Fukuyama, H; Ikeda, M; Ishii, K; Ito, K; Kato, T; Maeda, K; Meguro, K; Mitsuyama, Y; Okumura, A; Ouchi, Y; Senda, M; Washimi, Y; Yamamoto, Y | 1 |
| Arnaldi, D; Brugnolo, A; Buschiazzo, A; Chincarini, A; De Carli, F; Didic, M; Drzezga, A; Ferrara, M; Frisoni, GB; Galluzzi, S; Guedj, E; Morbelli, S; Nobili, F; Öberg, J; Ossenkoppele, R; Pagani, M; Perneczky, R; Picco, A; Sambuceti, G; van Berckel, BN | 1 |
| Cappa, SF; Cerami, C; Della Rosa, PA; Magnani, G; Marcone, A; Perani, D; Santangelo, R | 1 |
| Hyde, C; Martin, S; Sachpekidis, C; Smailagic, N; Ukoumunne, O; Vacante, M | 1 |
| Barkhof, F; Caroli, A; Carter, SF; Choo, IH; Frisoni, GB; Nordberg, A; Ossenkoppele, R; Prestia, A; Scheltens, P; Schöll, M; Teunissen, CE; Van Berckel, B; van der Flier, WM; Wade, SK; Wall, A | 1 |
| Baumann, S; Browning, CM; Craft, JF; Renker, M; Schoepf, UJ | 1 |
| Huber, GF; Hüllner, M; Kollias, S; Meerwein, CM; Queiroz, M; Veit-Haibach, P | 1 |
| Baek, H; Byun, MS; Choe, YM; Choi, HJ; Han, JY; Lee, DY; Lee, JH; Sohn, BK; Woo, JI; Yi, D | 1 |
| Galluzzo, A; Hayano, K; Sahani, DV; Zhu, AX | 1 |
| Fukao, K; Hamada, T; Kubo, N; Kuge, Y; Nakano, T; Shimizu, Y; Tamaki, N; Ukon, N; Watanabe, A; Yamasaki, K; Zhao, S; Zhao, Y | 1 |
| Peller, PJ | 1 |
| Kim, J; Lee, JM; Park, H; Seo, J; Son, SJ | 1 |
| Bartenstein, P; Habs, M; Hacker, M; Hetterich, H; Reiser, MF; Rominger, A; Saam, T; Volpers, S; Walter, L | 1 |
| Boerman, OC; Gerrits, D; Laverman, P; Metselaar, JM; Storm, G; van der Geest, T; van Lent, PL | 1 |
| Biersack, HJ; Buermann, J; Essler, M; Gärtner, FC; Skowasch, D | 1 |
| Cho, YH; Choi, DL; Jang, HY; Jang, JY; Jeong, SW; Kim, BS; Kim, HS; Kim, MJ; Kim, SG; Kim, YS; Lee, JM; Lee, MH; Lee, SH; Lee, WH; Park, JM; Song, JY | 1 |
| Allen, PJ; Cercek, A; Correa-Gallego, C; D'Angelica, MI; DeMatteo, RP; Fong, Y; Gavane, S; Gewirtz, AN; Grewal, R; Jarnagin, WR; Kemeny, N; Kingham, TP; Klimstra, DS | 1 |
| Eigentler, T; Pfannenberg, C; Schüle, SC | 1 |
| Borsi, E; Brioli, A; Cavo, M; Fanti, S; Mancuso, K; Martello, M; Marzocchi, G; Nanni, C; Pantani, L; Pezzi, A; Rambaldi, I; Rizzello, I; Rocchi, S; Tacchetti, P; Terragna, C; Zamagni, E; Zannetti, B | 1 |
| Dershaw, DD; Gibbons, G; Goldman, DA; Jochelson, MS; Morris, EA; Moskowitz, CS; Sutton, EJ; Watson, EJ | 1 |
| Guckenberger, M | 1 |
| Asami, Y; Hama, M; Ihata, A; Ishigatsubo, Y; Kamiyama, R; Kirino, Y; Kishimoto, D; Kunishita, Y; Ohno, S; Suda, A; Takase-Minegishi, K; Takeno, M; Tateishi, U; Ueda, A; Watanabe, T; Yoshimi, R | 1 |
| Ichimura, K; Kaji, M; Kanazawa, S; Mitsuhashi, T; Miyoshi, S; Sato, S; Shinya, T; Soh, J; Tanaka, T; Toyooka, S | 1 |
| Grothe, MJ; Krause, B; Kurth, J; Teipel, SJ | 1 |
| Bockisch, A; Bossone, E; Eggebrecht, H; Erbel, R; Gorla, R; Jakob, H; Jánosi, RA; Kahlert, P; Kuehl, H; Mahabadi, AA; Schlosser, T; Tsagakis, K | 1 |
| Kebebew, E; Summers, RM; Wong, KC; Yao, J | 1 |
| Kaneko, T; Kobayashi, T; Okamura, K; Okura, C; Takagishi, K; Takeuchi, K; Tsushima, Y; Yonemoto, Y | 1 |
| Bilska, K; Chaber, R; Drabko, K; Dziuk, M; Michalak, E; Muszyńska-Rosłan, K; Pogorzała, M; Połczyńska, K; Raciborska, A; Rodriguez-Galindo, C; Rychlowska-Pruszyńska, M; Sobol, G; Wieczorek, M | 1 |
| Jacene, H; Munshi, NC; Ramaiya, NH; Sakellis, C; Shinagare, AB; Tirumani, SH; Van den Abbeele, AD | 1 |
| Brekke, N; Fonnes, T; Haldorsen, IS; Kopperud, R; Krakstad, C; McCormack, E; Pavlin, T; Popa, M; Rygh, CB; Salvesen, HB; Visser, NC | 1 |
| Carapella, CM; Chiaravalloti, A; Fabi, A; Floris, R; Marzi, S; Pace, A; Piludu, F; Schillaci, O; Terrenato, I; Vidiri, A; Villani, V | 1 |
| Alongi, P; Evangelista, L; Gianolli, L; Picchio, M; Saladini, G; Spallino, M; Zattoni, F | 1 |
| Adams, HJ; de Klerk, JM; Dubois, SV; Fijnheer, R; Heggelman, BG; Kwee, TC; Nievelstein, RA | 1 |
| Fukuyama, H; Ito, K; Oishi, N; Ota, K | 2 |
| Bohlen, S; Deppe, M; Gigengack, F; Hermann, S; Hölzner, E; Jacobs, AH; Kugel, H; Lippross, V; Lücke, M; Nguyen, HP; Osada, N; Reilmann, R; Riess, O; Schäfers, K; Schäfers, M; Von Hörsten, S | 1 |
| Boon, NA; Brown, OS; Cartlidge, TR; Chin, CW; Dweck, MR; Fletcher, A; Jenkins, WS; McKillop, G; Mitchell, AJ; Newby, DE; Pawade, TA; Pessotto, R; Pringle, MA; Rudd, JH; Shah, AS; Van Beek, EJ; Vesey, AT; White, AC | 1 |
| Caminiti, SP; Cappa, SF; Cerami, C; Comi, G; Coppi, E; Falini, A; Ferrari, L; Gianolli, L; Iannaccone, S; Magnani, G; Passerini, G; Perani, D; Pinto, P; Santangelo, R | 1 |
| Cho, A; Keum, KC; Lee, CS; Lee, JH; Lee, SC; Suh, YG | 1 |
| Alexander, DC; Ourselin, S; Oxtoby, NP; Schott, JM; Young, AL | 1 |
| Borghammer, P; Lassen-Ramshad, Y; Mahajan, A; McGovern, SL; Petersen, JB; Tietze, A | 1 |
| Alongi, P; Caobelli, F; Castello, A; Cocciolillo, F; Crivellaro, C; De Biasi, V; Dolci, C; Evangelista, L; Geatti, O; Kirienko, M; Laghai, I; Picchio, M; Popescu, CE; Quartuccio, N; Rensi, M; Saladini, G; Seghezzi, S | 1 |
| Dankbaar, JW; De Keizer, B; Eppinga, W; Hendrikse, J; Robe, PA; Seute, T; Snijders, TJ | 1 |
| Benali, H; Bertin, H; Brice, A; Caroppo, P; Colliot, O; Corvol, JC; Deramecourt, V; Didic, M; Dubois, B; Durrleman, S; Edouart, G; Funkiewiez, A; Gaubert, M; Habert, MO; Hahn, V; Hannequin, D; Le Ber, I; Lehericy, S; Lejeune, P; Pasquier, F; Perlbarg, V; Rivaud-Pechoux, S; Routier, A; Valabregue, R; Vercelletto, M | 1 |
| Baseggio, L; Conte, MJ; Dupuis, JM; Itti, E; Michallet, AS; Rabe, KG; Salles, G; Sesques, P; Subtil, F; Tordot, J; Tychyj-Pinel, C | 1 |
| Hara, R; Kanetaka, T; Kikuchi, M; Mori, M; Nishimura, K; Nozawa, T; Sakurai, N; Yamazaki, K; Yokota, S | 1 |
| Hirayama, K; Karbwang, J; Matsuda, N; Na-Bangchang, K; Plengsuriyakarn, T; Viyanant, V | 1 |
| Boeve, BF; Gunter, JL; Jack, CR; Jones, DT; Kantarci, K; Knopman, DS; Lowe, VJ; Lundt, ES; Machulda, MM; Mielke, MM; Petersen, RC; Roberts, RO; Senjem, ML; Vemuri, P; Weigand, SD; Wiste, HJ | 1 |
| Bruls, S; Courtois, A; Defraigne, JO; Delvenne, P; Hustinx, R; Moutschen, M; Nusgens, B; Sakalihasan, N | 1 |
| Cho, A; Kang, WJ; Lee, JD; Lee, JW; Lyu, CJ; Yun, M | 1 |
| Balma, M; Bellò, M; Carobolante, F; Cavo, M; Chauviè, S; Dimitrakopoulou-Strauss, A; Fanti, S; Fard, N; Gamberi, B; Gay, F; Ghedini, P; Hillengass, J; Magarotto, V; Mancuso, K; Marzocchi, G; Musto, P; Nanni, C; Offidani, M; Palumbo, A; Pantani, L; Patriarca, F; Pezzi, A; Rambaldi, I; Rensi, M; Rocchi, S; Storto, G; Tacchetti, P; Versari, A; Zamagni, E; Zannetti, B | 1 |
| Brooks, DJ; Edison, P; Fan, Z; Okello, AA | 1 |
| Brink, C; Hansen, O; Pan, Y; Petersen, H; Schytte, T; Wu, YL | 1 |
| Cao, KJ; Chen, QY; Chen, WH; Fan, W; Guo, L; Guo, SS; Guo, X; Liu, LT; Mai, HQ; Qian, CN; Tang, LQ; Xie, D; Zeng, MS; Zhang, L; Zhang, X; Zhao, C | 1 |
| Castiglioni, I; Zippo, AG | 1 |
| Chen, S; Jie, B; Liu, M; Shen, D; Zhang, D; Zu, C | 1 |
| Brenner, W; Buchert, R; Frings, L; Lange, C; Spies, L; Suppa, P | 1 |
| Alexopoulos, P; Drzezga, A; Förster, S; Förstl, H; Goldhardt, O; Grimmer, T; Kurz, A; Ortner, M; Sorg, C; Wutz, C | 1 |
| Bertolino, A; Dukart, J; Sambataro, F | 1 |
| Albert, NL; Bartenstein, P; Boeck, S; Fendler, WP; Heinemann, V; Ilhan, H; Lehner, S; Michl, M; Paprottka, PM | 1 |
| Alberini, JL; Boisgard, R; Dollé, F; Guillermet, S; Jego, B; Kühnast, B; Maroy, R; Menet, E; Rezaï, K; Siquier, K; Tavitian, B; Thézé, B; Urien, S | 1 |
| Disselhorst, JA; Divine, MR; Katiyar, P; Kohlhofer, U; Pichler, BJ; Quintanilla-Martinez, L | 1 |
| Clavero, P; García-García, D; Gasca-Salas, C; Obeso, JA; Rodríguez-Oroz, MC | 1 |
| Cho, BC; Keum, KC; Kim, KH; Lee, CG; Lee, J; Roh, YH; Yoon, HI; Yun, M | 1 |
| Cunningham, I; Kohno, B | 1 |
| An, YS; Jeong, SH; Kang, DR; Kim, J; Kwon, SH; Lee, HW; Lee, SJ; Yoon, JK | 1 |
| Bentzen, SM; Fischer, BM; Klausen, TL; Langer, SW; Lonsdale, MN; Nygård, L; Persson, GF; Vogelius, IR | 1 |
| Bradley, KM; di Carlo, S; Findlay, JM; Franklin, JM; Gillies, RS; Gleeson, FV; Jones, GE; Maynard, ND; Middleton, MR; Teoh, EJ | 1 |
| Kim, CK; Park, BK; Park, JJ | 1 |
| Chen, K; Guo, X; Li, R; Long, Z; Wu, X; Xu, L; Yao, L; Zhang, J | 1 |
| Bomanji, JB; Brown, J; Capitanio, A; Carroll, B; Falzon, M; Fraioli, F; George, PJ; Groves, AM; Janes, SM; Kayani, I; Navani, N; Smith, LJ; Thakrar, RM | 1 |
| Adams, HJ; Kwee, TC | 1 |
| Abe, T; Fukumoto, Y; Sasaki, M; Tahara, N; Ueno, T | 1 |
| Boellaard, R; Bossuyt, PM; Dekken, HV; Hagen, PV; Heijl, MV; Henegouwen, MI; Hoekstra, OS; Kate, FJ; Lanschot, JJ; Sloof, GW | 1 |
| Bascuñana, P; Delgado, M; Fernández de la Rosa, R; García-García, L; Javela, J; Pozo, MÁ; Shiha, AA | 1 |
| Alavi, A; Bural, GG; Rubello, D; Torigian, D | 1 |
| Bi, GC; Fang, Y; Li, XM; Liang, Y; Liu, Y; Wu, N; Zhang, DS; Zhang, WJ; Zheng, R | 1 |
| Badawi, RD; Boone, JM; Chaudhari, AJ; Ferrero, A; Godinez, F; Hunter, JC; Naguwa, SM; Raychaudhuri, SP; Shelton, DK; Yang, K | 1 |
| Balogova, S; Calzada, M; Cassou-Mounat, T; Devaux, JY; Garderet, L; Huchet, V; Kerrou, K; Mohty, M; Nataf, V; Talbot, JN | 1 |
| Aisen, PS; Donohue, MC; Insel, PS; Jagust, WJ; Mackin, RS; Mattsson, N; Nosheny, RL; Schöll, M; Tosun, D; Weiner, MW | 1 |
| Andrzejewski, P; Baltzer, P; Georg, D; Georg, P; Grimm, C; Helbich, TH; Karanikas, G; Mitterhauser, M; Pinker, K; Poetter, R; Polanec, SH; Polterauer, S; Sturdza, A; Wadsak, W | 1 |
| Kitamura, K; Nagamachi, S; Nakamura, K; Nishimura, M; Tsuruda, T | 1 |
| Cao, H; Chen, X; Gao, R; Han, D; Reid, S; Wang, R; Zhou, Y | 1 |
| Higo, T; Ikeda, S; Ohtani, K; Uwatoku, T | 1 |
| Bleeker-Rovers, CP; de Geus-Oei, LF; Hermsen, R; Hoppenreijs, EP; IJland, MM; Mooij, CF | 1 |
| Balm, R; Indrakusuma, R; Jalalzadeh, H; Koelemay, MJ; Legemate, DA; Planken, RN | 1 |
| Cho, KJ; Choi, SH; Kim, JS; Kim, SY; Lee, JH; Nam, SY; Roh, JL; Ryu, IS | 1 |
| De Deyn, PP; Dierckx, RA; Sanchez, MA; Sanchez-Catasus, CA; Stormezand, GN; van Laar, PJ | 1 |
| Arnaldi, D; Bauckneht, M; Brugnolo, A; Buschiazzo, A; Chincarini, A; Giuliani, A; Morbelli, S; Nobili, F; Öberg, J; Pagani, M; Picco, A; Sambuceti, G | 1 |
| Kawasaki, H; Koyama, K; Nagai, H; Sasaki, K; Sato, M; Yoshimi, F | 1 |
| Bouchelouche, K; Bøtker, HE; Flyvbjerg, A; Harms, HJ; Iversen, P; Jorsal, A; Nielsen, R; Sørensen, J; Tolbod, L; Wiggers, H | 1 |
| Chiang, GC; Ferraro, R; Galla, N; Kovanlikaya, I | 1 |
| Sharma, P | 1 |
| Barry Iii, CE; Coussens, AK; Esmail, H; Flynn, JL; Graham, CM; Koegelenberg, CF; Lai, RP; Lesosky, M; O'Garra, A; Oni, T; Said-Hartley, Q; Walzl, G; Warwick, JM; Wilkinson, KA; Wilkinson, RJ; Young, DB | 1 |
| Ahn, JS; Ahn, MJ; Cho, YS; Kim, BT; Kim, HS; Lee, KH; Moon, SH; Park, K; Sun, JM | 1 |
| Anderson, TM; Cai, K; Knuttinen, MG; Kumar, N; Lu, H; Lu, Y; Mehta, R | 1 |
| Arai, H; Chiba, Y; Fujishiro, H; Hirayasu, Y; Iseki, E; Kasanuki, K; Kondo, D; Murayama, N; Ota, K; Sato, K | 1 |
| Cappa, SF; Cerami, C; Dodich, A; Greco, L; Iannaccone, S; Magnani, G; Marcone, A; Pelagallo, E; Perani, D; Santangelo, R | 1 |
| Bom, HS; Cho, SG; Jabin, Z; Jeong, GC; Kang, SR; Kim, J; Kim, YJ; Kwon, SY; Min, JJ; Park, KS; Seon, HJ; Song, HC; Song, M | 1 |
| Fayad, ZA; Ishai, A; Joseph, P; Kallend, D; Mani, V; Rudd, JH; Tawakol, A | 1 |
| Ko, CL; Ko, KY; Liu, CJ; Yen, RF | 1 |
| Gunn, RN; Janisch, R; Khan, S; Matthews, PM; Orchard, TR; Rabiner, EA; Russo, EA; Taylor, SA | 1 |
| Anile, G; Banna, GL; Calcara, G; Castaing, M; Fraggetta, F; Gieri, S; Ippolito, M; Marletta, F; Nicolosi, M; Patanè, D; Russo, G; Spina, R; Stefano, A; Strano, S; Vigneri, P | 1 |
| Baldwin, N; Flynn, JL; Gideon, HP; Lin, PL; Skinner, JA | 1 |
| Balzarotti, M; Cabrera, ME; Ceriani, L; Chiappella, A; Cunningham, D; Ferreri, AJ; Giovanella, L; Gospodarowicz, MK; Guarini, A; Johnson, PW; Martelli, M; Ricardi, U; Stelitano, C; Zinzani, PL; Zucca, E | 1 |
| Bikas, A; Burman, KD; Desale, S; Garcia, CA; Singh, I; Wartofsky, L | 1 |
| Kaneko, T; Kobayashi, T; Okamura, K; Okura, C; Suto, T; Tachibana, M; Takagishi, K; Tsushima, Y; Yonemoto, Y | 1 |
| Fujihata, S; Kitagami, H; Kondo, Y; Miyai, H; Nonoyama, K; Shimizu, Y; Tanaka, M; Watanabe, K; Yamamoto, M; Yasuda, A | 1 |
| Abuodeh, Y; Ahmed, KA; Anaya, DA; Biebel, B; Choi, J; El-Haddad, G; Frakes, JM; Hoffe, SE; Kim, R; Kim, Y; Kis, B; Malafa, M; Naghavi, AO; Sweeney, J; Venkat, PS | 1 |
| Akhtari, M; Chuang, H; Dabaja, BS; Dong, W; Fanale, M; Garg, N; Gunther, JR; Khoury, JD; Mawlawi, O; Milgrom, SA; Oki, Y; Osborne, EM; Pinnix, CC; Reddy, JP; Rohren, E; Smith, GL; Suki, T; Yehia, ZA | 1 |
| Bodner, WR; Cheng, H; Garg, M; Halmos, B; Kalnicki, S; Keller, SM; Ohri, N; Perez-Soler, R | 1 |
| Abria, C; Chaudhari, AJ; Kundu-Raychaudhuri, S; Mitra, A; Raychaudhuri, SP; Rona, A | 1 |
| Brunner, TB; Hawkins, MA; Mukherjee, S; Partridge, M; Wilson, JM | 1 |
| Alegret, M; Assal, F; Austin, M; Balasa, M; Bastin, C; Bocchetta, M; Bosco, P; Bougea, A; Chincarini, A; Collins, DL; Duchesne, S; Emek-Savaş, DD; Engelborghs, S; Ferrari, C; Frisoni, GB; Galluzzi, S; Grimmer, T; Grosu, G; Kramberger, MG; Lawlor, B; Mandic Stojmenovic, G; Maréchal, B; Marinescu, M; Mecocci, P; Mega, A; Molinuevo, JL; Morais, R; Niemantsverdriet, E; Nobili, F; Ntovas, K; O'Dwyer, S; Paraskevas, GP; Pelini, L; Picco, A; Popovic, KS; Redolfi, A; Roche, A; Salmon, E; Santana, I; Sensi, F; Sotolongo-Grau, O; Spiru, L; Stefanova, E; Tsolaki, M; Wolz, R; Yener, GG; Zekry, D | 1 |
| Accardo, J; Arnaldi, D; Bauckneht, M; Bongioanni, F; Chincarini, A; De Carli, F; Girtler, N; Giuliani, A; Jonsson, C; Morbelli, S; Nobili, F; Öberg, J; Pagani, M; Sambuceti, G | 1 |
| Au, WY; Khong, PL; Kwong, YL; Liang, R; Pang, CB | 1 |
| Barrie, M; Chinot, O; Colavolpe, C; Figarella-Branger, D; Guedj, E; Metellus, P; Mundler, O | 1 |
| Berghold, A; Enzinger, C; Fazekas, F; Kolassa, H; Ofner, P; Pendl, B; Ropele, S; Schmidt, H; Schmidt, R; Windisch, M | 1 |
| Cheson, BD | 1 |
| Fletcher, JW; Jennings, SG; Sandrasegaran, K; Tann, M; Welling, ME; Winer-Muram, HT | 1 |
| Fu, Z; Hu, M; Li, M; Liu, N; Shi, F; Yang, G; Yu, J; Yuan, S; Zhang, P | 1 |
| Chinaglia, D; Finocchiaro, G; Guerra, U; Maderna, E; Nappini, S; Pareyson, D; Pollo, B; Salsano, E; Savoiardo, M | 1 |
| Bruno, G; Lenzi, GL; Talarico, G; Tosto, G | 1 |
| Castelnovo, G; Collombier, L; Labauge, P; Laplanche, JL; Remy, A; Renard, D | 1 |
| Kostakoglu, L | 1 |
| Badimon, JJ; Buchsbaum, MS; Fayad, ZA; Fuster, V; Helft, G; Liew, GY; Machac, J; Tang, C; Worthley, MI; Worthley, SG; Zaman, AG; Zhang, ZY | 1 |
| Gu, ZX; Wei, WS; Yuan, Y | 1 |
| van der Laarse, A; van der Wall, EE | 1 |
| Ishii, H; Ishikawa, H; Meguro, K; Tashiro, M; Yamaguchi, S | 1 |
| Boersma, L; Bootsma, G; De Ruysscher, D; Dingemans, AM; Fatah, SA; Geraedts, W; Grutters, J; Hochstenbag, M; Lambin, P; Oellers, M; Pitz, C; Simons, J; Snoep, G; van Loon, J; Wanders, R | 1 |
| Benhattar, J; Delaloye, AB; Elsig, V; Guillou, L; Leyvraz, S; Luthi, F; Michielin, O; Montemurro, M; Orcurto, MV; Prior, JO; Stupp, R | 1 |
| Hamlin, PA; Hoppe, BS; Maragulia, JC; Moskowitz, CH; Reiner, AS; Rice, RD; Yahalom, J; Zelenetz, AD; Zhang, Z | 1 |
| Aresi, A; Bizzi, A; Giovagnoli, AR; Gobbo, C; Reati, F; Riva, A | 1 |
| Reske, SN | 1 |
| Dedeckova, K; Dietlein, M; Eich, HT; Engert, A; Klaskova, K; Kobe, C; Kozak, T; Markova, J; Plütschow, A; Skopalova, M | 1 |
| Denecke, T; Rothe, JH; Röttgen, R | 1 |
| Aalto, S; Bergman, J; Brück, A; Marttila, R; Rauhala, E; Rinne, JO | 1 |
| Morita, N; Nishitani, H; Otomi, Y; Otsuka, H; Terazawa, K; Yamashita, K | 1 |
| Bardet, S; Couturier, O; Hotta, T; Hutchings, M; Lau, J; Nagai, H; Nihashi, T; Terasawa, T | 1 |
| Belloli, S; Bellone, M; Fazio, F; Freschi, M; Hess Michelini, R; Jachetti, E; Lecchi, M; Moresco, RM; Picchio, M; Valtorta, S | 1 |
| Barrio, JR; Huang, SC; Kepe, V; Petric, A; Satyamurthy, N; Small, GW | 1 |
| Bou-Assaly, W; Broski, SM; Fig, LM; Gross, MD | 1 |
| Fields, R; McWhorter, A; Mercante, DE; Nuss, D; Pou, AM; Rabalais, AG; Walvekar, R; Wood, C | 1 |
| Hatano, E; Higashi, T; Ikai, I; Iwaisako, K; Kitamura, K; Nakajima, A; Nakamoto, Y; Seo, S; Tada, M; Tamaki, N; Uemoto, S | 1 |
| Guan, YS; Luo, ZM; Pan, WM; Su, XH; Sun, L; Wei, JH; Wu, H; Zhao, L | 1 |
| Aoki, K; Hirata, M; Hyodo, T; Miyagawa, M; Mochizuki, T; Murakami, M; Sugawara, Y; Tanji, N; Tsuda, T; Yanagihara, Y; Yokoyama, M | 1 |
| Endres, C; Hidalgo, M; Jacene, H; Jimeno, A; Laheru, D; Ma, WW; Messersmith, WA; Pomper, MG; Song, D; Vilardell, F; Wahl, R | 1 |
| Grutters, JC; Keijsers, RG; van den Bosch, JM; van Diepen, DM; Verzijlbergen, JF | 1 |
| Cross, DJ; Galasko, D; Minoshima, S; Peskind, ER; Petrie, EC; Raskind, MA; Schellenberg, GD | 1 |
| Chatzikonstantinou, A; Hennerici, MG; Kern, R; Ottomeyer, C; Szabo, K | 1 |
| Boucher, E; Bouriel, C; Cuggia, M; de Lajarte-Thirouard, AS; Devillers, A; Garin, E; Le Jeune, F; Raoul, JL | 1 |
| Baron, JC; Chételat, G; de la Sayette, V; Desgranges, B; Duchesnay, E; Eustache, F; Fouquet, M; Landeau, B; Mézenge, F; Viader, F | 1 |
| Han, JY; Kang, KW; Kim, HT; Kim, HY; Kim, SK; Lee, DH; Lee, HY; Lee, JS; Lee, SY; Park, SH | 1 |
| Almubarak, S; Gan, YC; Goddard, K; Hendson, G; Hukin, J; Nadel, H; Poskitt, K; Steinbok, P | 1 |
| Carpentieri, DF; Chen, K; Dickman, PS; Etzl, MM; Irving, A; Kaplan, AM; Kruer, MC; Mathieson, K | 1 |
| Aurengo, A; Leenhardt, L; Lloret Linares, C; Sellier, P; Troisvallets, D | 1 |
| Foster, NL; Harvey, D; Jagust, WJ; Koeppe, RA; Landau, SM; Madison, CM; Reiman, EM; Weiner, MW | 1 |
| Adams, JL; Elner, VM; Flint, A; Pynnonen, MA; Smith, LB | 1 |
| Bergner, R; Dimitrakopoulou-Strauss, A; Haberkorn, U; Hoffmann, M; Strauss, LG; Uppenkamp, M | 1 |
| Armoni, S; Chisin, R; Cohen-Cymberknoh, M; Freedman, N; Kerem, E; Klein, M; Orevi, M; Shoseyov, D | 1 |
| Egerer, G; Ho, AD; Kasper, B; Schmitt, T; Wuchter, P | 1 |
| Antoch, G; Buck, AK; Herrmann, K; Heusner, TA | 1 |
| de Geus-Oei, LF; Heerschap, A; Krabbe, PF; Oyen, WJ; Punt, CJ; van Asten, JJ; van Laarhoven, HW; Visser, EP; Vriens, D | 1 |
| Agostinelli, C; Baccarani, M; Broccoli, A; Castellucci, P; Derenzini, E; Fanti, S; Fina, MP; Gandolfi, L; Lopci, E; Pellegrini, C; Pileri, S; Stefoni, V; Venturini, F; Zinzani, PL | 1 |
| Kubota, K; Kurata, A; Murata, Y; Osanai, T; Shibuya, H | 1 |
| Mercier, G; Peller, P; Sakai, O; Subramaniam, RM; Truong, M | 1 |
| Hattori, N; Ishii, K; Kambe, T; Motoi, Y | 1 |
| Borghi, A; Cheng, Z; Defraigne, JO; Gomez, P; Leung, J; Nchimi, A; Sakalihasan, N; Xu, XY | 1 |
| Bernstine, H; Groshar, D; Sopov, V; Sosna, J; Stern, D; Yefremov, N | 1 |
| Brugnolo, A; Dessi, B; Larsson, SA; Mazzei, D; Morbelli, S; Nobili, F; Pagani, M; Piccini, A; Rodriguez, G; Salmaso, D; Villavecchia, G | 1 |
| Bendahl, PO; Bjurberg, M; Brun, E; Kjellén, E; Ohlsson, T | 1 |
| Amador, R; Galeano, I; Lucas, A; Martín, M; Martínez, JC; Prat, R; Reynés, G | 1 |
| Eguchi, K; Hayashida, T; Izumi, Y; Kawakami, A; Koga, T; Makiyama, J; Migita, K; Miyashita, T; Nishino, Y; Tamai, M | 1 |
| Braunbeck, A; Daecke, W; Fiebig, C; Geiger, EV; Maier, M; Marzi, I; Weber, R | 1 |
| Amthauer, H; Denecke, T; Grabik, W; Grieser, C; Hamm, B; Hänninen, EL; Lüdemann, L; Ricke, J; Rühl, R; Schnapauff, D; Steffen, IG; Wust, P | 1 |
| Claassen, DO; Josephs, KA; Peller, PJ | 1 |
| Hickeson, M; Makis, W | 1 |
| Lichauco, JJ; Santos Estrella, PV; Vista, EG | 1 |
| Guedj, E; Jennesson, M; Maillard, L; Mancini, J; Marie, PY; Milh, M; Raffo, E; Vespignani, H; Vignal, JP; Villeneuve, N | 1 |
| Fischer, SM; Herschman, HR; Huang, SC; Ishikawa, TO; Kumar, IP; Kusewitt, D; Machado, HB; Wong, KP | 1 |
| Amadori, D; De Giorgi, U | 1 |
| Chung, DH; Goo, JM; Jang, BG; Kang, CH; Kang, KW; Kim, YT; Lee, CH; Lee, HJ; Lee, HY; Park, CM | 1 |
| Bashir, H; Daw, NC; Dome, JS; Gelfand, MJ; Moinul Hossain, AK; Nadel, HR; Sharp, SE; Shulkin, BL | 1 |
| Hoffmann, S; Jurkat-Rott, K; Kassubek, J; Lehmann-Horn, F; Lerche, H; Mottaghy, FM; Reske, SN; Roebling, R; Rosenbohm, A; Steinbach, P; Walter, H; Weber, YG; Wolf, M | 1 |
| Abolmaali, N; Abramyuk, A; Appold, S; Baumann, M; Herrmann, T; Lazanyi, KS; Tokalov, S; Wolf, G; Zöphel, K | 1 |
| Fujimaki, T; Kato, K; Kato, N; Murohara, T; Nishio, A; Usami, H | 1 |
| Bundschuh, RA; Dobritz, M; Eckstein, HH; Essler, M; Gurdan, M; Ockert, S; Pelisek, J; Reeps, C; Zimmermann, A | 1 |
| Carlis, JV; Dysken, MW; Fink, H; Kuskowski, MA; Lee, JT; Lewis, SM; McCarten, JR; McPherson, S; Munch, KR; Pardo, JV; Rottunda, S; Shah, HH; Sheikh, SA; Surerus, C | 1 |
| Bertram, L; Craig, DW; Farrer, LA; Foroud, TM; Green, RC; Huentelman, MJ; Jack, CR; Kim, S; Moore, JH; Nho, K; Potkin, SG; Risacher, SL; Saykin, AJ; Shen, L; Stein, JL; Swaminathan, S; Thompson, PM; Weiner, MW | 1 |
| Han, SH; Hendriksz, TR; Huiskes, AW; Jansen, I; van Bommel, EF | 1 |
| Abolmaali, N; Abramyuk, A; Appold, S; Haberland, U; Koch, A; Shakirin, G; Tokalov, S; Wolf, G; Zöphel, K | 1 |
| Aisen, PS; Foster, NL; Harvey, D; Jack, CR; Jagust, WJ; Landau, SM; Madison, CM; Petersen, RC; Reiman, EM; Shaw, LM; Trojanowski, JQ; Weiner, MW | 1 |
| Alexopoulos, P; Drzezga, A; Förschler, A; Förstl, H; Grimmer, T; Henriksen, G; Klunk, WE; Kurz, A; Mathis, CA; Perneczky, R; Sorg, C; Tholen, S; Yousefi, BH | 1 |
| Kochhar, R; Leahy, M; Manoharan, P; Taylor, MB | 1 |
| Ball, D; Binns, D; Callahan, J; Everitt, S; Herschtal, A; Hicks, RJ; Kron, T; MacManus, M; Plumridge, N; Schneider-Kolsky, M | 1 |
| Giesel, FL; Haberkorn, U; Kratochwil, C | 1 |
| Czernin, J; Hacke, K; Hildebrandt, IJ; Kelly, O; Kesner, AL; Lawson, GW; Phelps, ME; Schiestl, RH; Walter, MA; Weber, WA | 1 |
| Almkvist, O; Engler, H; Forsberg, A; Kadir, A; Långström, B; Nordberg, A; Wall, A | 1 |
| Berthelsen, AK; Engelholm, SA; Høgdall, C; Høgdall, E; Loft, A; Lundvall, L; Nedergaard, L; Risum, S | 1 |
| Basu, S | 1 |
| Fabbri, A; Forconi, F; Gozzetti, A; Lauria, F | 1 |
| Araki, O; Chida, M; Fukushima, Y; Honma, K; Inoue, T; Tamura, M; Tatewaki, M; Umezu, H | 1 |
| Schwarz, J | 1 |
| Antonini, A; Dhawan, V; Eidelberg, D; Hirano, S; Isaias, IU; Ma, Y; Mure, H; Tang, CC | 1 |
| Klaeser, B; Krause, T | 1 |
| Bandy, D; Bird, NP; Brown, AP; Castiglia, M; Chen, K; Cunningham, VJ; Dixon, IJ; Gold, M; Hallett, WA; Jeter, B; Lai, RY; Lotay, N; Matthews, JC; Matthews, PM; Mistry, P; Nichols, TE; Rabiner, EA; Reiman, EM; Searle, G; Tzimopoulou, S; Whitcher, B; Zvartau-Hind, M | 1 |
| Ayala-Ramirez, M; Chuang, H; Habra, MA; Jimenez, C; Kyle, K; Núñez, R; Rich, T | 1 |
| Herholz, K | 1 |
| Bruce, I; Ghosal, N; Hastings, D; Homer, J; Julyan, P; Mais, K; Ryder, WD; Shenjere, P; Slevin, NJ; Ward, T | 1 |
| De Ruysscher, D; Lambin, P; Öllers, M; van Elmpt, W | 1 |
| Chida, M; Honma, K; Inoue, T; Murakami, K | 1 |
| Chugani, HT; Kumar, A | 1 |
| Boada, FE; Davis, DK; Deeb, EL; Imani, F; Lieberman, FS; Mountz, JM | 1 |
| Dyer, MJ; Gesk, S; Harder, L; Majid, A; Morgan, B; Siebert, R; Walewska, R | 1 |
| Elliott, BM; Isola, L; Kostakoglu, L; Lee, D; Osman, K; Peti, S; Scigliano, E | 1 |
| Alavi, A; Boyett, JM; Fahey, FH; Geyer, JR; Haas-Kogan, DA; Kocak, M; Kun, LE; Poussaint, TY; Shulkin, BL; Treves, ST; Vajapeyam, S; Wong, TZ; Zukotynski, KA | 1 |
| Au, WL; Calne, DB; Cragg, J; de la Fuente-Fernández, R; Kuramoto, L; Lee, CS; Mak, E; McCormick, S; McKenzie, J; Ramachandiran, N; Ruth, TJ; Schulzer, M; Sossi, V; Stoessl, AJ | 1 |
| Chevreau, C; Courbon, F; Julian, A; Meyer, N; Payoux, P; Wagner, T; Zerdoud, S | 1 |
| Ahn, JS; Bae, SY; Bom, HS; Chung, IJ; Chung, WK; Jeong, YY; Kim, HJ; Kim, YK; Lee, JJ; Min, JJ; Song, HC; Yang, DH | 1 |
| Amler, LC; Charu, V; Fine, BM; Gitlitz, BJ; Hicks, RJ; Hughes, BG; Macfarlane, D; Mileshkin, L; Mitchell, PL; Pirzkall, A; Solomon, B; Yu, W | 1 |
| Apostolopoulos, DJ; Dimitrakopoulou-Strauss, A; Hohenberger, P; Roumia, S; Strauss, LG | 1 |
| Bartsch, DK; Fendrich, V; Jacobsen, ID; Maitra, A; Opfermann, T; Schneider, R | 1 |
| Bülow, J; Friberg, L; Jensen, MR; Karlsmark, T | 1 |
| Ito, H; Tahara, E; Toi, M; Yasui, W | 1 |
| De Ruysscher, D; Dingemans, AM; Lambin, P; Offermann, C; Ollers, M; Rahmy, A; van Elmpt, W; van Loon, J; Vegt, E | 1 |
| Dammacco, F; Guariglia, R; Iodice, G; Musto, P; Reale, A; Ria, R; Vacca, A | 1 |
| Albin, RL; Bohnen, NI; Frey, KA; Giordani, B; Koeppe, RA; Kuhl, DE; Minoshima, S | 1 |
| Abgral, R; Cavarec, MB; Le Duc-Pennec, A; Le Roux, PY; Marianovski, R; Nowak, E; Potard, G; Querellou, S; Salaün, PY; Valette, G | 1 |
| Berghmans, T; Flamen, P; Garcia, C; Meert, AP; Paesmans, M; Sculier, JP; van Ruychevelt, V | 1 |
| Baek, S; Choi, CM; Kim, SW; Lee, DH; Lee, JS; Moon, DH; Ryu, JS; Suh, C; Yoon, DH | 1 |
| Blais, N | 1 |
| Dunn, G; Haense, C; Herholz, K; Westwood, S | 1 |
| Ho-Shon, I; Koh, ES; Lin, M; Lin, P; Som, S; Vinod, SK; Yap, J | 1 |
| Cooley, T; Davison, JM; Mercier, G; Peller, PJ; Subramaniam, RM; Surasi, DS | 1 |
| Dupuy, DE; Fernando, HC; Hillman, SL; Rilling, WS; Shepard, JA; Siegel, BA; Yoo, DC | 1 |
| Brunken, R; Culver, DA; Isiguzo, M; Tchou, P; Xu, M | 1 |
| Bansilal, S; Burgess, T; Farkouh, ME; Fayad, ZA; Fuster, V; Kallend, D; Mani, V; Pozza, J; Rudd, JH; Tawakol, A; Woodward, M | 1 |
| Ataka, S; Miki, T; Mori, H; Shimada, H; Takechi, H; Tomiyama, T | 1 |
| Archetti, S; Arnaldi, D; di Lorenzo, D; Ferrara, M; Morbelli, S; Nobili, F; Piccini, A; Picco, A; Serrati, C | 1 |
| Hu, SL; Zhang, YJ; Zhou, ZR | 1 |
| Barst, RJ; Bokhari, J; Bokhari, S; Einstein, AJ; Johnson, LL; Raina, A; Rosenweig, EB; Schulze, PC | 1 |
| Calcagno, C; Dickson, SD; Fayad, ZA; Fisher, EA; Fuster, V; Hayashi, K; Lin, J; Moon, MJ; Moshier, E; Mounessa, JS; Nicolay, K; Roytman, M; Rudd, JH; Tsimikas, S; Vucic, E | 1 |
| Blaney, JE; Byrum, R; Chen, DY; Dyall, J; Huzella, L; Jahrling, PB; Jennings, G; Johnson, RF; Mollura, DJ; Paragas, J; Ragland, DR; Reba, RC | 1 |
| Broggi, S; Calandrino, R; Cattaneo, GM; Dell'Oca, I; Di Muzio, NG; Fiorino, C; Fodor, A; Gianolli, L; Pasetti, M | 1 |
| Arai, H; Fujishiro, H; Furukawa, Y; Higashi, S; Hino, H; Iseki, E; Kasanuki, K; Katsuse, O; Kosaka, K; Minegishi, M; Sato, K; Togo, T; Uchikado, H; Yamamoto, R | 1 |
| Allen-Auerbach, MS; Benz, MR; Czernin, J; Figlin, R; Garon, EB; Herrmann, K; Phelps, ME; Reckamp, KL; Walter, F; Weber, WA | 1 |
| Belloli, S; Capobianco, A; Cottone, L; Fazio, F; Manfredi, AA; Moresco, RM; Rovere-Querini, P; Valtorta, S | 1 |
| Baudin, E; Caramella, C; Deandreis, D; Leboulleux, S; Schlumberger, M | 1 |
| Gurel, D; Kargi, A; Onen, A; Ozdogan, O; Sevinc, C; Turan, O | 1 |
| Denisenko, AN; Kostenikov, NA; Maslennikova, AV; Orlova, AG; Prianikova, TI; Vinogradova, IuN | 1 |
| Archer, SL; Bache-Wiig, P; Chen, CT; Haney, CR; Marsboom, G; Morrow, E; Paul, J; Piao, L; Ryan, JJ; Thenappan, T; Toth, PT; Wietholt, C | 1 |
| Advani, R; Graves, EE; Hoppe, RT; Horning, S; Loo, BW; Quon, A; Rachakonda, LP; Su, Z; Tran, PT; Tseng, D | 1 |
| Chang, DT; Chu, KP; Graves, EE; Hsu, A; Iagaru, A; Krakow, TE; La, TH; Le, QT; Loo, B; Maxim, PG; Murphy, JD | 1 |
| Eikelenboom, P; Schmand, B; van Gool, WA | 1 |
| Basu, S; Kand, P; Kumar Dhingra, V | 1 |
| Duffy, JR; Jack, CR; Josephs, KA; Lowe, VJ; Machulda, MM; Master, AV; Senjem, ML; Strand, EA; Whitwell, JL | 1 |
| Harris, J; Hu, J; Kurien, G; Seikaly, H | 1 |
| Daisaki, H; Kinoshita, T; Kubota, K; Macapinlac, HA; Miyake, M; Nagaoka, T; Tateishi, U; Terauchi, T | 1 |
| Boeve, BF; Gunter, JL; Ivnik, RJ; Jack, CR; Kantarci, K; Knopman, DS; Lowe, V; Petersen, RC; Roberts, RO; Rocca, WA; Senjem, ML; Vemuri, P; Weigand, SD; Wiste, HJ | 1 |
| Ahnert-Hilger, G; Buchert, R; Dalmau, J; Gomez, A; Harms, L; Höltje, M; Klingbeil, C; Kohler, S; Kopp, U; Maier, N; Probst, C; Prüss, H; Schmitz, D; Schwab, JM; Stoecker, W; Terborg, C; Wandinger, KP | 1 |
| Boeve, BF; Gunter, JL; Ivnik, RJ; Jack, CR; Kantarci, K; Knopman, DS; Lowe, V; Petersen, RC; Roberts, RO; Senjem, ML; Vemuri, P; Weigand, SD; Wiste, HJ | 1 |
| Eidelberg, D; Feigin, A; Niethammer, M | 1 |
| Cristofanilli, M; De Giorgi, U; Giordano, A; Giuliano, M; Hortobagyi, GN; Mego, M; Reuben, JM; Scarpi, E; Ueno, NT; Valero, V | 1 |
| Bale, RJ; Eisterer, W; Gabriel, M; Gastl, G; Kendler, D; Kroiss, A; Madleitner, R; Putzer, D; Uprimny, C; Virgolini, IJ | 1 |
| Akashi-Tanaka, S; Daisaki, H; Kano, D; Kinoshita, T; Macapinlac, HA; Murano, T; Tateishi, U; Terauchi, T; Tsuda, H | 1 |
| Lopez, WO; Mader, I; Nguyen, T; Nikkhah, G; Pinsker, MO; Reithmeier, T; Spehl, TS | 1 |
| Binns, D; Cardamone, L; Hicks, RJ; Jones, N; Jupp, B; O'Brien, TJ; Rees, S; Williams, J | 1 |
| Backes, H; Bjerkvig, R; Brekka, N; Hoehn, M; Jacobs, AH; Jikeli, JF; Miletic, H; Monfared, P; Neumaier, B; Niclou, SP; Stieber, D; Talasila, KM; Tavitian, B; Thorsen, F; Viel, T; Waerzeggers, Y; Wang, J; Winkeler, A | 1 |
| Abernethy, AP; Beasley, GM; Broadwater, G; Eikman, EA; Marzban, S; Parsons, C; Salama, AK; Selim, MA; Tyler, DS; Wong, T; Zager, JS | 1 |
| Chen, HH; Chiu, NT; Guo, HR; Lee, BF; Su, WC | 1 |
| Barocco, F; Caffarra, P; Cappa, S; Concari, L; Dieci, F; Gardini, S; Ghetti, C; Prati, GD; Ruffini, L | 1 |
| Babiak, M; Caso, F; Comi, G; Filippi, M; Gesierich, B; Gorno-Tempini, ML; Henry, M; Huang, EJ; LaMarre, A; Magnani, G; Miller, BL; Rabinovici, GD; Seeley, WW; Sidhu, M | 1 |
| Isono, M; Kato, N; Kuwagata, S; Mizutani, H; Morita, Y; Suehiro, M; Tsujimura, Y | 1 |
| Correa, PD; Han, S; Rizwanullah, M; Shrimali, RK | 1 |
| Bowman, FD; Derado, G; Zhang, L | 1 |
| Ambrosini, V; Angelucci, S; Cantelli, E; D'ambrosio, D; Di Leo, K; Fanti, S; Lodi, F; Marengo, M; Nanni, C; Pession, A; Quarta, C; Tonelli, R; Weiss, WA; Zagni, F | 1 |
| Bae, SH; Choi, BG; Choi, JY; Chun, HJ; Jang, JW; Lee, HG; Park, CH; Song, MJ; Yoo, IeR; Yoon, SK | 1 |
| Biko, DM; Greene, G; Mezheritskiy, I | 1 |
| Blockmans, D | 1 |
| Kong, FM; Mahasittiwat, P; Quint, LE; Wang, J; Wong, KK | 1 |
| Hatt, M; Lambin, P; Lammering, G; le Pogam, A; van Stiphout, R; Visvikis, D | 1 |
| Brown, K; Bucerius, J; Calcagno, C; Dickson, SD; Fayad, ZA; Fisher, EA; Fuster, V; Hayashi, K; Kotsuma, M; Lin, J; Moon, MJ; Moshier, E; Mounessa, JS; Nicolay, K; Ramachandran, S; Roytman, M; Rudd, JH; Tanimoto, T; Tsimikas, S; Vucic, E | 1 |
| Biller, AE; Camp, JV; Chu, YK; Jonsson, CB; Kraenzle, JL; Mollura, DJ; Ng, CK; Proctor, M; Sherwood, L; Steffen, MC; Vanover, CD; Wu, A; Zheng, H | 1 |
| Albisinni, U; Battista, G; Bazzocchi, A; Brioli, A; Cavo, M; Fanti, S; Nanni, C; Salizzoni, E; Spinnato, P; Zamagni, E | 1 |
| Vanitallie, TB | 1 |
| Almkvist, O; Choo, IH; Ni, R; Nordberg, A; Schöll, M; Wall, A | 1 |
| Borrego-Dorado, I; Cuenca-Cuenca, JI; Gómez-Camarero, P; Navarro-González, E; Ortiz-de Tena, A; Ruiz-Franco-Baux, JV; Vázquez-Albertino, RJ | 1 |
| Allende-Riera, A; Cárdenas-Negro, C; Desequera-Rahola, M; Martínez-Gimeno, E; Ochoa-Figueroa, MA; Uña-Gorospe, J | 1 |
| Brouwers, AH; de Groot, JW; Hofstra, RM; Koopmans, KP; Links, TP; Muller Kobold, AC; Plukker, JT; van der Horst-Schrivers, AN; Verbeek, HH | 1 |
| Aisen, PS; Jagust, WJ; Joshi, AD; Koeppe, RA; Landau, SM; Mintun, MA; Petersen, RC; Weiner, MW | 1 |
| Brændengen, M; Glimelius, B; Hansson, K; Isacsson, U; Norrlid, O; Radu, C | 1 |
| Baggio, HC; Bargalló, N; Ibarretxe-Bilbao, N; Junqué, C; Martí, MJ; Sala-Llonch, R; Segura, B; Tolosa, E; Valldeoriola, F; Vendrell, P | 1 |
| Ben-Arush, M; Ben-Barak, A; Ilivitzki, A; Israel, O; Radan, L | 1 |
| Aalten, P; Adriaanse, SF; Handels, RL; Hoekstra, OS; Lammertsma, AA; Lemstra, AW; Ossenkoppele, R; Pijnenburg, YA; Prins, ND; Scheltens, P; van Berckel, BN; van Buchem, MA; van der Flier, WM; Verbeek, MM; Verhey, FR; Windhorst, AD; Wolfs, CA | 1 |
| Calles, L; García-Espantaleón, M; Iglesias, E; Jiménez, JS; Mucientes, J; Pereira, A; Perez-Medina, T; Rodríguez, B | 1 |
| Adeli, A; Boeve, BF; Crum, BA; Dejesus-Hernandez, M; Fields, JA; Jack, CR; Knopman, DS; Lowe, VJ; Petersen, RC; Rademakers, R; Savica, R; Vemuri, P | 1 |
| Berveling, MJ; Beukema, JC; Langendijk, JA; Muijs, CT; Plukker, JT; Pruim, J | 1 |
| Ikeda, H; Kawano, M; Matsumoto, I; Mochizuki, T; Nakajima, K; Oda, M; Takizawa, M; Waseda, R; Watanabe, G | 1 |
| Chin, J; Jung, DS; Kim, BC; Kim, EJ; Kim, SJ; Lee, KH; Na, DL; Sin, JS; Yoon, YJ | 1 |
| Ahn, JS; Bom, HS; Byun, BH; Chae, YS; Jung, SH; Kim, HJ; Kim, HW; Kim, YK; Kweon, SS; Lee, JJ; Lee, SW; Min, JJ; Sohn, SK; Yang, DH | 1 |
| Armenise, F; Canniello, E; D'Aluisio, L; Fazio, V; Gadaleta, CD; Gadaleta-Caldarola, G; Gaudiano, A; Goffredo, V; Goldberg, SN; Mattioli, V; Ranieri, G; Rubini, G; Solbiati, L; Vinciarelli, G | 1 |
| Boerman, O; Bussink, J; de Geus-Oei, LF; Heerschap, A; Heijmen, L; Oyen, WJ; Punt, CJ; Span, PN; Sweep, CG; Ter Voert, EG; van Laarhoven, HW; Zerbi, V | 1 |
| Castiglioni, I; Di Grigoli, G; Gallivanone, F; Gilardi, MC; Górriz, JM; Grosso, E; López, M; Moresco, R; Ramírez, J; Salvatore, C; Valtorta, S | 1 |
| Al-Nabhani, K; Almukhailed, O; Bomanji, J; Haroon, A; Syed, R | 1 |
| Caroli, A; Chen, K; Frisoni, GB; Herholz, K; Jagust, WJ; Prestia, A; Reiman, E | 1 |
| Alexander, GE; Hampel, H; Möller, HJ; Pogarell, O; Rapoport, SI; Teipel, SJ | 1 |
| Beguin, YP; Jerusalem, GH | 1 |
| Belhocine, T; De Labrassinne, M; Lahaye, T; Pierard, G; Rigo, P | 1 |
| Bruckner, JD; Chandhury, KR; Conrad, EU; Eary, JF; O'Sullivan, F; Powitan, Y; Vernon, C | 1 |
| D'Agnolo, A; Durie, BG; Waxman, AD; Williams, CM | 1 |
| Akhurst, T; Bains, MS; Downey, RJ; Ginsberg, R; Gollub, M; Gonen, M; Ilson, D; Koong, H; Larson, SM; Minsky, BD; Rusch, V; Turnbull, A; Zakowski, M | 1 |
| Dehdashti, F; Grigsby, PW; Mutch, DG; Siegel, BA | 1 |
| Capovilla, G; Chiapparini, L; Ciceri, E; Dalla Bernardina, B; Erbetta, A; Farina, L; Freri, E; Fusco, L; Giordano, L; Gobbi, G; Granata, T; Ragona, F; Savoiardo, M; Spreafico, R; Tassi, L; Viri, M | 1 |
| Chugani, DC; Chugani, HT; Juhász, C; Kagawa, K; Lee, JS; Muzik, O; Pfund, Z; Shen, C | 1 |
| Baron, JC; Chételat, G; de la Sayette, V; Desgranges, B; Eustache, F; Viader, F | 1 |
| Reigman, HI; Smit, JW; Stokkel, MP; Verkooijen, RB | 1 |
| Drzezga, A; Kurz, A; Lautenschlager, N; Minoshima, S; Riemenschneider, M; Schwaiger, M; Siebner, H; Willoch, F | 1 |
| Fukuyama, Y; Hori, T; Imai, K; Ishii, K; Ishiwata, K; Kubo, O; Maeda, Y; Mutoh, A; Oguni, H; Osawa, M; Saitou, Y; Yamane, F | 1 |
| Asano, E; Chugani, HT; Fain, D; Juhász, C; Kupsky, WJ; Shah, JR; Sood, S | 1 |
| Comans, EF; Hoekstra, OS; Huijgens, PC; Jonkhoff, AR; Lammertsma, AA; Raijmakers, PG; Teule, GJ; v Tinteren, H; van der Hoeven, JJ; Zijlstra, JM | 1 |
| Bastiaannet, E; Cobben, DC; Groen, H; Hoekstra, HJ; Jager, PL; Vaalburg, W; van der Graaf, WT | 1 |
| Carmichael, ST; Katsman, D; Kornblum, HI; Tatsukawa, K; Tsuyuguchi, N | 1 |
| Dominguez, ML; Garcia, L; Maldonado, A; Muñoz, JA; Otero, C; Resino, MC | 1 |
| Diehl, J; Drzezga, A; Förstl, H; Grimmer, T; Kurz, A | 1 |
| Beal, MF; Brownell, AL; Chen, YI; Cicchetti, F; Dedeoglu, A; Jenkins, BG; Wang, X; Yu, M | 1 |
| Haioun, C; Itti, E; Meignan, M; Rahmouni, A; Reyes, F | 1 |
| Abbey, CK; Borowsky, AD; Cardiff, RD; Cherry, SR; Gregg, JP; Maglione, JE; McGoldrick, ET | 1 |
| Bittner, D; Grön, G; Reske, SN; Riepe, MW; Schirrmeister, H | 1 |
| Asanuma, K; Carbon, M; Dhawan, V; Eidelberg, D | 1 |
| Rummeny, E; Schwaiger, M; Stollfuss, J; Wieder, H | 1 |
| Broome, J; du Plessis, DG; Fildes, D; Haylock, B; Husband, D; Jenkinson, MD; Joyce, KA; Kopitski, K; Prosser, J; Smith, T; Vinjamuri, S; Walker, C; Warnke, PC | 1 |
| Hashimoto, M; Hirono, N; Ishii, K; Kazui, H; Mori, E | 1 |
| Baron, JC; Borroni, B; Bracco, L; De Cristofaro, MT; Franceschi, M; Herholz, K; Holthoff, V; Mosconi, L; Nacmias, B; Padovani, A; Perani, D; Pupi, A; Salmon, E; Sorbi, S | 1 |
| Allen, P; Cox, JD; Erasmus, J; Forster, K; Herbst, RS; Komaki, R; Macapinlac, H; Moran, CA; Podoloff, DA; Putnam, JB; Roth, JA; Sasaki, R | 1 |
| Benito, C; Desco, M; Gispert, JD; Luque, R; Martínez, R; Molina, V; Pascau, J; Reig, S; Sanz, J; Sarramea, F | 1 |
| Lengyel, Z; Molnar, P; Novak, L; Tron, L | 1 |
| Akhurst, T; Chu, E; Ditullio, M; Heller, G; Kelly, WK; Larson, SM; Morris, MJ; Scher, HI; Schwartz, L; Siedlecki, K; Slovin, S; Verbel, D | 1 |
| García-Velloso, MJ; Moreno, D; Prieto, J; Rodríguez, M; Yuste, JR | 1 |
| Leenders, KL; Maguire, RP; Pruim, J; Roos, RA; van Oostrom, JC; Veenma-van der Duin, L; Verschuuren-Bemelmans, CC | 1 |
| Eisen, RN; Fey, C; Hollister, D; Lee, MS; Portlock, CS | 1 |
| Ishii, K; Minoshima, S | 1 |
| Nobili, FM; Pupi, A | 1 |
| Anchisi, D; Beuthien-Beumann, B; Borroni, B; Cappa, S; Fazio, F; Franceschi, M; Herholz, K; Holthoff, V; Kalbe, E; Kerrouche, N; Lenz, O; Ludecke, S; Marcone, A; Mielke, R; Ortelli, P; Padovani, A; Pelati, O; Perani, D; Pupi, A; Salmon, E; Scarpini, E; Sorbi, S; Weisenbach, S | 1 |
| Amitani, M; Hatazawa, J; Hosoi, R; Inoue, O; Matsuura, N; Shukuri, M; Takai, N | 1 |
| de Klerk, JM; Geerts, MC; Kramer, MH; Quarles van Ufford, HM; van Waes, PF | 1 |
| Debus, J; Eisenhut, M; Haberkorn, U; Henze, M; Hipp, P; Mier, W; Ozdemir-Sahin, N | 1 |
| Kassubek, J; Ludolph, AC; Mottaghy, FM; Riecker, A; Schreiber, H; Uttner, I | 1 |
| Pruim, J; Schot, BW; Sluiter, WJ; Vaalburg, W; van Imhoff, GW; Vellenga, E | 1 |
| Briest, S; Kluge, R; Scheid, R; Voltz, R; von Cramon, DY | 1 |
| Alexopoulos, P; Domes, G; Grimmer, T; Kurz, A; Perneczky, R | 1 |
| Amanuma, M; Endo, K; Ida, I; Kumano, H; Matsuda, H; Mikuni, M; Oriuchi, N; Oshima, A; Takahashi, K; Yuuki, N | 1 |
| Bénard, F; Langlois, MF; Leboeuf, R | 1 |
| Bastiaannet, E; Hoekstra, HJ; Hoekstra, OS; Jager, PL; Oyen, WJ; Wobbes, T | 1 |
| Alinari, L; Ambrosini, V; Castellucci, P; Fanti, S; Farsad, M; Franchi, R; Nanni, C; Rubello, D; Stefoni, V; Tani, M; Zinzani, PL | 1 |
| Almkvist, O; Blomquist, G; Engler, H; Forsberg, A; Långström, B; Larsson, E; Nordberg, A; Ringheim, A; Savitcheva, I; Wall, A | 1 |
| Boni, G; Capirci, C; Chierichetti, F; Crepaldi, G; Fanti, S; Mandoliti, G; Mariani, G; Polico, C; Rampin, L; Rubello, D; Salviato, S | 1 |
| Alavi, A; Cohen, AB; Dalmau, J; Galetta, SL; Mathew, RM | 1 |
| Broome, J; du Plessis, DG; Fildes, D; Haylock, B; Husband, D; Jenkinson, MD; Joyce, KA; Kopitzki, K; Prosser, J; Smith, T; Vinjamuri, S; Walker, C; Warnke, PC | 1 |
| Danno, K; Fukunaga, H; Gu, J; Hatazawa, J; Ikeda, M; Monden, M; Nishimura, T; Sekimoto, M; Takemasa, I; Tatsumi, M; Yamamoto, H | 1 |
| Abbey, CK; Borowsky, AD; Cardiff, RD; Cherry, SR; Gregg, JP | 1 |
| Cheng, CY; Cherng, SC; Fan, YM; Hsu, HH; Huang, WS; Lee, SC; Shen, DH | 1 |
| Dunnwald, LK; Ellis, GK; Gralow, JR; Kurland, BF; Linden, HM; Livingston, RB; Mankoff, DA; Schubert, EK; Specht, JM; Tam, SL | 1 |
| Nguyen, BD; Roarke, MC | 1 |
| Dhawan, V; Eidelberg, D; Feigin, A; Huang, C; Lesser, M; Ma, Y; Pourfar, M; Tang, C | 1 |
| Benjamin, RS; Burgess, MA; Charnsangavej, C; Chen, LL; Choi, H; Faria, SC; Macapinlac, HA; Patel, SR; Podoloff, DA | 1 |
| Almkvist, O; Blomquist, G; Engler, H; Forsberg, A; Hagman, G; Långström, B; Nordberg, A; Ringheim, A; Wall, A | 1 |
| Abdel-Dayem, H; Altinyay, ME; Castellon, I; Heiba, S; Libes, R; Piperkova, E; Raphael, B; Sandella, N | 1 |
| Arii, S; Ishiwata, K; Kawamura, K; Liu, HY; Oda, K; Teramoto, K | 1 |
| Haberkorn, U; Henze, M; Hunt, A; Schönknecht, P; Schröder, J; Seidl, U | 1 |
| Drzezga, A; Grimmer, T; Hartmann, J; Kurz, A; Perneczky, R | 1 |
| Arnold, SE; Barbas, NR; Clark, CM; DeCarli, CS; Foster, NL; Heidebrink, JL; Higdon, R; Jagust, WJ; Koeppe, RA; Minoshima, S; Turner, RS | 1 |
| Hicks, RJ; MacManus, MP; Seymour, JF | 1 |
| Dedeurwaerdere, S; Jupp, B; O'Brien, TJ | 1 |
| Ammendola, S; Bilo, L; Bonavita, V; de Leva, MF; De Michele, G; Filla, A; Pappatà, S; Piscitelli, V; Quarantelli, M; Salvatore, E; Striano, S; Varrone, A | 1 |
| Donington, JS; Graves, EE; Hara, W; Lavori, PW; Le, QT; Lee, P; Loo, BW; Maxim, PG; Quon, A; Wakelee, HA; Weerasuriya, DK | 1 |
| Dhawan, V; Eidelberg, D; Feigin, A; Guttman, M; Ma, Y; Mattis, P; Paulsen, JS; Tang, C; Zgaljardic, D | 1 |
| Ahn, YH; Bang, OY; Huh, K; Joo, IS; Kim, JW; Lee, PH | 1 |
| Endo, K; Hisada, T; Ishizuka, T; Kaira, K; Mori, M; Oriuchi, N; Sunaga, N; Tomizawa, Y; Yanagitani, N | 1 |
| Amthauer, H; Denecke, T; Hänninen, EL; Hildebrandt, B; Langrehr, J; Lehmkuhl, L; Ricke, J; Rühl, R; Steffen, I; Streitparth, F | 1 |
| Dalesio, O; de Jong, WK; Groen, HJ; Oyen, WJ; Pruim, J; van der Heijden, HF | 1 |
| Belohlávek, O; Klener, P; Koren, J; Pytlík, R; Sálková, J; Trnený, M | 1 |
| Fayad, ZA; Myers, KS; Rudd, JH; Sanz, J | 1 |
| He, ZY; Qiao, WL; Wang, C; Wang, TS; Xing, Y; Zhao, JH | 1 |
| Antoch, G; Barkhausen, J; Bockisch, A; Boes, T; Eggebrecht, H; Erbel, R; Kuehl, H; Ladd, S; Rosenbaum, S | 1 |
| Alavi, A; Basu, S; Cnaan, A; Dombi, E; Fisher, MJ; Phillips, PC; Pollock, AN; Widemann, BC; Yu, JQ; Zhuang, H | 1 |
| Bomanji, J; Buchler, T; Edwards, SG; Lee, SM; Ramsay, A | 1 |
| Chernov, MF; Hayashi, M; Hori, T; Izawa, M; Kubo, O; Muragaki, Y; Ono, Y; Takakura, K; Usukura, M; Yoshida, S | 1 |
| Akhurst, T; Blumgart, LH; Corvera, CU; D'Angelica, M; DeMatteo, RP; Fong, Y; Jarnagin, WR | 1 |
| Barrio, JR; Huang, SC; Kepe, V; Satyamurthy, N; Small, G | 1 |
| Bodet-Milin, C; Campion, L; Dupas, B; Gastinne, T; Goldenberg, DM; Harousseau, JL; Huglo, D; Kraeber-Bodéré, F; Le Gouill, S; Morschhauser, F; Wegener, WA | 1 |
| Bizzi, A; Boiardi, A; Fariselli, L; Laguzzi, E; Lamperti, E; Maccagnano, E; Milanesi, I; Rudà, R; Salmaggi, A; Silvani, A; Soffietti, R; Trevisan, E | 1 |
| Bellomi, M; Bertolotti, R; Leo, F; Maisonneuve, P; Mulshine, JL; Paganelli, G; Pelosi, G; Preda, L; Scanagatta, P; Solli, P; Spaggiari, L; Veronesi, G | 1 |
| Bodet-Milin, C; Campion, L; Dupas, B; Kraeber-Bodéré, F; Le Gouill, S; Moreau, P | 1 |
| Fujibayashi, Y; Okazawa, H; Takeuchi, H; Tsuchida, T; Tsujikawa, T | 1 |
| Cristofanilli, M; Dawood, S; Gamez, C; Macapinlac, HA; Tateishi, U; Yeung, HW | 1 |
| Herrmann, K; Krause, BJ; Lordick, F; Ott, K; Schuhmacher, C; Siewert, JR | 1 |
| Barlier, A; Colavolpe, C; De Micco, C; Henry, JF; Morange, I; Mundler, O; Niccoli-Sire, P; Palazzo, FF; Sebag, F; Taïeb, D; Tessonnier, L | 1 |
| Borghetti, D; Ceravolo, R; Frosini, D; Giorgetti, A; Kiferle, L; Murri, L; Neglia, D; Petrozzi, L; Rossi, C; Sassi, N; Siciliano, G; Tognoni, G | 1 |
| Choi, H | 1 |
| Van den Abbeele, AD | 1 |
| Hicks, RJ; Toner, GC | 1 |
| Akaki, S; Gobara, H; Higaki, F; Hiraki, T; Kanazawa, S; Mimura, H; Okumura, Y; Sato, S; Tsuda, T | 1 |
| Dhawan, V; Eidelberg, D; Fahn, S; Ishikawa, T; Moeller, JR; Przedborski, S; Spetsieris, P | 1 |
| Alger, JR; Bonavita, S; Di Chiro, G; Duyn, JH; Lundbom, N; Raman, R; Tedeschi, G | 1 |
| Bruckner, JD; Conrad, EU; Eary, JF; Folpe, A; Howlett, AT; Hunt, KJ; Mankoff, DA | 1 |
| Blinkenberg, M; Holm, S; Jensen, CV; Paulson, OB; Sørensen, PS | 1 |
| Alavi, A; Albelda, SM; Bénard, F; Kaiser, LR; Smith, RJ; Sterman, D | 1 |
| Cortese, C; Hogan, RE; Kaiboriboon, K | 1 |
| Beguin, Y; Fassotte, MF; Fillet, G; Jerusalem, G; Najjar, F; Paulus, P; Rigo, P | 1 |
| Beattie, BJ; Blasberg, RG; Malkin, MG; Thiessen, B; Vlassenko, AG | 1 |
| Brown, C; Djavani, M; Hanson, JM; Horejsh, D; Lu, Y; Mitchen, JL; Pauza, CD; Perlman, SB; Pyzalski, R; Wallace, M | 1 |
| Ayabe, K; Higashi, K; Katsuda, S; Nambu, Y; Oguchi, M; Sakurai, A; Seki, H; Shikata, H; Taki, S; Tonami, H; Ueda, Y; Yamamoto, I | 1 |
| Kohlmyer, SG; Li, M; Pugsley, JM; Schmidt, RA; Vallires, E; Vesselle, H; Wood, DE | 1 |
| Abdel-Dayem, HM; el-Zeftawy, H; Heiba, SI; Jana, S; Rosen, G; Salem, S; Santiago, JF | 1 |
| Glatting, G; Greten, FR; Neumaier, B; Reske, SN; Schmid, RM; Seitz, U; Vogg, AT; Wagner, M | 1 |
| Mandelkern, M; Tatlidil, R | 1 |
| Al-Sugair, AA; Coleman, RE; Crain, BJ; Fiorella, DJ; Provenzale, JM | 1 |
| Dehdashti, F; Grigsby, PW; Siegel, BA | 1 |
| Jankovic, J; Kapadia, AS | 1 |
| Alavi, A; Alexander, GE; Chang, CY; Chen, W; Clark, CM; Cummings, JL; Czernin, J; de Leon, MJ; Gambhir, SS; Hoffman, JM; Hoh, CK; Jagust, WJ; Kowell, AP; Kung De Aburto, MA; Lu, CS; Mielke, R; Phelps, ME; Pietrini, P; Rapoport, SI; Salmon, E; Schapiro, MB; Silverman, DH; Small, GW; Welsh-Bohmer, KA | 1 |
| Balzarini, J; De Wolf-Peeters, C; Dupont, P; Mortelmans, L; Spaepen, K; Stroobants, S; Thomas, J; Vandenberghe, P; Verhoef, G | 1 |
| Baron, JC; de La Sayette, V; Desgranges, B; Eustache, F; Giffard, B; Lalevée, C; Viader, F | 1 |
| Alexander, GE; Chen, K; Pietrini, P; Rapoport, SI; Reiman, EM | 1 |
66 review(s) available for fluorodeoxyglucose f18 and Disease Exacerbation
| Article | Year |
|---|---|
Multimodality Imaging of Prostate Cancer.
Topics: Aged; Antigens, Surface; Carboxylic Acids; Choline; Cyclobutanes; Disease Progression; Fluorodeoxyglucose F18; Glutamate Carboxypeptidase II; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Multiparametric Magnetic Resonance Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Radionuclide Imaging; Theranostic Nanomedicine; Tomography, X-Ray Computed; Whole Body Imaging | 2019 |
Aortic valve stenosis-multimodality assessment with PET/CT and PET/MRI.
Topics: Aortic Valve; Aortic Valve Stenosis; Disease Progression; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Vascular Calcification | 2020 |
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Checklist; Clinical Protocols; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Immunotherapy; Male; Middle Aged; Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Treatment Outcome | 2020 |
Current and potential applications of positron emission tomography for multiple myeloma and plasma cell disorders.
Topics: ADP-ribosyl Cyclase 1; B-Cell Maturation Antigen; Biomarkers, Tumor; Bone Marrow; Disease Progression; Fluorodeoxyglucose F18; Gene Expression; Humans; Membrane Glycoproteins; Neoplasm Proteins; Neoplasm, Residual; Plasma Cells; Plasmacytoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Receptors, CXCR4; Smoldering Multiple Myeloma | 2020 |
Post-treatment FDG PET/CT predicts progression-free survival in young patients with small round blue cell tumors: Ewing sarcoma and PNET.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; Cohort Studies; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Neuroectodermal Tumors, Primitive; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Progression-Free Survival; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sarcoma, Ewing; Sensitivity and Specificity; Treatment Outcome; Young Adult | 2020 |
Advances in PET to assess pulmonary inflammation: A systematic review.
Topics: Animals; Disease Progression; Fluorodeoxyglucose F18; Forecasting; Humans; Pneumonia; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome | 2020 |
Diffuse large B cell lymphoma in a preceding IgG4-related disease with kidney restricted lambda light chain expression: case report and literature review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Immunoglobulin G4-Related Disease; Immunoglobulin lambda-Chains; Immunosuppressive Agents; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Missed Diagnosis; Nephritis, Interstitial; Positron Emission Tomography Computed Tomography; Prednisone; Radiopharmaceuticals; Renal Insufficiency, Chronic | 2020 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Prognostic value of
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Survival Rate | 2020 |
Imaging Glioblastoma Posttreatment: Progression, Pseudoprogression, Pseudoresponse, Radiation Necrosis.
Topics: Brain; Brain Neoplasms; Contrast Media; Diagnostic Imaging; Disease Progression; Fluorodeoxyglucose F18; Glioblastoma; Humans; Image Enhancement; Magnetic Resonance Imaging; Necrosis; Positron-Emission Tomography; Radiation Injuries; Radiopharmaceuticals; Treatment Outcome | 2021 |
Prognostic and predictive values of interim
Topics: Chemoradiotherapy; Disease Progression; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Treatment Outcome | 2021 |
Topics: Abdominal Pain; Animals; Biomarkers; Disease Progression; Dyspepsia; Fluorodeoxyglucose F18; Humans; Hypoxia; Idiopathic Pulmonary Fibrosis; Mice; Misonidazole; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Prevalence; Radiopharmaceuticals; Sleep Wake Disorders | 2021 |
Coordination and optimization of FDG PET/CT and COVID-19 vaccination; Lessons learned in the early stages of mass vaccination.
Topics: COVID-19; COVID-19 Vaccines; Diagnosis, Differential; Disease Progression; Fluorodeoxyglucose F18; Humans; Lymphadenopathy; Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; SARS-CoV-2; Vaccination | 2021 |
Prognostic value of early response assessment using (18F)FDG-PET in patients with advanced non-small cell lung cancer treated with tyrosine-kinase inhibitors.
Topics: Afatinib; Aged; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free Survival; Erlotinib Hydrochloride; Female; Fluorodeoxyglucose F18; Gefitinib; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Protein Kinase Inhibitors; Quinazolines; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Reproducibility of Results; Treatment Outcome | 2017 |
International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017).
Topics: Antineoplastic Agents; Consensus; Contrast Media; Disease Progression; Disease-Free Survival; Endpoint Determination; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Response Evaluation Criteria in Solid Tumors; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2017 |
Sarcomatoid renal cell carcinoma: a case report and literature review.
Topics: Carcinoma, Renal Cell; Disease Progression; Fatal Outcome; Fluorodeoxyglucose F18; Hematuria; Humans; Kidney Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Rhabdomyosarcoma; Tomography, X-Ray Computed | 2018 |
Emerging imaging targets for infiltrative cardiomyopathy: Inflammation and fibrosis.
Topics: Cardiology; Cardiomyopathies; Disease Progression; Fibrosis; Fluorodeoxyglucose F18; Heart Failure; Humans; Inflammation; Myocardium; Regeneration | 2019 |
FDG-PET/CT in the management of lymphomas: current status and future directions.
Topics: Biopsy; Bone Marrow; Cell Transformation, Neoplastic; Disease Progression; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Treatment Outcome; Tumor Burden | 2018 |
18F-FDG PET for Prediction of Conversion to Alzheimer's Disease Dementia in People with Mild Cognitive Impairment: An Updated Systematic Review of Test Accuracy.
Topics: Alzheimer Disease; Brain; Cognitive Dysfunction; Disease Progression; Fluorodeoxyglucose F18; Humans; Neuropsychological Tests; Positron-Emission Tomography | 2018 |
Advanced cardiovascular imaging for the evaluation of cardiac sarcoidosis.
Topics: Algorithms; Cardiology; Cardiomyopathies; Disease Progression; Fluorodeoxyglucose F18; Heart Failure; Humans; Immunosuppressive Agents; Inflammation; Nuclear Medicine; Positron-Emission Tomography; Prognosis; Sarcoidosis | 2019 |
Prognostic value of 18F-fluorodeoxyglucose bone marrow uptake in patients with solid tumors: A meta-analysis.
Topics: Biomarkers, Tumor; Bone Marrow; Disease Progression; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals | 2018 |
Evolving Role of PET in Detecting and Characterizing Atherosclerosis.
Topics: Adult; Aged; Aged, 80 and over; Animals; Contrast Media; Coronary Artery Disease; Disease Models, Animal; Disease Progression; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Rabbits; Risk Factors; Sodium Fluoride; Swine; Young Adult | 2019 |
Recent Advancement and Clinical Implications of 18FDG-PET in Parkinson's Disease, Atypical Parkinsonisms, and Other Movement Disorders.
Topics: Apathy; Brain; Cognitive Dysfunction; Dementia; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Huntington Disease; Male; Movement Disorders; Parkinson Disease; Parkinsonian Disorders; Positron-Emission Tomography; REM Sleep Behavior Disorder; Tomography, Emission-Computed, Single-Photon | 2019 |
Tuberculosis biomarkers discovery: developments, needs, and challenges.
Topics: Antigens, Bacterial; Antitubercular Agents; Biomarkers; Disease Progression; DNA, Bacterial; Enzyme-Linked Immunosorbent Assay; Fluorodeoxyglucose F18; Gene Expression Regulation, Bacterial; Humans; Interferon-gamma; Interleukin-18; Lipopolysaccharides; Metabolome; MicroRNAs; Multimodal Imaging; Mycobacterium tuberculosis; Polymerase Chain Reaction; Positron-Emission Tomography; Predictive Value of Tests; Recurrence; Reproducibility of Results; Tomography, X-Ray Computed; Tuberculosis; Tuberculosis Vaccines | 2013 |
Functional imaging in chronic migraine.
Topics: Brain Stem; Cerebrovascular Circulation; Chronic Disease; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Migraine Disorders; Positron-Emission Tomography; Radiopharmaceuticals; Severity of Illness Index | 2013 |
Targeted PET/CT imaging of vulnerable atherosclerotic plaques: microcalcification with sodium fluoride and inflammation with fluorodeoxyglucose.
Topics: Calcinosis; Coronary Angiography; Coronary Artery Disease; Disease Progression; Early Diagnosis; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Multimodal Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Rupture, Spontaneous; Sodium Fluoride; Tomography, X-Ray Computed | 2013 |
Resistance to treatment in gastrointestinal stromal tumours: what radiologists should know.
Topics: Antineoplastic Agents; Benzamides; Contrast Media; Disease Progression; Drug Resistance, Neoplasm; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Mutation; Piperazines; Positron-Emission Tomography; Pyrimidines; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Positron emission tomography/computed tomography imaging and rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Disease Progression; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Prognosis; Severity of Illness Index; Tomography, X-Ray Computed | 2014 |
[Adrenocortical carcinoma: Update in 2014].
Topics: Adrenal Cortex Hormones; Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Biomarkers, Tumor; Combined Modality Therapy; Disease Progression; Female; Fluorodeoxyglucose F18; Gene Expression Profiling; Genetic Predisposition to Disease; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Prognosis; Survival Rate; Tomography, X-Ray Computed | 2014 |
[Importance of FDG-PET/CT for surgery of rectal cancer].
Topics: Diagnosis, Differential; Disease Progression; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Molecular Imaging; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Rectal Neoplasms; Rectum; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
FDG-PET/CT is a pivotal imaging modality to diagnose rare intravascular large B-cell lymphoma: case report and review of literature.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain; Cough; Disease Progression; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Lung; Lymphoma, Large B-Cell, Diffuse; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Thyroid Gland; Tissue Distribution; Tomography, X-Ray Computed; Transplantation, Autologous; Vascular Neoplasms | 2015 |
Aggressive primary olfactory neuroblastoma of the sphenoclival region: a case report and literature review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Disease Progression; Esthesioneuroblastoma, Olfactory; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiotherapy, Adjuvant; Rare Diseases; Skull Base; Sphenoid Sinus; Tomography, X-Ray Computed | 2015 |
¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
Topics: Aged; Alzheimer Disease; Brain; Cognitive Dysfunction; Dementia; Disease Progression; Early Diagnosis; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2015 |
Multiple myeloma.
Topics: Aged; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Multiple Myeloma; Neoplasm Metastasis; Neoplasm Staging; Paraproteinemias; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Integration of (18)FDG-PET Metabolic and Functional Connectomes in the Early Diagnosis and Prognosis of the Alzheimer's Disease.
Topics: Alzheimer Disease; Disease Progression; Early Diagnosis; Electroencephalography; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography | 2016 |
Prognostic value of pretransplant FDG-PET in refractory/relapsed Hodgkin lymphoma treated with autologous stem cell transplantation: systematic review and meta-analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Clinical Trials as Topic; Cohort Studies; Combined Modality Therapy; Disease Progression; Drug Resistance, Neoplasm; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Neoplasm, Residual; Peripheral Blood Stem Cell Transplantation; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Salvage Therapy; Sensitivity and Specificity; Survival Analysis; Transplantation, Autologous; Treatment Outcome | 2016 |
Inflammation as a Predictor of Abdominal Aortic Aneurysm Growth and Rupture: A Systematic Review of Imaging Biomarkers.
Topics: Aorta, Abdominal; Aortic Aneurysm, Abdominal; Aortic Rupture; Aortitis; Aortography; Computed Tomography Angiography; Contrast Media; Dextrans; Disease Progression; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Angiography; Magnetite Nanoparticles; Molecular Imaging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors | 2016 |
FDG-PET for Prediction of AD Dementia in Mild Cognitive Impairment. A Review of the State of the Art with Particular Emphasis on the Comparison with Other Neuroimaging Modalities (MRI and Perfusion SPECT).
Topics: Alzheimer Disease; Cognitive Dysfunction; Disease Progression; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neuroimaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2017 |
Fluorodeoxyglucose-positron-emission tomography, single-photon emission tomography, and structural MR imaging for prediction of rapid conversion to Alzheimer disease in patients with mild cognitive impairment: a meta-analysis.
Topics: Alzheimer Disease; Cognition Disorders; Disease Progression; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Predictive Value of Tests; Severity of Illness Index; Tomography, Emission-Computed, Single-Photon | 2009 |
[PET and PET-CT of malignant tumors of the exocrine pancreas].
Topics: Adenocarcinoma; Carcinoma, Acinar Cell; Carcinoma, Pancreatic Ductal; Diagnosis, Differential; Disease Progression; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Pancreas; Pancreatic Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Fluorine-18-fluorodeoxyglucose positron emission tomography for interim response assessment of advanced-stage Hodgkin's lymphoma and diffuse large B-cell lymphoma: a systematic review.
Topics: Adolescent; Adult; Child; Disease Progression; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals | 2009 |
[Imaging procedures for gastrointestinal stromal tumors].
Topics: Blood Glucose; Chemotherapy, Adjuvant; Diagnosis, Differential; Disease Progression; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrointestinal Stromal Tumors; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed | 2009 |
The metabolic spectrum of venous thrombotic disorders found on PET/CT.
Topics: Contrast Media; Disease Progression; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Venous Thrombosis; Whole Body Imaging | 2009 |
Imaging in gastrointestinal stromal tumours: current status and future directions.
Topics: Disease Progression; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
[PET/CT for diagnostics and therapy stratification of lung cancer].
Topics: Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Diagnosis, Differential; Disease Progression; Energy Metabolism; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiographic Image Enhancement; Radiotherapy Planning, Computer-Assisted; Sensitivity and Specificity; Tomography, Spiral Computed; Tomography, X-Ray Computed | 2010 |
Personalized versus evidence-based medicine with PET-based imaging.
Topics: Disease Progression; Evidence-Based Medicine; Fluorodeoxyglucose F18; Humans; Molecular Biology; Neoadjuvant Therapy; Neoplasms; Positron-Emission Tomography; Time Factors | 2010 |
[Nuclear medicine imaging in patients with Parkinson's syndrome: an update].
Topics: Animals; Brain; Dihydroxyphenylalanine; Disease Progression; Dopamine; Energy Metabolism; Fluorodeoxyglucose F18; Genetic Predisposition to Disease; Humans; Nerve Degeneration; Neurons; Parkinson Disease; Parkinsonian Disorders; Positron-Emission Tomography; Receptors, Dopamine; Regional Blood Flow; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2010 |
Cerebral glucose metabolism in preclinical and prodromal Alzheimer's disease.
Topics: Alzheimer Disease; Brain; Cognition Disorders; Disease Progression; Fluorodeoxyglucose F18; Glucose; Humans; Positron-Emission Tomography | 2010 |
Are we undertreating invasive bladder cancer? Optimizing outcomes in a high-risk disease.
Topics: Antineoplastic Agents; Biomarkers, Tumor; Cystectomy; Disease Progression; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Risk Factors; Treatment Outcome; Urinary Bladder Neoplasms | 2011 |
FDG PET/CT in patients with HIV.
Topics: Antiretroviral Therapy, Highly Active; Central Nervous System; Disease Progression; Fever of Unknown Origin; Fluorodeoxyglucose F18; HIV Infections; Humans; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
FDG PET in the management of patients with adrenal masses and adrenocortical carcinoma.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Adrenocortical Carcinoma; Animals; Disease Progression; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
[Clinical significance of and diagnostic methods for tumoral hypoxia].
Topics: Biomarkers, Tumor; Cell Hypoxia; Coordination Complexes; Disease Progression; Drug Resistance, Neoplasm; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasms; Organometallic Compounds; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Spectrum Analysis; Thiosemicarbazones; Tomography, Emission-Computed, Single-Photon; Tomography, Optical | 2011 |
Impact of FDG-PET and -PET/CT imaging in the clinical decision-making of ovarian carcinoma: an evidence-based approach.
Topics: Carcinoma, Ovarian Epithelial; Decision Making; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Tomography, X-Ray Computed | 2012 |
Functional neuroimaging in Parkinson's disease.
Topics: Antiparkinson Agents; Brain Diseases, Metabolic; Cognition Disorders; Disease Progression; Dopamine; Dyskinesia, Drug-Induced; Fluorodeoxyglucose F18; Functional Neuroimaging; Humans; Levodopa; Lewy Bodies; Magnetic Resonance Imaging; Neurotransmitter Agents; Parkinson Disease; Positron-Emission Tomography; Psychomotor Disorders; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2012 |
Diagnosis and extension of giant cell arteritis. Contribution of imaging techniques.
Topics: Cerebral Angiography; Diagnostic Imaging; Disease Progression; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Preclinical sporadic Alzheimer's disease: target for personalized diagnosis and preventive intervention.
Topics: Age Factors; Alzheimer Disease; Amyloid beta-Peptides; Apolipoprotein E4; Brain; Cellular Senescence; Disease Progression; Early Diagnosis; Fluorodeoxyglucose F18; Genetic Markers; Genetic Predisposition to Disease; Glucose; Humans; Magnetic Resonance Imaging; Mass Screening; Mitochondria; Neuroimaging; Positron-Emission Tomography; Precision Medicine; Radiopharmaceuticals; Risk Factors | 2013 |
Positron emission tomography in non-Hodgkin's lymphoma (NHL): relationship between tracer uptake and pathological findings, including preliminary experience in the staging of low-grade NHL.
Topics: Carbon Radioisotopes; Cell Division; Disease Progression; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Methionine; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed | 2002 |
The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis.
Topics: Adolescent; Adult; Aged; Biopsy, Needle; Bone Neoplasms; Combined Modality Therapy; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Staging; Randomized Controlled Trials as Topic; Risk Assessment; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Survival Analysis; Tomography, Emission-Computed | 2004 |
PET scan in the therapeutic strategy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Disease Progression; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms; Radiopharmaceuticals; Remission Induction; Tomography, Emission-Computed; Treatment Outcome | 2004 |
Preclinical imaging of mammary intraepithelial neoplasia with positron emission tomography.
Topics: Animals; Carcinoma in Situ; Carcinoma, Ductal, Breast; Disease Models, Animal; Disease Progression; Fluorodeoxyglucose F18; Longitudinal Studies; Lymphatic Metastasis; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Mice; Positron-Emission Tomography; Whole-Body Counting | 2006 |
Overview of early response assessment in lymphoma with FDG-PET.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; Disease Management; Disease Progression; Disease-Free Survival; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Middle Aged; Outcome Assessment, Health Care; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals | 2007 |
Multimodality imaging of atherosclerosis (magnetic resonance imaging/computed tomography/positron emission tomography-computed tomography).
Topics: Animals; Atherosclerosis; Calcinosis; Contrast Media; Disease Progression; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2007 |
The new credo: induction chemotherapy in locally advanced gastric cancer: consequences for surgical strategies.
Topics: Antineoplastic Agents; Contrast Media; Disease Progression; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Stomach Neoplasms; Treatment Outcome | 2008 |
Response evaluation of gastrointestinal stromal tumors.
Topics: Antineoplastic Agents; Benzamides; Contrast Media; Disease Progression; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Neoplasm Recurrence, Local; Piperazines; Positron-Emission Tomography; Pyrimidines; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
The lessons of GIST--PET and PET/CT: a new paradigm for imaging.
Topics: Benzamides; Contrast Media; Disease Progression; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Neoplasm Recurrence, Local; Piperazines; Positron-Emission Tomography; Pyrimidines; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
PET for sarcomas other than gastrointestinal stromal tumors.
Topics: Biopsy; Dideoxynucleosides; Disease Progression; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Misonidazole; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Sarcoma; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 2008 |
50 trial(s) available for fluorodeoxyglucose f18 and Disease Exacerbation
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Benfotiamine and Cognitive Decline in Alzheimer's Disease: Results of a Randomized Placebo-Controlled Phase IIa Clinical Trial.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Apolipoprotein E4; Brain; Cognitive Dysfunction; Disease Progression; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Glycation End Products, Advanced; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Thiamine; Treatment Outcome | 2020 |
A molecular pathology, neurobiology, biochemical, genetic and neuroimaging study of progressive apraxia of speech.
Topics: Aged; Aged, 80 and over; Anisotropy; Apraxias; Cognitive Dysfunction; Diffusion Tensor Imaging; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Male; Middle Aged; Neurobiology; Neuroimaging; Neurons; Pathology, Molecular; Positron-Emission Tomography; Speech; tau Proteins | 2021 |
18F-Fluorodeoxyglucose PET/CT and dynamic contrast-enhanced MRI as imaging biomarkers in malignant pleural mesothelioma.
Topics: Aged; Aged, 80 and over; Contrast Media; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Magnetic Resonance Imaging; Male; Mesothelioma; Mesothelioma, Malignant; Positron Emission Tomography Computed Tomography; Survival Analysis | 2018 |
Prospective evaluation of plasma Epstein-Barr virus DNA clearance and fluorodeoxyglucose positron emission scan in assessing early response to chemotherapy in patients with advanced or recurrent nasopharyngeal carcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; DNA, Viral; Drug Monitoring; Epstein-Barr Virus Infections; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Herpesvirus 4, Human; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Response Evaluation Criteria in Solid Tumors; Time Factors; Treatment Outcome; Tumor Burden; Viral Load | 2018 |
Prognosis of conversion of mild cognitive impairment to Alzheimer's dementia by voxel-wise Cox regression based on FDG PET data.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Positron-Emission Tomography; Prognosis | 2019 |
Long term follow-up of neoadjuvant chemotherapy for non-small cell lung cancer (NSCLC) investigating early positron emission tomography (PET) scan as a predictor of outcome.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Treatment Outcome | 2019 |
Predictive and prognostic value of early response assessment using 18FDG-PET in advanced non-small cell lung cancer patients treated with erlotinib.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free Survival; Erlotinib Hydrochloride; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Protein Kinase Inhibitors; Quinazolines; Radiopharmaceuticals; Treatment Outcome | 2014 |
18F-sodium fluoride uptake is a marker of active calcification and disease progression in patients with aortic stenosis.
Topics: Aged; Aged, 80 and over; Aortic Valve Stenosis; Biomarkers; Calcinosis; Disease Progression; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Reproducibility of Results; Severity of Illness Index; Sodium Fluoride | 2014 |
Peptide receptor radionuclide therapy with 177Lu-DOTATATE for patients with somatostatin receptor-expressing neuroendocrine tumors: the first US phase 2 experience.
Topics: Adult; Aged; Digestive System Neoplasms; Disease Progression; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Predictive Value of Tests; Quality of Life; Radiopharmaceuticals; Receptors, Somatostatin; Texas; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Correlating tumor metabolic progression index measured by serial FDG PET-CT, apparent diffusion coefficient measured by magnetic resonance imaging (MRI) and blood genomics to patient's outcome in advanced colorectal cancer: the CORIOLAN study.
Topics: Aged, 80 and over; Colorectal Neoplasms; Diffusion Magnetic Resonance Imaging; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Neoplastic Cells, Circulating; Positron-Emission Tomography; Prognosis; Treatment Outcome | 2014 |
Measuring treatment response to systemic therapy and predicting outcome in biliary tract cancer: comparing tumor size, volume, density, and metabolism.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biliary Tract Neoplasms; Contrast Media; Deoxycytidine; Disease Progression; Female; Fluorodeoxyglucose F18; Gemcitabine; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Prospective evaluation of 18F-fluorodeoxyglucose positron emission tomography in patients receiving hepatic arterial and systemic chemotherapy for unresectable colorectal liver metastases.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; New York City; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Risk Factors; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
[Oligoprogression].
Topics: Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Disease Progression; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Drug Administration Schedule; Erlotinib Hydrochloride; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Quinazolines; Radiosurgery; Radiotherapy Dosage; Retreatment; Survival Rate; Treatment Failure | 2015 |
Planned FDG PET-CT Scan in Follow-Up Detects Disease Progression in Patients With Locally Advanced NSCLC Receiving Curative Chemoradiotherapy Earlier Than Standard CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Denmark; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiography | 2015 |
Prediction of disease-free survival using relative change in FDG-uptake early during neoadjuvant chemoradiotherapy for potentially curable esophageal cancer: A prospective cohort study.
Topics: Adult; Aged; Chemoradiotherapy, Adjuvant; Disease Progression; Disease-Free Survival; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Treatment Outcome | 2017 |
Atherosclerotic 18F-FDG and MDP uptake in femoral arteries, changes with age.
Topics: Adult; Aged; Aged, 80 and over; Aging; Atherosclerosis; Disease Progression; Female; Femoral Artery; Fluorodeoxyglucose F18; Humans; Male; Metabolic Clearance Rate; Middle Aged; Radiopharmaceuticals; Technetium Tc 99m Medronate; Whole Body Imaging | 2016 |
Heart failure patients with prediabetes and newly diagnosed diabetes display abnormalities in myocardial metabolism.
Topics: Aged; Cicatrix; Coronary Circulation; Diabetes Complications; Diabetes Mellitus, Type 2; Disease Progression; Echocardiography; Female; Fluorodeoxyglucose F18; Glucose; Glucose Tolerance Test; Heart; Heart Failure; Humans; Liraglutide; Male; Metabolic Syndrome; Middle Aged; Myocardium; Perfusion; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Prediabetic State; Ventricular Dysfunction, Left | 2018 |
Value of volume-based early metabolic response in patients with unresectable thymic epithelial tumor.
Topics: Adult; Aged; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Positron-Emission Tomography; Prognosis; Prospective Studies; Retrospective Studies; Thymus Neoplasms; Treatment Outcome | 2016 |
Short-term changes in arterial inflammation predict long-term changes in atherosclerosis progression.
Topics: Arteritis; Carotid Arteries; Carotid Artery Diseases; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2017 |
Correlation of
Topics: Adult; Aged; Area Under Curve; Chemoradiotherapy; Disease Progression; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed; Tumor Burden | 2017 |
Fluorine-18 fluorodeoxyglucose positron emission tomography in mature T-cell and natural killer cell malignancies.
Topics: Adolescent; Adult; Aged; Cohort Studies; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Killer Cells, Natural; Lymphoma, T-Cell; Male; Middle Aged; Positron-Emission Tomography | 2008 |
Longitudinal multimodal imaging in mild to moderate Alzheimer disease: a pilot study with memantine.
Topics: Aged; Alzheimer Disease; Antiparkinson Agents; Biomarkers; Disease Progression; Double-Blind Method; Female; Fluorodeoxyglucose F18; Glucose; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Memantine; Middle Aged; Pilot Projects; Placebos | 2008 |
Early prediction of response to sunitinib after imatinib failure by 18F-fluorodeoxyglucose positron emission tomography in patients with gastrointestinal stromal tumor.
Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Disease Progression; Drug Resistance, Neoplasm; Female; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Indoles; Male; Middle Aged; Mutation; Piperazines; Positron-Emission Tomography; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-kit; Pyrimidines; Pyrroles; Receptor, Platelet-Derived Growth Factor alpha; Salvage Therapy; Sunitinib | 2009 |
FDG-PET for assessment of early treatment response after four cycles of chemotherapy in patients with advanced-stage Hodgkin's lymphoma has a high negative predictive value.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Progression; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Procarbazine; Prognosis; Radiopharmaceuticals; Treatment Outcome; Vincristine; Young Adult | 2009 |
[18F]fluorodeoxyglucose positron emission tomography correlates with Akt pathway activity but is not predictive of clinical outcome during mTOR inhibitor therapy.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Proliferation; Disease Progression; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Mice; Mice, Nude; Neoplasms; Patient Selection; Phosphorylation; Positron-Emission Tomography; Predictive Value of Tests; Protein Kinases; Proto-Oncogene Proteins c-akt; Radiopharmaceuticals; Sirolimus; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Treatment Outcome; Xenograft Model Antitumor Assays | 2009 |
Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Blood Glucose; Cognitive Dysfunction; Disability Evaluation; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Neuropsychological Tests; Positron-Emission Tomography; Predictive Value of Tests; Severity of Illness Index | 2011 |
Prediction of progression-free survival in patients with multiple myeloma following anthracycline-based chemotherapy based on dynamic FDG-PET.
Topics: Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Discriminant Analysis; Disease Progression; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Multiple Myeloma; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Risk; Survival Analysis; Time Factors | 2009 |
Chemotherapy response monitoring of colorectal liver metastases by dynamic Gd-DTPA-enhanced MRI perfusion parameters and 18F-FDG PET metabolic rate.
Topics: Aged; Antineoplastic Agents; Colorectal Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Radionuclide Imaging; Survival Rate; Treatment Outcome | 2009 |
Prediction of patient outcome with 2-deoxy-2-[18F]fluoro-D-glucose-positron emission tomography early during radiotherapy for locally advanced cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Carcinoma, Squamous Cell; Disease Progression; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Positron-Emission Tomography; Prognosis; Survival Analysis; Time Factors; Treatment Outcome; Uterine Cervical Neoplasms | 2009 |
(18)F-fluorodeoxyglucose position emission tomography (FDG-PET) for monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis.
Topics: Acute-Phase Proteins; Aged; Antineoplastic Agents, Hormonal; Disease Progression; Drug Monitoring; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Recurrence; Regression Analysis; Retroperitoneal Fibrosis; Tamoxifen; Tomography, X-Ray Computed | 2010 |
A multi-center randomized proof-of-concept clinical trial applying [¹⁸F]FDG-PET for evaluation of metabolic therapy with rosiglitazone XR in mild to moderate Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Brain Mapping; Disease Progression; Double-Blind Method; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Rosiglitazone; Thiazolidinediones; Treatment Outcome | 2010 |
Phase II study of cisplatin and imatinib in advanced salivary adenoid cystic carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Carcinoma, Adenoid Cystic; Cisplatin; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Imatinib Mesylate; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Piperazines; Positron-Emission Tomography; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-kit; Pyrimidines; Radiography, Thoracic; Radiopharmaceuticals; Remission Induction; Salivary Gland Neoplasms; Survival Rate; Tomography, X-Ray Computed; Young Adult | 2011 |
Changes in 18F-fluorodeoxyglucose and 18F-fluorodeoxythymidine positron emission tomography imaging in patients with non-small cell lung cancer treated with erlotinib.
Topics: Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Disease Progression; Erlotinib Hydrochloride; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Quinazolines; Radiopharmaceuticals; Survival Analysis; Thymidine | 2011 |
90Y-ibritumomab tiuxetan as consolidation therapy after autologous stem cell transplantation in aggressive non-Hodgkin lymphoma.
Topics: Adult; Antibodies, Monoclonal; Antineoplastic Agents; Combined Modality Therapy; Disease Progression; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Radioimmunotherapy; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome | 2011 |
FDG-PET as a potential tool for selecting patients with advanced non-small cell lung cancer who may be spared maintenance therapy after first-line chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Patient Selection; Positron-Emission Tomography; Prognosis; Treatment Outcome | 2011 |
Rationale and design of dal-PLAQUE: a study assessing efficacy and safety of dalcetrapib on progression or regression of atherosclerosis using magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography/computed tomography.
Topics: Adolescent; Adult; Aged; Amides; Anticholesteremic Agents; Coronary Disease; Diagnosis, Differential; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Esters; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Sulfhydryl Compounds; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2011 |
(18)F-FDG PET/CT for monitoring treatment responses to the epidermal growth factor receptor inhibitor erlotinib.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Carcinoma, Non-Small-Cell Lung; Disease Progression; ErbB Receptors; Erlotinib Hydrochloride; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Protein Kinase Inhibitors; Quinazolines; Survival Analysis; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
First experience with proteasome inhibitor treatment of radioiodine nonavid thyroid cancer using bortezomib.
Topics: Aged; Aged, 80 and over; Boronic Acids; Bortezomib; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Protease Inhibitors; Proteasome Inhibitors; Pyrazines; Quality of Life; Thyroid Neoplasms; Treatment Failure | 2012 |
Impact of molecular imaging on the diagnostic process in a memory clinic.
Topics: Aged; Alzheimer Disease; Aniline Compounds; Brain; Carbon Radioisotopes; Dementia; Diagnosis, Differential; Disease Progression; Early Diagnosis; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; France; Frontotemporal Dementia; Humans; Lewy Body Disease; Male; Memory Disorders; Middle Aged; Molecular Imaging; Outpatient Clinics, Hospital; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Thiazoles; Treatment Outcome | 2013 |
Prospective evaluation of 18-fluoro-2-deoxy-D-glucose positron emission tomography for the discrimination of paraaortic nodal spread in patients with locally advanced cervical carcinoma.
Topics: Adult; Aged; Aorta, Abdominal; Carcinoma, Squamous Cell; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Uterine Cervical Neoplasms | 2013 |
Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: results of a prospective trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Disease-Free Survival; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome | 2003 |
Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study.
Topics: Aged; Alzheimer Disease; Brain Mapping; Cerebral Cortex; Cognition Disorders; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Longitudinal Studies; Male; Neuropsychological Tests; Prognosis; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Statistics as Topic; Tomography, Emission-Computed | 2003 |
Region-specific decline of cerebral glucose metabolism in patients with frontotemporal dementia: a prospective 18F-FDG-PET study.
Topics: Brain Chemistry; Cognition; Dementia; Disease Progression; Female; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neuropsychological Tests; Prospective Studies; Radiopharmaceuticals; Temporal Lobe; Tomography, Emission-Computed | 2004 |
The role of serial pre-transplantation positron emission tomography in predicting progressive disease in relapsed lymphoma.
Topics: Disease Progression; Fluorodeoxyglucose F18; Humans; Lymphoma; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Recurrence | 2006 |
Autologous mesenchymal stem cell therapy delays the progression of neurological deficits in patients with multiple system atrophy.
Topics: Brain; Disease Progression; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Mesenchymal Stem Cell Transplantation; Middle Aged; Multiple System Atrophy; Positron-Emission Tomography; Prospective Studies | 2008 |
Evaluation of response to fractionated radioimmunotherapy with 90Y-epratuzumab in non-Hodgkin's lymphoma by 18F-fluorodeoxyglucose positron emission tomography.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antigens, Neoplasm; Disease Progression; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radioimmunotherapy; Radiopharmaceuticals; Salvage Therapy; Sensitivity and Specificity; Sialic Acid Binding Ig-like Lectin 2; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2008 |
Investigation of FDG-PET/CT imaging to guide biopsies in the detection of histological transformation of indolent lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Biopsy; Disease Progression; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiology, Interventional; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Grading of brain glioma with 1-11C-acetate PET: comparison with 18F-FDG PET.
Topics: Acetates; Adult; Aged; Aged, 80 and over; Astrocytoma; Brain Neoplasms; Carbon Radioisotopes; Cerebral Cortex; Disease Progression; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
FDG PET in the evaluation of the aggressiveness of pulmonary adenocarcinoma: correlation with histopathological features.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Aged; Aged, 80 and over; Disease Progression; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lung Neoplasms; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Survival Analysis | 2000 |
569 other study(ies) available for fluorodeoxyglucose f18 and Disease Exacerbation
| Article | Year |
|---|---|
Patterns of Distribution of 18F-THK5351 Positron Emission Tomography in Alzheimer's Disease Continuum.
Topics: Aged; Alzheimer Disease; Aminopyridines; Amnesia; Aniline Compounds; Brain; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Quinolines; Radiopharmaceuticals; Severity of Illness Index; tau Proteins; Thiazoles | 2022 |
The Transition of Mild Cognitive Impairment Over Time: An AV45- and FDG-PET Study of Reversion and Conversion Phenomena.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Cognitive Dysfunction; Disease Progression; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Positron-Emission Tomography | 2021 |
Using radiomics-based modelling to predict individual progression from mild cognitive impairment to Alzheimer's disease.
Topics: Alzheimer Disease; Biomarkers; Cognitive Dysfunction; Disease Progression; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography | 2022 |
A case of [
Topics: COVID-19; Disease Progression; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Positron Emission Tomography Computed Tomography; Quinolines | 2022 |
Longitudinal Characterization of Vascular Inflammation and Disease Activity in Takayasu Arteritis and Giant Cell Arteritis: A Single-Center Prospective Study.
Topics: Disease Progression; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Inflammation; Prospective Studies; Takayasu Arteritis | 2023 |
Monitoring Alzheimer's Disease Progression in Mild Cognitive Impairment Stage Using Machine Learning-Based FDG-PET Classification Methods.
Topics: Alzheimer Disease; Cognitive Dysfunction; Disease Progression; Fluorodeoxyglucose F18; Humans; Machine Learning; Prodromal Symptoms | 2022 |
Alzheimer's Disease Prediction Algorithm Based on Group Convolution and a Joint Loss Function.
Topics: Algorithms; Alzheimer Disease; Cognitive Dysfunction; Disease Progression; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography | 2022 |
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Machine Learning; Male; Neuroimaging; Positron-Emission Tomography; Radiopharmaceuticals; White Matter | 2023 |
Early Hyperprogression of Lymphoma Detected by 18 F-FDG PET/CT After Chimeric Antigen Receptor T-Cell Therapy.
Topics: Aged; Cell- and Tissue-Based Therapy; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Receptors, Chimeric Antigen | 2023 |
Vigorous, regular physical exercise may slow disease progression in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cognitive Dysfunction; Disease Progression; Exercise; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography | 2023 |
18F-FDG PET-CT in Cutaneous Metastases in Breast Carcinoma: An unusual presentation.
Topics: Breast Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Skin Neoplasms | 2023 |
Expert elicitation of risk factors for progression to dementia in individuals with mild cognitive impairment.
Topics: Alzheimer Disease; Atrophy; Cognitive Dysfunction; Disease Progression; Fluorodeoxyglucose F18; Humans | 2023 |
Longitudinal changes in metabolic network activity in early Alzheimer's disease.
Topics: Alzheimer Disease; Brain; Cognitive Dysfunction; Disease Progression; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography | 2023 |
Predictive value of
Topics: Aged; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms; Tumor Burden | 2023 |
Alzheimer's deterioration in intellectual and neurobiological staging supports the retrogenesis model: a double dissociation between verbal/non-verbal judgments and the left/right parieto-temporal glucose metabolism. A retrospective data analysis from the
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Atrophy; Brain; Data Analysis; Disease Progression; Female; Fluorodeoxyglucose F18; Glucose; Hippocampus; Humans; Judgment; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Retrospective Studies; Stanford-Binet Test; Temporal Lobe | 2020 |
Association between F-18 fluorodeoxyglucose uptake of noncancerous lung area and acute exacerbation of interstitial pneumonia in patients with lung cancer after resection.
Topics: Adult; Aged; Aged, 80 and over; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Idiopathic Pulmonary Fibrosis; Lung Neoplasms; Male; Middle Aged; Pneumonectomy; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Respiration; Risk Assessment; Risk Factors; Treatment Outcome; Young Adult | 2020 |
Brown adipose tissue and cancer progression.
Topics: Adipose Tissue, Brown; Adult; Aged; Aged, 80 and over; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Young Adult | 2020 |
Reciprocal Incremental Value of 18F-FDG-PET and Cerebrospinal Fluid Biomarkers in Mild Cognitive Impairment Patients Suspected for Alzheimer's Disease and Inconclusive First Biomarker.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Brain; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Retrospective Studies; tau Proteins | 2019 |
Feasibility of Assessing Inflammation in Asymptomatic Abdominal Aortic Aneurysms With Integrated 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging.
Topics: Aged; Aged, 80 and over; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Aortitis; Asymptomatic Diseases; Disease Progression; Feasibility Studies; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Angiography; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals | 2020 |
FDG PET Findings of Hyperprogression During Immunotherapy in a Patient With Hepatocellular Carcinoma.
Topics: Adult; Carcinoma, Hepatocellular; Disease Progression; Fluorodeoxyglucose F18; Humans; Immunotherapy; Liver Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals | 2020 |
Incremental value of FDG-PET/CT to monitor treatment response in infectious spondylodiscitis.
Topics: Aged; Anti-Bacterial Agents; Discitis; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2020 |
Topics: Aged; Blood Flow Velocity; Carotid Artery Diseases; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Incidence; Magnetic Resonance Imaging; Male; Middle Aged; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2020 |
Brain metabolic connectome classify mild cognitive impairment into Alzheimer's dementia
Topics: Alzheimer Disease; Brain; Cognitive Dysfunction; Connectome; Disease Progression; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography | 2019 |
Longitudinal 18F-FDG Images in Patients With Alzheimer Disease Over More Than 9 Years From a Preclinical Stage.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2020 |
The Value of PET-CT in Ovarian Epithelial Carcinoma: A Population-Based Study in British Columbia, Canada.
Topics: British Columbia; Carcinoma, Ovarian Epithelial; Cytoreduction Surgical Procedures; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2020 |
FDG PET/CT of COVID-19.
Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Disease Progression; Fluorodeoxyglucose F18; Humans; Lung; Male; Middle Aged; Pandemics; Pneumonia, Viral; Positron Emission Tomography Computed Tomography; SARS-CoV-2; Tomography, X-Ray Computed | 2020 |
A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease.
Topics: Adult; Aged; Alzheimer Disease; Amyloid; Atrophy; Brain; Cognition; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Inheritance Patterns; Magnetic Resonance Imaging; Male; Middle Aged; Neuroimaging; Phosphorylation; Plaque, Amyloid; Solubility; tau Proteins | 2020 |
FDG-PET/CT diagnosis of aortitis and pseudoaneurysms.
Topics: Aged; Aneurysm, False; Aortitis; C-Reactive Protein; Cardiology; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Immunosuppressive Agents; Inflammation; Magnetic Resonance Angiography; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2020 |
Stereotactic body radiotherapy in patients with lung tumors composed of mainly ground-glass opacity.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Disease Progression; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiosurgery; Retrospective Studies; Tomography, X-Ray Computed | 2020 |
Radiomics, Tumor Volume, and Blood Biomarkers for Early Prediction of Pseudoprogression in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibition.
Topics: Adult; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Immune Checkpoint Inhibitors; Male; Melanoma; Middle Aged; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Progression-Free Survival; Radiopharmaceuticals; Tumor Burden; Young Adult | 2020 |
Predicting MCI progression with FDG-PET and cognitive scores: a longitudinal study.
Topics: Algorithms; Alzheimer Disease; Brain; Cognitive Dysfunction; Disease Progression; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Mental Status and Dementia Tests; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity | 2020 |
Individual brain metabolic connectome indicator based on Kullback-Leibler Divergence Similarity Estimation predicts progression from mild cognitive impairment to Alzheimer's dementia.
Topics: Alzheimer Disease; Brain; Cognitive Dysfunction; Connectome; Disease Progression; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Tomography, X-Ray Computed | 2020 |
CSF p-tau/Aβ
Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Brain; Cognitive Dysfunction; Disease Progression; Fluorodeoxyglucose F18; Humans; Peptide Fragments; tau Proteins | 2020 |
18F-FDG PET/CT in Sporadic Creutzfeldt-Jakob Disease.
Topics: Creutzfeldt-Jakob Syndrome; Disease Progression; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography | 2020 |
The impact of atlas-based MR attenuation correction on the diagnosis of FDG-PET/MR for Alzheimer's diseases- A simulation study combining multi-center data and ADNI-data.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cognitive Dysfunction; Computer Simulation; Datasets as Topic; Diagnosis, Differential; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Neuroimaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2020 |
Prostate Cancer Lymphangitic Pulmonary Carcinomatosis: Appearance on 18F-FDG PET/CT and 18F-DCFPyL PET/CT.
Topics: Disease Progression; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lysine; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prednisone; Prostatic Neoplasms; Urea | 2020 |
A Prospective Trial of
Topics: Aged; Androgen Antagonists; Disease Progression; Drug Resistance, Neoplasm; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Kallikreins; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radiopharmaceuticals; Tumor Burden | 2020 |
Topics: Aged; Aorta; Aortic Dissection; Biological Transport; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Organ Size; Positron Emission Tomography Computed Tomography | 2020 |
Longitudinal structural and metabolic changes in frontotemporal dementia.
Topics: Aged; Atrophy; Cerebral Cortex; Disease Progression; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Neuroimaging; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals | 2020 |
Creutzfeldt-Jakob disease in a man with COVID-19: SARS-CoV-2-accelerated neurodegeneration?
Topics: Aged; Betacoronavirus; Brain; Coronavirus Infections; COVID-19; Creutzfeldt-Jakob Syndrome; Disease Progression; Electroencephalography; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Pandemics; Pneumonia, Viral; Positron-Emission Tomography; Radiopharmaceuticals; SARS-CoV-2 | 2020 |
The Prognostic Value of SUVmax of 18F-FDG PET/CT in Patients with Metastatic Colorectal Cancer.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Colonic Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; ROC Curve | 2020 |
Diffuse Increased 68Ga-DOTATATE But Unimpressive 18F-FDG Osseous Activity in a Patient With Rapid-Progressing Synchronous Multifocal Osteosarcoma.
Topics: Adolescent; Bone and Bones; Disease Progression; Fluorodeoxyglucose F18; Humans; Male; Organometallic Compounds; Osteosarcoma; Positron Emission Tomography Computed Tomography | 2020 |
MM2-type sporadic Creutzfeldt-Jakob disease: new diagnostic criteria for MM2-cortical type.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Cerebral Cortex; Cerebrovascular Circulation; Creutzfeldt-Jakob Syndrome; Cysteine; Diffusion Magnetic Resonance Imaging; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Iofetamine; Male; Middle Aged; Organotechnetium Compounds; Prion Proteins; PrPSc Proteins; Radiopharmaceuticals; Sensitivity and Specificity; Thalamus; Tomography, Emission-Computed, Single-Photon | 2020 |
Long-term results of PET-guided radiation in patients with advanced-stage diffuse large B-cell lymphoma treated with R-CHOP.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Cyclophosphamide; Disease Progression; Doxorubicin; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Radiotherapy, Adjuvant; Radiotherapy, Image-Guided; Retrospective Studies; Rituximab; Single-Blind Method; Treatment Outcome; Tumor Burden; Vincristine; Young Adult | 2021 |
Multi-View Separable Pyramid Network for AD Prediction at MCI Stage by
Topics: Aged; Alzheimer Disease; Brain; Cognitive Dysfunction; Disease Progression; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography | 2021 |
A Novel Metabolic Connectome Method to Predict Progression to Mild Cognitive Impairment.
Topics: Alzheimer Disease; Brain; Cognitive Dysfunction; Connectome; Disease Progression; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography | 2020 |
Editorial for: "PET/MRI in Cervical Cancer: Associations Between Imaging Biomarkers and Tumor Stage, Disease Progression, and Overall Survival".
Topics: Biomarkers; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2021 |
Identifying optimal candidates for induction chemotherapy among stage II-IVa nasopharyngeal carcinoma based on pretreatment Epstein-Barr virus DNA and nodal maximal standard uptake values of [
Topics: Clinical Decision-Making; Disease Progression; DNA, Viral; Epstein-Barr Virus Infections; Female; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Induction Chemotherapy; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Progression-Free Survival; Radiopharmaceuticals; Retrospective Studies; Time Factors | 2020 |
Prediction of Acute Exacerbation of Interstitial Pneumonia Using Visual Evaluation of PET.
Topics: Adult; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Male; Middle Aged; Pneumonectomy; Positron Emission Tomography Computed Tomography; Postoperative Complications; Preoperative Care; Prognosis; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed | 2021 |
Clinically isolated aortitis: imaging features and clinical outcomes: comparison with giant cell arteritis and giant cell aortitis.
Topics: Adrenal Cortex Hormones; Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Aortic Aneurysm; Aortitis; Aortography; Computed Tomography Angiography; Diagnosis, Differential; Dilatation, Pathologic; Disease Progression; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Magnetic Resonance Angiography; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2021 |
Potential and Clinical Significance of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Evaluating Liver Cancer Response to Lenvatinib Treatment.
Topics: Administration, Oral; Aged; Aged, 80 and over; alpha-Fetoproteins; Antineoplastic Agents; Carcinoma, Hepatocellular; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Phenylurea Compounds; Positron Emission Tomography Computed Tomography; Prognosis; Quinolines; Retrospective Studies; Treatment Outcome | 2021 |
Usual and Rare Abdominal Location of Giant Cell Arteritis Diagnosed and Follow-up With 18F-FDG PET/CT.
Topics: Abdomen; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Giant Cell Arteritis; Humans; Middle Aged; Positron Emission Tomography Computed Tomography | 2021 |
Baseline Total Metabolic Tumor Volume and Total Lesion Glycolysis Measured on 18F-FDG PET-CT Predict Outcomes in T-Cell Lymphoblastic Lymphoma.
Topics: Adolescent; Adult; Aged; Child; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Progression-Free Survival; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; ROC Curve; Tumor Burden; Warburg Effect, Oncologic; Young Adult | 2021 |
18F-FDG PET/CT for Monitoring of Disease Progression in Metastatic Perivascular Epithelioid Cell Tumor.
Topics: Adult; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Perivascular Epithelioid Cell Neoplasms; Positron Emission Tomography Computed Tomography | 2021 |
2-[
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Biomarkers, Tumor; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Multivariate Analysis; Positron Emission Tomography Computed Tomography; Prognosis; ROC Curve | 2021 |
Neuropsychiatric symptoms are early indicators of an upcoming metabolic decline in Alzheimer's disease.
Topics: Adult; Age of Onset; Aged; Alzheimer Disease; Disease Progression; Factor Analysis, Statistical; Female; Fluorodeoxyglucose F18; Heterozygote; Humans; Longitudinal Studies; Male; Mental Disorders; Middle Aged; Mutation; Nervous System Diseases; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
Validation of the Alzheimer Disease Dementia Conversion-Related Pattern as an ATN Biomarker of Neurodegeneration.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cognitive Dysfunction; Cohort Studies; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neurofilament Proteins; Neuropsychological Tests; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Risk Assessment; tau Proteins | 2021 |
Acute Brain Stroke Evolution Detected by 18F-FDG PET/CT and MRI Justifies the Discordance of Lesions in a Patient With Lymphoproliferative Syndrome.
Topics: Diagnosis, Differential; Disease Progression; Fluorodeoxyglucose F18; Humans; Lymphoproliferative Disorders; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Stroke | 2021 |
Mediastinal FDG-positive lymph nodes simulating melanoma progression: drug-induced sarcoidosis like/lymphadenopathy related to ipilimumab.
Topics: Adult; Back; Biopsy; Diagnosis, Differential; Disease Progression; Female; Fluorodeoxyglucose F18; Granuloma; Humans; Immune Checkpoint Inhibitors; Ipilimumab; Lymph Nodes; Lymphadenopathy; Mediastinum; Melanoma; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Skin Neoplasms | 2021 |
A Comparison of Two Statistical Mapping Tools for Automated Brain FDG-PET Analysis in Predicting Conversion to Alzheimer's Disease in Subjects with Mild Cognitive Impairment.
Topics: Aged; Alzheimer Disease; Brain; Brain Mapping; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Models, Statistical; Positron-Emission Tomography; Radiopharmaceuticals; Sweden | 2020 |
Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency-Features of CT and
Topics: Common Variable Immunodeficiency; Disease Progression; Fluorodeoxyglucose F18; Humans; Lung Diseases, Interstitial; Positron Emission Tomography Computed Tomography; Respiratory Function Tests; Respiratory Insufficiency; Retrospective Studies | 2020 |
COVID-19 mRNA Vaccination-Induced Lymphadenopathy Mimics Lymphoma Progression on FDG PET/CT.
Topics: Aged; COVID-19; COVID-19 Vaccines; Diagnosis, Differential; Disease Progression; Fluorodeoxyglucose F18; Humans; Lymphadenopathy; Lymphoma; Male; Positron Emission Tomography Computed Tomography; RNA, Messenger; SARS-CoV-2; Subcutaneous Tissue; Vaccination | 2021 |
A Case of Rapidly Progressing Granulomatous Myocarditis: What Is the Diagnosis?
Topics: Atrioventricular Block; Biopsy; Cardiomyopathies; Diagnosis, Differential; Disease Progression; Echocardiography; Fluorodeoxyglucose F18; Giant Cells; Granuloma; Heart Block; Heart Failure; Heart Transplantation; Humans; Lymph Nodes; Magnetic Resonance Imaging; Male; Middle Aged; Myocarditis; Myocardium; Natriuretic Peptide, Brain; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis; Stroke Volume; Troponin I | 2021 |
New Trajectory of Clinical and Biomarker Changes in Sporadic Alzheimer's Disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Biomarkers; Brain; Cognitive Dysfunction; Disease Progression; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Linear Models; Longitudinal Studies; Magnetic Resonance Imaging; Male; Organ Size; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
Analysis of PET parameters as prognosticators of survival and tumor extent in Oropharyngeal Cancer treated with surgery and postoperative radiotherapy.
Topics: Adult; Aged; Disease Progression; Disease-Free Survival; Feasibility Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Oropharynx; Pharyngectomy; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy, Adjuvant; Retrospective Studies; Tumor Burden | 2021 |
Spatiotemporal Evolution of Radiation Myositis on 18F-FDG PET/CT Following Hypofractionated Radiotherapy of Intramuscular Melanoma Metastases.
Topics: Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Melanoma; Middle Aged; Myositis; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Radiation Dose Hypofractionation; Radiation Injuries | 2021 |
Complete metabolic response in patients with advanced nonsmall cell lung cancer with prolonged response to immune checkpoint inhibitor therapy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Disease Progression; Drug Administration Schedule; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Immune Checkpoint Inhibitors; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Progression-Free Survival; Radiopharmaceuticals; Retrospective Studies; Time Factors; Tumor Microenvironment | 2021 |
Case Report: Abdominal Lymph Node Metastases of Parathyroid Carcinoma: Diagnostic Workup, Molecular Diagnosis, and Clinical Management.
Topics: Antibodies, Monoclonal, Humanized; Calcium; Cinacalcet; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Immune System; Immunotherapy; Liver Neoplasms; Lymphatic Metastasis; Middle Aged; Molecular Biology; Neoplasm Metastasis; Neoplasm Recurrence, Local; Parathyroid Hormone; Parathyroid Neoplasms; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography | 2021 |
PET/MR imaging for the evaluation of cervical cancer during pregnancy.
Topics: Adult; Cervix Uteri; Disease Progression; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Neoplasm Staging; Papanicolaou Test; Positron-Emission Tomography; Pregnancy; Pregnancy Complications, Neoplastic; Preoperative Period; Radiopharmaceuticals; Uterine Cervical Neoplasms; Vaginal Smears | 2021 |
The Pattern of Use of PET/CT Scans in the Clinical Management of Chronic Lymphocytic Leukemia.
Topics: Aged; Biomarkers; Clinical Decision-Making; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Israel; L-Lactate Dehydrogenase; Leukemia, Lymphocytic, Chronic, B-Cell; Liver; Lymphocyte Count; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Survival Analysis | 2021 |
Microenvironment-triggered multimodal precision diagnostics.
Topics: Acidosis; Animals; Colorectal Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Mice; Mice, Inbred BALB C; Multimodal Imaging; Positron-Emission Tomography; Precision Medicine; Tumor Microenvironment | 2021 |
Monitoring Immune Activation with Whole-Body Fluorodeoxyglucose-Positron-Emission Tomography in Simian Immunodeficiency Virus-Infected Rhesus Macaques.
Topics: Animals; Bone Marrow; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Disease Models, Animal; Disease Progression; Female; Fluorodeoxyglucose F18; Gastrointestinal Tract; Humans; Liver; Lymph Nodes; Macaca mulatta; Male; Positron-Emission Tomography; Radiopharmaceuticals; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Spleen; Viral Load | 2021 |
Rapid Progression After 177Lu-DOTATATE in Patients With Neuroendocrine Tumors.
Topics: Adult; Aged; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Outcome Assessment, Health Care; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Peptide | 2021 |
Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Apolipoproteins E; Biomarkers; Cerebral Cortex; Cognitive Dysfunction; Disease Progression; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Neurodegenerative Diseases; Parietal Lobe; Positron-Emission Tomography; Temporal Lobe | 2017 |
Prognostic Value of Fluorine-18 Fluorodeoxyglucose Uptake of Bone Marrow on Positron Emission Tomography/Computed Tomography for Prediction of Disease Progression in Cervical Cancer.
Topics: Adult; Aged; Bone Marrow; Chemoradiotherapy; Cytoreduction Surgical Procedures; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Inflammation Mediators; Lymph Node Excision; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Uterine Cervical Neoplasms | 2017 |
Atherosclerotic plaque metabolism in high cardiovascular risk subjects - A subclinical atherosclerosis imaging study with
Topics: Adult; Calcinosis; Cardiovascular Diseases; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Molecular Imaging; Plaque, Atherosclerotic; Portugal; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prevalence; Prospective Studies; Radiopharmaceuticals; Risk Factors; Survival Rate | 2017 |
Identifying an early indicator of drug efficacy in patients with metastatic colorectal cancer-a prospective evaluation of circulating tumor cells, 18F-fluorodeoxyglucose positron-emission tomography and the RECIST criteria.
Topics: Aged; Antineoplastic Agents; Colorectal Neoplasms; Disease Progression; Disease-Free Survival; Endpoint Determination; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multidetector Computed Tomography; Neoplasm Metastasis; Neoplastic Cells, Circulating; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Risk Factors; Time Factors; Treatment Outcome | 2017 |
Abnormal metabolic brain network associated with Parkinson's disease: replication on a new European sample.
Topics: Aged; Brain; Case-Control Studies; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2017 |
Response assessment of stereotactic body radiation therapy using dynamic contrast-enhanced integrated MR-PET in non-small cell lung cancer patients.
Topics: Aged; Aged, 80 and over; Area Under Curve; Carcinoma, Non-Small-Cell Lung; Contrast Media; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiosurgery; Tomography, X-Ray Computed; Treatment Outcome | 2018 |
Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer's disease dementia.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Brain; Cognition; Cognitive Dysfunction; Dementia; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Longitudinal Studies; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Quinolines; Radiopharmaceuticals; tau Proteins | 2018 |
"Pseudo-progression" in advanced thyroid cancer in response to kinase inhibitor therapy.
Topics: Antineoplastic Agents; Carcinoma, Papillary; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Phenylurea Compounds; Positron-Emission Tomography; Protein Kinase Inhibitors; Quinolines; Thyroid Neoplasms; Thyroidectomy; Thyrotropin | 2017 |
[
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Disease Progression; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Induction Chemotherapy; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Urinary Bladder Neoplasms; Vinblastine | 2017 |
Prognostic value of metabolic parameters determined by preoperative ¹⁸F-FDG PET/CT in patients with uterine carcinosarcoma.
Topics: Adult; Aged; Carcinosarcoma; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Preoperative Period; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Survival Rate; Tumor Burden; Uterine Cervical Neoplasms | 2017 |
Cerebrovascular resistance: effects on cognitive decline, cortical atrophy, and progression to dementia.
Topics: Aged; Alzheimer Disease; Amyloid; Aniline Compounds; Atrophy; Blood Pressure; Brain; Cerebral Cortex; Cognitive Dysfunction; Disease Progression; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neuroimaging; Neurons; Neuropsychological Tests; Positron-Emission Tomography; Spin Labels; Vascular Resistance; White Matter | 2017 |
Role of [
Topics: Adult; Carcinoma, Hepatocellular; Clinical Decision-Making; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Patient Selection; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2017 |
Multiorgan Involvement of Chemotherapy-Induced Sarcoidosis Mimicking Progression of Lymphoma on FDG PET/CT.
Topics: Biopsy; Diagnosis, Differential; Disease Progression; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron Emission Tomography Computed Tomography; Recurrence; Sarcoidosis | 2017 |
A Cross-Validation of FDG- and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer's Disease in a Clinical Setting.
Topics: Aged; Alzheimer Disease; Amyloid; Aniline Compounds; Biomarkers; Cognitive Dysfunction; Dementia; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; ROC Curve; Thiazoles | 2017 |
Role of FDG-PET/MRI, FDG-PET/CT, and Dynamic Susceptibility Contrast Perfusion MRI in Differentiating Radiation Necrosis from Tumor Recurrence in Glioblastomas.
Topics: Adult; Aged; Aged, 80 and over; Brain; Brain Neoplasms; Diagnosis, Differential; Disease Progression; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiation Injuries; Retrospective Studies; Tomography, X-Ray Computed | 2018 |
Fluorescence imaging of bombesin and transferrin receptor expression is comparable to 18F-FDG PET in early detection of sorafenib-induced changes in tumor metabolism.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Colonic Neoplasms; Disease Progression; Dose-Response Relationship, Drug; Fluorescent Dyes; Fluorodeoxyglucose F18; Humans; Mice, Transgenic; Molecular Imaging; Neoplasm Transplantation; Niacinamide; Optical Imaging; Phenylurea Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Random Allocation; Receptors, Bombesin; Receptors, Transferrin; Sorafenib; Treatment Outcome; Tumor Burden | 2017 |
Prognostic Impact of Extent, Severity, and Heterogeneity of Abnormalities on
Topics: Adult; Aged; Cardiomyopathies; Coronary Circulation; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Severity of Illness Index; Time Factors | 2018 |
Mid-radiotherapy PET/CT for prognostication and detection of early progression in patients with stage III non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2017 |
Alzheimer's Disease Diagnosis Relies on a Twofold Clinical-Biological Algorithm: Three Memory Clinic Case Reports.
Topics: Aged; Algorithms; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Psychiatric Status Rating Scales; tau Proteins; Tomography, Emission-Computed, Single-Photon; Tropanes | 2017 |
Tau positron emission tomography using [
Topics: Aged; Alzheimer Disease; Aminopyridines; Amnesia; Brain; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Quinolines; Radiopharmaceuticals; Severity of Illness Index; tau Proteins | 2017 |
Longer-Term Investigation of the Value of 18F-FDG-PET and Magnetic Resonance Imaging for Predicting the Conversion of Mild Cognitive Impairment to Alzheimer's Disease: A Multicenter Study.
Topics: Aged; Alzheimer Disease; Brain; Cognitive Dysfunction; Disease Progression; Educational Status; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Logistic Models; Magnetic Resonance Imaging; Male; Multivariate Analysis; Neuropsychological Tests; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2017 |
The Alzheimer's disease metabolic brain pattern in mild cognitive impairment.
Topics: Aging; Alzheimer Disease; Brain; Cognitive Dysfunction; Disease Progression; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Positron-Emission Tomography; Radiopharmaceuticals | 2017 |
Learning Metabolic Brain Networks in MCI and AD by Robustness and Leave-One-Out Analysis: An FDG-PET Study.
Topics: Aged; Alzheimer Disease; Brain; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Learning; Male; Metabolic Networks and Pathways; Neuropsychological Tests; Positron-Emission Tomography | 2018 |
Utility of Molecular and Structural Brain Imaging to Predict Progression from Mild Cognitive Impairment to Dementia.
Topics: Aged; Aged, 80 and over; Aniline Compounds; Apolipoproteins E; Benzothiazoles; Brain; Cognitive Dysfunction; Dementia; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Middle Aged; Organ Size; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Thiazoles | 2017 |
Topics: Brain; Brain Mapping; Dihydroxyphenylalanine; Disease Progression; Dopamine Agents; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Nortropanes; Parkinson Disease; Positron-Emission Tomography; Severity of Illness Index | 2018 |
Association of Tumor Necrosis Factor Inhibitor Treatment With Reduced Indices of Subclinical Atherosclerosis in Patients With Psoriatic Disease.
Topics: Adult; Aged; Antirheumatic Agents; Atherosclerosis; Canada; Cohort Studies; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Prospective Studies; Psoriasis; Risk Factors; Tumor Necrosis Factor-alpha | 2018 |
End-of-Treatment Positron Emission Tomography After Uniform First-Line Therapy of B-Cell Posttransplant Lymphoproliferative Disorder Identifies Patients at Low Risk of Relapse in the Prospective German PTLD Registry.
Topics: Adult; Aged; Aged, 80 and over; B-Lymphocytes; Contrast Media; Disease Progression; Female; Fluorodeoxyglucose F18; Germany; Humans; Immunosuppressive Agents; Lymphoproliferative Disorders; Male; Middle Aged; Neoplasm Staging; Organ Transplantation; Positron-Emission Tomography; Predictive Value of Tests; Progression-Free Survival; Recurrence; Registries; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Young Adult | 2018 |
Combination of high-fat/high-fructose diet and low-dose streptozotocin to model long-term type-2 diabetes complications.
Topics: Animals; Diabetes Complications; Diabetes Mellitus, Experimental; Diet, High-Fat; Disease Progression; Fluorodeoxyglucose F18; Fructose; Humans; Insulin Resistance; Male; Positron-Emission Tomography; Prediabetic State; Rats; Streptozocin | 2018 |
Complement pathway gene activation and rising circulating immune complexes characterize early disease in HIV-associated tuberculosis.
Topics: Antibodies; Antigen-Antibody Complex; Cluster Analysis; Coinfection; Comorbidity; Complement System Proteins; Disease Progression; Fluorodeoxyglucose F18; HIV Infections; Humans; Interferons; Oligonucleotide Array Sequence Analysis; Positron Emission Tomography Computed Tomography; Signal Transduction; Transcription, Genetic; Transcriptional Activation; Transcriptome; Tuberculosis | 2018 |
FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Brain; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Male; Middle Aged; Neuropsychological Tests; Phosphorylation; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity; tau Proteins | 2018 |
Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Biomarkers; Brain; Disease Progression; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Positron-Emission Tomography; tau Proteins | 2018 |
Heterozygous genotype at codon 129 correlates with prolonged disease course in Heidenhain variant sporadic CJD: case report.
Topics: Aged; Amyloid beta-Peptides; Creutzfeldt-Jakob Syndrome; Disease Progression; Electroencephalography; Fluorodeoxyglucose F18; Genotype; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Prion Proteins; Tomography, Emission-Computed, Single-Photon | 2018 |
Joint Assessment of Quantitative 18F-Florbetapir and 18F-FDG Regional Uptake Using Baseline Data from the ADNI.
Topics: Aged; Alzheimer Disease; Aniline Compounds; Brain; Brain Mapping; Cognitive Dysfunction; Cross-Sectional Studies; Disease Progression; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2018 |
Anosognosia predicts default mode network hypometabolism and clinical progression to dementia.
Topics: Aged; Agnosia; Amyloid; Aniline Compounds; Apolipoprotein E4; Biomarkers; Brain; Cognitive Dysfunction; Dementia; Disease Progression; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Prognosis; Radiopharmaceuticals | 2018 |
A case of late-onset OCD developing PLS and FTD.
Topics: Brain; Disease Progression; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Magnetic Resonance Imaging; Middle Aged; Motor Neuron Disease; Obsessive-Compulsive Disorder; Positron-Emission Tomography | 2018 |
Single-subject SPM FDG-PET patterns predict risk of dementia progression in Parkinson disease.
Topics: Aged; Brain; Dementia; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Models, Statistical; Parkinson Disease; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Risk Assessment; Sensitivity and Specificity | 2018 |
Succinate Dehydrogenase B Subunit-Negative Jugular Foramen Paraganglioma Manifesting Malignant Progression with Pseudohypoxia-Related Atypical Uptake of [
Topics: Biomarkers, Tumor; Diagnosis, Differential; Disease Progression; Fatal Outcome; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypoxia, Brain; Middle Aged; Paraganglioma; Protein Subunits; Skull Base; Succinate Dehydrogenase | 2018 |
Metabolic brain networks in aging and preclinical Alzheimer's disease.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Aging; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Apolipoprotein E4; Brain; Correlation of Data; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Positron-Emission Tomography; Thiazoles; Young Adult | 2018 |
Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD).
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloidosis; Brain; Cognitive Dysfunction; Cohort Studies; Disease Progression; Educational Status; Female; Fluorodeoxyglucose F18; Humans; Male; Mental Status Schedule; Middle Aged; Positron-Emission Tomography | 2018 |
Predicting Imminent Progression to Clinically Significant Memory Decline Using Volumetric MRI and FDG PET.
Topics: Aged; Alzheimer Disease; Apolipoproteins E; Brain; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2018 |
Anti-inflammatory effect of statin in coronary aneurysms late after Kawasaki disease.
Topics: Adult; Anti-Inflammatory Agents; Computed Tomography Angiography; Coronary Aneurysm; Coronary Angiography; Coronary Artery Bypass; Coronary Vessels; Disease Progression; Fluorodeoxyglucose F18; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Male; Mucocutaneous Lymph Node Syndrome; Positron-Emission Tomography | 2019 |
Relationship between inflammation and progression of an abdominal aortic aneurysm in a rabbit model based on 18F-FDG PET/CT imaging.
Topics: Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Aortitis; Disease Models, Animal; Disease Progression; Fluorodeoxyglucose F18; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Pancreatic Elastase; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Rabbits; Radiopharmaceuticals; Time Factors; Vascular Remodeling | 2018 |
Added prognostic value of FDG-PET/CT in relapsing multiple myeloma patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multiple Myeloma; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Progression-Free Survival; Radiopharmaceuticals; Stem Cell Transplantation; Transplantation, Autologous | 2019 |
Impact of
Topics: Adult; Aged; Brain Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Glioma; Heavy Ion Radiotherapy; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiotherapy, Computer-Assisted; Retrospective Studies; Sensitivity and Specificity; Survival Analysis; Tumor Burden | 2018 |
Prospective Study of Serial
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Disease Progression; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Middle Aged; Positron-Emission Tomography; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals | 2018 |
Evolution of lobar abnormalities of cerebral glucose metabolism in 41 children with drug-resistant epilepsy.
Topics: Adolescent; Anticonvulsants; Blood Glucose; Brain; Child; Child, Preschool; Developmental Disabilities; Disease Progression; Dominance, Cerebral; Drug Resistant Epilepsy; Electroencephalography; Energy Metabolism; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Infant; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Retrospective Studies | 2018 |
TSPO-PET imaging using [18F]PBR06 is a potential translatable biomarker for treatment response in Huntington's disease: preclinical evidence with the p75NTR ligand LM11A-31.
Topics: Animals; Cerebral Cortex; Disease Models, Animal; Disease Progression; Fluorodeoxyglucose F18; Hippocampus; Humans; Huntington Disease; Isoleucine; Male; Mice; Microglia; Morpholines; Positron-Emission Tomography; Protein Binding; Receptors, GABA; Receptors, Nerve Growth Factor | 2018 |
Spatial Patterns of Hypometabolism and Amyloid Deposition in Variants of Alzheimer's Disease Corresponding to Brain Networks: a Prospective Cohort Study.
Topics: Aged; Alzheimer Disease; Amyloid; Aniline Compounds; Benzothiazoles; Brain; Brain Diseases, Metabolic; Carbon Radioisotopes; Case-Control Studies; Cohort Studies; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Net; Plaque, Amyloid; Positron-Emission Tomography; Thiazoles; Time Factors; Tissue Distribution | 2019 |
Patterns of Failure Following Dose-escalated Chemoradiotherapy for Fluorodeoxyglucose Positron Emission Tomography Staged Squamous Cell Carcinoma of the Oesophagus.
Topics: Adult; Aged; Chemoradiotherapy; Disease Progression; Disease-Free Survival; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Retrospective Studies; Survival Rate; Treatment Failure | 2018 |
Osteoblastic bone response mimicking bone progression during treatment with pembrolizumab in advanced cutaneous melanoma.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Bone Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Immunotherapy; Melanoma; Middle Aged; Osteoblasts; Positron-Emission Tomography; Skin Neoplasms; Tomography, X-Ray Computed | 2018 |
Metabolic positron emission tomography parameters predict failure patterns in early non-small-cell lung cancer treated with stereotactic body radiation therapy: a single institution experience.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiosurgery; Retrospective Studies | 2018 |
Combined positron emission tomography/computed tomography for diagnosis and monitoring of orbital adnexal lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Child; Diagnosis, Differential; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Neoplasm Staging; Orbit; Orbital Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Young Adult | 2018 |
FDG PET Parkinson's disease-related pattern as a biomarker for clinical trials in early stage disease.
Topics: Adult; Aged; Aged, 80 and over; Clinical Trials as Topic; Cohort Studies; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multivariate Analysis; Parkinson Disease; Positron-Emission Tomography | 2018 |
Indirect relation based individual metabolic network for identification of mild cognitive impairment.
Topics: Aged; Biomarkers; Brain Mapping; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Metabolic Networks and Pathways; Positron-Emission Tomography; ROC Curve | 2018 |
Characteristic patterns of inter- and intra-hemispheric metabolic connectivity in patients with stable and progressive mild cognitive impairment and Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Brain; Cognitive Dysfunction; Connectome; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Net; Positron-Emission Tomography | 2018 |
The added value of whole-body magnetic resonance imaging in the management of patients with advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast; Breast Neoplasms; Disease Progression; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Patient Selection; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome; Whole Body Imaging | 2018 |
Head and Neck Cancer Soft Tissue Radiation Necrosis-Diagnostic Challenge.
Topics: Carcinoma, Squamous Cell; Chemoradiotherapy; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Necrosis; Positron Emission Tomography Computed Tomography; Radiation Injuries; Salvage Therapy; Tongue Neoplasms | 2019 |
Prognostic significance of maximum standardized uptake value on 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in bone sarcomas.
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Child; Child, Preschool; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Osteosarcoma; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Young Adult | 2018 |
Ectopic adrenocorticotropic hormone syndrome associated with olfactory neuroblastoma: acquirement of adrenocorticotropic hormone expression during disease course as shown by serial immunohistochemistry examinations.
Topics: Adrenocorticotropic Hormone; Blood Glucose; Disease Progression; Eosinophils; Esthesioneuroblastoma, Olfactory; Fluorodeoxyglucose F18; Humans; Hydrocortisone; Immunohistochemistry; Leukocyte Count; Male; Metyrapone; Middle Aged; Octreotide; Positron-Emission Tomography; Potassium; Syndrome | 2018 |
B-cell peripheral neurolymphomatosis: MRI and
Topics: Aged; B-Lymphocytes; Biopsy; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neurolymphomatosis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2019 |
Head-to-Head Comparison among Semi-Quantification Tools of Brain FDG-PET to Aid the Diagnosis of Prodromal Alzheimer's Disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Disease Progression; Early Diagnosis; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Prodromal Symptoms; Support Vector Machine | 2019 |
Integrated PET-MRI for Glioma Surveillance: Perfusion-Metabolism Discordance Rate and Association With Molecular Profiling.
Topics: Adult; Aged; Brain Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Glioma; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Grading; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tumor Burden | 2019 |
Covariance statistics and network analysis of brain PET imaging studies.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Case-Control Studies; Cross-Sectional Studies; Dihydroxyphenylalanine; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Neuroimaging; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals | 2019 |
Hybrid positron emission tomography-magnetic resonance imaging for assessing different stages of cardiac impairment in patients with Anderson-Fabry disease: AFFINITY study group.
Topics: Adult; Cardiovascular Diseases; Case-Control Studies; Contrast Media; Disease Progression; Fabry Disease; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals | 2019 |
Unconventional immune-related phenomena observed using 18F-FDG PET/CT in Hodgkin lymphoma treated with anti PD-1 monoclonal antibodies.
Topics: Disease Progression; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Immune System; Immunotherapy; Nivolumab; Positron Emission Tomography Computed Tomography; Programmed Cell Death 1 Receptor; Recurrence; Retrospective Studies; Treatment Outcome | 2019 |
Early evaluation of tumor response to
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; B-Lymphocytes; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prospective Studies; Radioimmunotherapy; Radionuclide Imaging | 2019 |
Cardiac sarcoidosis mimicking myocardial infarction: a comprehensive evaluation using computed tomography and positron emission tomography.
Topics: Aged; Biopsy; Disease Progression; Electrocardiography; Female; Fluorodeoxyglucose F18; Heart; Humans; Magnetic Resonance Imaging; Myocardial Infarction; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sarcoidosis | 2020 |
Prognostic value of metabolic tumour volume on baseline
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Progression-Free Survival; Proportional Hazards Models; Retrospective Studies; ROC Curve; Severity of Illness Index; Tumor Burden; Young Adult | 2019 |
Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Case-Control Studies; Cerebral Cortex; Cerebral Ventricles; Cognitive Dysfunction; Cohort Studies; Disease Progression; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Mental Status and Dementia Tests; Neurofilament Proteins; Organ Size; Peptide Fragments; Phosphoproteins; Positron-Emission Tomography; Radiopharmaceuticals; tau Proteins | 2019 |
Prognostic utility of pre- and post-treatment FDG-PET parameters in anal squamous cell carcinoma.
Topics: Adult; Aged; Anus Neoplasms; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2019 |
Chemoradiation induces epithelial-to-mesenchymal transition in esophageal adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cell Line, Tumor; Chemoradiotherapy; Disease Progression; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Esophageal Mucosa; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymph Nodes; Male; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Positron-Emission Tomography; Primary Cell Culture; Progression-Free Survival; Signal Transduction; Transforming Growth Factor beta; Treatment Outcome; Xenograft Model Antitumor Assays | 2019 |
Screening for brain metastases in patients with stage III non-small-cell lung cancer, magnetic resonance imaging or computed tomography? A prospective study.
Topics: Aged; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Disease Progression; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Netherlands; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Time Factors | 2019 |
Predicting long-term clinical stability in amyloid-positive subjects by FDG-PET.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Brain; Clinical Trials as Topic; Cognitive Dysfunction; Dementia; Disease Progression; Female; Fluorodeoxyglucose F18; Healthy Volunteers; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography | 2019 |
EEG evidence of compensatory mechanisms in preclinical Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Biomarkers; Brain Waves; Case-Control Studies; Disease Progression; Electroencephalography; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Nerve Degeneration; Positron-Emission Tomography; Prodromal Symptoms | 2019 |
FDG-PET as an independent biomarker for Alzheimer's biological diagnosis: a longitudinal study.
Topics: Aged; Alzheimer Disease; Biomarkers; Brain; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Male; Positron-Emission Tomography | 2019 |
Prognostic value of Alzheimer's biomarkers in mild cognitive impairment: the effect of age at onset.
Topics: Age of Onset; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cerebral Cortex; Cognitive Dysfunction; Datasets as Topic; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Peptide Fragments; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; tau Proteins | 2019 |
Rapidly Progressing Renal Cell Cancer of the Left Native Kidney in a Renal Transplant Recipient With Unusual Sites of Metastasis Demonstrated in Serial 18F-FDG PET/CT.
Topics: Carcinoma, Renal Cell; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Kidney; Kidney Neoplasms; Kidney Transplantation; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography | 2019 |
Progressive Hydrocephalus Due to Ventriculoperitoneal Shunt Infection: Detection With FDG PET CT.
Topics: Child; Disease Progression; Fluorodeoxyglucose F18; Humans; Hydrocephalus; Infections; Male; Positron Emission Tomography Computed Tomography; Ventriculoperitoneal Shunt | 2020 |
A Rapidly Progressing Polycystic Liver Disease?
Topics: Biopsy; Cysts; Diagnosis, Differential; Disease Progression; Fluorodeoxyglucose F18; Humans; Liver; Liver Diseases; Liver Neoplasms; Lymph Nodes; Male; Middle Aged; Nasal Cavity; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Nasopharynx; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Time Factors | 2020 |
Detection of local tumor progression by (18)F-FDG PET/CT following lung radiofrequency ablation: PET versus CT.
Topics: Adult; Aged; Aged, 80 and over; Catheter Ablation; Colonic Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; ROC Curve; Tomography, X-Ray Computed | 2013 |
18F-fluorodeoxyglucose PET/CT predicts tumour progression after transarterial chemoembolization in hepatocellular carcinoma.
Topics: Adolescent; Adult; Aged; Arteries; Carcinoma, Hepatocellular; Disease Progression; Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Prognosis; Retrospective Studies; Time Factors; Treatment Outcome; Young Adult | 2013 |
Detection of early onset of hypophysitis by (18)F-FDG PET-CT in a patient with advanced stage melanoma treated with ipilimumab.
Topics: Aged; Antibodies, Monoclonal; Disease Progression; Fluorodeoxyglucose F18; Humans; Ipilimumab; Male; Melanoma; Multimodal Imaging; Neoplasm Staging; Pituitary Diseases; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
Serial non-invasive assessment of antibody induced nephritis in mice using positron emission tomography.
Topics: Animals; Autoantibodies; Disease Progression; Female; Fluorodeoxyglucose F18; Glucose Transport Proteins, Facilitative; Inflammation; Kidney; Kidney Function Tests; Mice; Multimodal Imaging; Nephritis; Organ Size; Positron-Emission Tomography; Tomography, X-Ray Computed; Vascular Cell Adhesion Molecule-1 | 2013 |
Distinguishing pseudoprogression from progression in high-grade gliomas: a brief review of current clinical practice and demonstration of the potential value of 18F-FDG PET.
Topics: Diagnosis, Differential; Disease Progression; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Neoplasm Grading; Positron-Emission Tomography | 2013 |
Monitoring plaque inflammation in atherosclerotic rabbits with an iron oxide (P904) and (18)F-FDG using a combined PET/MR scanner.
Topics: Animals; Aorta, Abdominal; Aortic Diseases; Atherosclerosis; Atorvastatin; Contrast Media; Dextrans; Disease Models, Animal; Disease Progression; Fluorodeoxyglucose F18; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Magnetic Resonance Imaging; Magnetite Nanoparticles; Plaque, Atherosclerotic; Positron-Emission Tomography; Predictive Value of Tests; Pyrroles; Rabbits; Radiography; Radiopharmaceuticals; Time Factors | 2013 |
Generative FDG-PET and MRI model of aging and disease progression in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Brain; Case-Control Studies; Disease Progression; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Software | 2013 |
Metabolic response evaluated by 18F-FDG PET/CT as a potential screening tool in identifying a subgroup of patients with advanced non-small cell lung cancer for immediate maintenance therapy after first-line chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Maintenance Chemotherapy; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
FDG-PET in early AD diagnosis.
Topics: Aged; Alzheimer Disease; Asymptomatic Diseases; Blood Glucose; Brain; Cognitive Dysfunction; Diagnosis, Differential; Disease Progression; Early Diagnosis; Energy Metabolism; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Neuropsychological Tests; Positron-Emission Tomography; Prognosis | 2013 |
2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography examination in patients with chronic lymphocytic leukemia may reveal Richter transformation.
Topics: Adult; Aged; Disease Progression; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Male; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Prospective Studies; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
A new natural history of Charcot foot: clinical evolution and final outcome of stage 0 Charcot neuroarthropathy in a tertiary referral diabetic foot clinic.
Topics: Diabetic Foot; Disease Progression; Female; Fluorodeoxyglucose F18; Foot Joints; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiography; Referral and Consultation; Skin Temperature; Tertiary Care Centers; Treatment Outcome | 2013 |
Progressive striatal necrosis associated with anti-NMDA receptor antibodies.
Topics: Adolescent; Antibodies; Brain Diseases; Corpus Striatum; Disease Progression; Fluorodeoxyglucose F18; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Male; Necrosis; Positron-Emission Tomography; Receptors, N-Methyl-D-Aspartate; Tomography, X-Ray Computed | 2013 |
Necrosis on FDG PET/CT correlates with prognosis and mortality in sarcomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Bone Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Necrosis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Survival Rate; Tomography, X-Ray Computed | 2013 |
Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Transitional Cell; Combined Modality Therapy; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2013 |
Diagnosed mild cognitive impairment due to Alzheimer's disease with PET biomarkers of beta amyloid and neuronal dysfunction.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Biomarkers; Cerebral Cortex; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thiazoles | 2013 |
[11C]PIB, [18F]FDG and MR imaging in patients with mild cognitive impairment.
Topics: Aged; Aniline Compounds; Benzothiazoles; Cerebral Cortex; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Thiazoles | 2013 |
Focal arterial inflammation precedes subsequent calcification in the same location: a longitudinal FDG-PET/CT study.
Topics: Adult; Aged; Aorta, Thoracic; Aortitis; Aortography; Chi-Square Distribution; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Longitudinal Studies; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Observer Variation; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Signal-To-Noise Ratio; Time Factors; Tomography, X-Ray Computed; Vascular Calcification | 2013 |
Monitoring of tumor response to cisplatin with simultaneous fluorescence and positron emission tomography: a feasibility study.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cisplatin; Disease Progression; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Injections, Intraperitoneal; Luminescent Proteins; Mice; Mice, Inbred BALB C; Microscopy, Fluorescence; Molecular Imaging; Neoplasm Transplantation; Neoplasms; Positron-Emission Tomography; Red Fluorescent Protein | 2014 |
Total lesion glycolysis by 18F-FDG PET/CT is a reliable predictor of prognosis in soft-tissue sarcoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Area Under Curve; Disease Progression; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Retrospective Studies; ROC Curve; Sarcoma; Tomography, X-Ray Computed; Young Adult | 2013 |
Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid; Aniline Compounds; Apolipoproteins E; Brain; Cognitive Dysfunction; Cohort Studies; Disease Progression; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Forecasting; Genotype; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuroimaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Temporal Lobe; Thiazoles | 2014 |
Patterns of disease progression on 18F-fluorodeoxyglucose positron emission tomography-computed tomography in patients with malignant pleural mesothelioma undergoing multimodality therapy with pleurectomy/decortication.
Topics: Aged; Combined Modality Therapy; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Mesothelioma; Middle Aged; Neoplasm Recurrence, Local; Pleural Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Anterior brain glucose hypometabolism predates dementia in progranulin mutation carriers.
Topics: Adult; Aged; Brain Mapping; Dementia; Disease Progression; Female; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Humans; Intercellular Signaling Peptides and Proteins; Magnetic Resonance Imaging; Male; Middle Aged; Mutation; Positron-Emission Tomography; Progranulins; Retrospective Studies | 2013 |
Acute exacerbation of interstitial lung disease with lung cancer after surgery: evaluation with 2-[18]-fluoro-2-deoxy-D-glucose positron emission tomography.
Topics: Acute Disease; Aged; Aged, 80 and over; Disease Progression; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Diseases, Interstitial; Lung Neoplasms; Male; Middle Aged; Pneumonectomy; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2014 |
Clinical and imaging characterization of progressive spastic dysarthria.
Topics: Aged; Aged, 80 and over; Brain; Cognition Disorders; Disease Progression; Dysarthria; Female; Fluorodeoxyglucose F18; Humans; Intellectual Disability; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies | 2014 |
The Progression and Early detection of Subclinical Atherosclerosis (PESA) study: rationale and design.
Topics: Adult; Aorta, Abdominal; Arteries; Asymptomatic Diseases; Atherosclerosis; Carotid Arteries; Cohort Studies; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Risk Assessment; Spain; Tomography, X-Ray Computed; Ultrasonography; Vascular Calcification | 2013 |
Measurement of arterial activity on routine FDG PET/CT images improves prediction of risk of future CV events.
Topics: Adult; Aged; Arteritis; Boston; Disease Progression; Female; Fluorodeoxyglucose F18; Hospitals, General; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Tomography, X-Ray Computed; Vascular Calcification | 2013 |
Reduced FDG-PET brain metabolism and executive function predict clinical progression in elderly healthy subjects.
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Cerebral Cortex; Cognitive Dysfunction; Disease Progression; Executive Function; Female; Fluorodeoxyglucose F18; Gray Matter; Humans; Logistic Models; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Predictive Value of Tests; ROC Curve | 2014 |
Early determination of prognosis by interim 3'-deoxy-3'-18F-fluorothymidine PET in patients with non-Hodgkin lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies; Recurrence; ROC Curve; Thymine; Treatment Outcome | 2014 |
Pretreatment [18F]-fluoro-2-deoxy-glucose positron emission tomography maximum standardized uptake value as predictor of distant metastasis in early-stage non-small cell lung cancer treated with definitive radiation therapy: rethinking the role of positro
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome | 2014 |
Slowly progressive frontotemporal lobar degeneration caused by the C9ORF72 repeat expansion: a 20-year follow-up study.
Topics: C9orf72 Protein; Disease Progression; DNA Repeat Expansion; Fluorodeoxyglucose F18; Follow-Up Studies; Frontotemporal Lobar Degeneration; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Proteins | 2015 |
Is [F-18]-fluorodeoxy-D-glucose positron emission tomography of value in the management of patients with craniofacial bone sarcomas undergoing neo-adjuvant treatment?
Topics: Adult; Bone Neoplasms; Chemotherapy, Adjuvant; Disease Progression; Disease-Free Survival; Facial Bones; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Necrosis; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Osteosarcoma; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Skull; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2014 |
SUV as an adjunct in evaluating disease activity in idiopathic pulmonary fibrosis - a pilot study.
Topics: Aged; Biological Transport; Disease Progression; Fluorodeoxyglucose F18; Humans; Idiopathic Pulmonary Fibrosis; Lung; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Radiography, Thoracic; Tomography, X-Ray Computed; Vital Capacity | 2014 |
The rate of reduction in the maximum standardized uptake value from the initial to the post-R-CHOP therapy in positron emission tomography scan predicts disease progression in diffuse large B cell lymphoma patients.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prednisolone; Prognosis; Radiopharmaceuticals; Retrospective Studies; Rituximab; Survival Rate; Vincristine | 2014 |
Generation of orthotopic patient-derived xenografts from gastrointestinal stromal tumor.
Topics: Aged; Animals; Demography; Disease Progression; Female; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Male; Mice; Mice, SCID; Middle Aged; Positron-Emission Tomography; Ultrasonography; Xenograft Model Antitumor Assays | 2014 |
Three presenile patients in which neuropsychological and neuroimaging examinations suggest possible progression to dementia with Lewy bodies.
Topics: Brain; Diagnosis, Differential; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Magnetic Resonance Imaging; Middle Aged; Neuroimaging; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals | 2014 |
CT signal heterogeneity of abdominal aortic aneurysm as a possible predictive biomarker for expansion.
Topics: Aged; Aged, 80 and over; Algorithms; Aortic Aneurysm, Abdominal; Disease Progression; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Multidetector Computed Tomography; Multimodal Imaging; Observer Variation; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Radiopharmaceuticals; Risk Assessment; Ultrasonography | 2014 |
Combined measurement of tumor perfusion and glucose metabolism for improved tumor characterization in advanced cervical carcinoma. A PET/CT pilot study using [15O]water and [18F]fluorodeoxyglucose.
Topics: Adult; Aged; Blood Glucose; Cervix Uteri; Chemoradiotherapy; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Middle Aged; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Staging; Oxygen Radioisotopes; Perfusion Imaging; Pilot Projects; Positron-Emission Tomography; Regional Blood Flow; Retrospective Studies; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2014 |
A pilot study of FDG PET/CT detects a link between brown adipose tissue and breast cancer.
Topics: Adipose Tissue, Brown; Aged; Aged, 80 and over; Breast Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Pilot Projects; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Brain; Cognition; Cognitive Dysfunction; Cohort Studies; Cross-Sectional Studies; Databases, Factual; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Neuropsychological Tests; Peptide Fragments; Psychiatric Status Rating Scales; Radionuclide Imaging; tau Proteins; Time Factors | 2014 |
Extension and refinement of the predictive value of different classes of markers in ADNI: four-year follow-up data.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Apolipoproteins E; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Longitudinal Studies; Magnetic Resonance Imaging; Male; Memory, Episodic; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Psychiatric Status Rating Scales; tau Proteins | 2014 |
Early Changes by (18)Fluorodeoxyglucose positron emission tomography coregistered with computed tomography predict outcome after Mycobacterium tuberculosis infection in cynomolgus macaques.
Topics: Animals; Disease Progression; Fluorodeoxyglucose F18; Macaca fascicularis; Monkey Diseases; Mycobacterium tuberculosis; Positron-Emission Tomography; Predictive Value of Tests; Tomography, X-Ray Computed; Tuberculosis | 2014 |
Positron emission tomography/computed tomography findings during therapy predict outcome in patients with diffuse large B-cell lymphoma treated with chemotherapy alone but not in those who receive consolidation radiation.
Topics: Age Factors; Aged; Analysis of Variance; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Disease Progression; Doxorubicin; Drug Administration Schedule; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Positron-Emission Tomography; Prednisone; Prognosis; Radiopharmaceuticals; Remission Induction; Retrospective Studies; Rituximab; Sex Factors; Time Factors; Tomography, X-Ray Computed; Treatment Failure; Treatment Outcome; Vincristine | 2014 |
Striatal metabolism and psychomotor speed as predictors of motor onset in Huntington's disease.
Topics: Adult; Cognition Disorders; Cohort Studies; Corpus Striatum; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Huntington Disease; Male; Middle Aged; Neurologic Examination; Neuropsychological Tests; Positron-Emission Tomography; Predictive Value of Tests; Psychomotor Disorders; Statistics, Nonparametric | 2014 |
Differential (18)F-FDG and (18)F-FLT Uptake on Serial PET/CT Imaging Before and During Definitive Chemoradiation for Non-Small Cell Lung Cancer.
Topics: Aged; Aged, 80 and over; Biological Transport; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Chemoradiotherapy; Dideoxynucleosides; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Survival Analysis; Tomography, X-Ray Computed | 2014 |
Regional fluorodeoxyglucose metabolism and instrumental activities of daily living across the Alzheimer's disease spectrum.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alzheimer Disease; Brain; Brain Mapping; Cognitive Dysfunction; Cross-Sectional Studies; Databases, Factual; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Longitudinal Studies; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Surveys and Questionnaires | 2014 |
Utility of FDG-PET in clinical neuroendocrine prostate cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Bone Neoplasms; Disease Progression; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuroendocrine Tumors; Positron-Emission Tomography; Prevalence; Prostatic Neoplasms; Retrospective Studies; Soft Tissue Neoplasms | 2014 |
CT versus FDG-PET/CT response evaluation in patients with metastatic colorectal cancer treated with irinotecan and cetuximab.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cetuximab; Colorectal Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Irinotecan; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); ras Proteins; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Apathy as a feature of prodromal Alzheimer's disease: an FDG-PET ADNI study.
Topics: Aged; Alzheimer Disease; Apathy; Atrophy; Brain; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Neuroimaging; Positron-Emission Tomography | 2015 |
Predictive value of pattern classification 24 hours after radiofrequency ablation of liver metastases on CT and positron emission tomography/CT.
Topics: Catheter Ablation; Contrast Media; Disease Progression; Fluorodeoxyglucose F18; Humans; Iohexol; Liver Neoplasms; Metastasectomy; Multimodal Imaging; Neoplasm, Residual; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Risk Factors; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
In vivo quantification of mouse autoimmune arthritis by PET/CT.
Topics: Animals; Arthritis, Experimental; Autoimmunity; Collagen; Disease Progression; Fluorodeoxyglucose F18; Joints; Male; Mice, Inbred DBA; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Severity of Illness Index; Time Factors | 2016 |
Biomarker progressions explain higher variability in stage-specific cognitive decline than baseline values in Alzheimer disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Biomarkers; Cognition Disorders; Databases, Factual; Disease Progression; Executive Function; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Memory; Mental Status Schedule; Neuropsychological Tests; Positron-Emission Tomography | 2014 |
Monitoring dominant strictures in primary sclerosing cholangitis with brush cytology and FDG-PET.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Cholangitis, Sclerosing; Constriction, Pathologic; Cytological Techniques; Disease Progression; Feasibility Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Transplantation; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity | 2014 |
The evolution of primary progressive apraxia of speech.
Topics: Age of Onset; Aged; Brain; Cognition; Diffusion Tensor Imaging; Disease Progression; Educational Status; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neuroimaging; Neurologic Examination; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; Speech; Speech Disorders; Supranuclear Palsy, Progressive | 2014 |
Temporal evolution of biomarkers and cognitive markers in the asymptomatic, MCI, and dementia stage of Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Peptide Fragments; Positron-Emission Tomography; tau Proteins | 2015 |
Oxidized low-density lipoprotein stimulates macrophage 18F-FDG uptake via hypoxia-inducible factor-1α activation through Nox2-dependent reactive oxygen species generation.
Topics: Animals; Cell Line; Cell Membrane; Disease Progression; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Hexokinase; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lactic Acid; Lipoproteins, LDL; Macrophages; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; NADPH Oxidase 2; NADPH Oxidases; Radionuclide Imaging; Radiopharmaceuticals; Reactive Oxygen Species | 2014 |
Usefulness of 11C-methionine-positron emission tomography for the diagnosis of progressive multifocal leukoencephalopathy.
Topics: Aged; Aged, 80 and over; Antimalarials; Brain; Disease Progression; Early Diagnosis; Female; Fluorodeoxyglucose F18; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Male; Mefloquine; Methionine; Middle Aged; Positron-Emission Tomography; Prognosis; Treatment Outcome | 2014 |
High prognostic value of 18F-FDG PET for metastatic gastroenteropancreatic neuroendocrine tumors: a long-term evaluation.
Topics: Aged; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Metastasis; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Probability; Prognosis; Proportional Hazards Models; Radionuclide Imaging; ROC Curve; Stomach Neoplasms; Treatment Outcome | 2014 |
Heterogeneous bone marrow uptake on interim 18F-fluorodeoxyglucose positron emission tomography for lymphoma mimicking disease progression: a case report.
Topics: Bone Marrow; Disease Progression; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Middle Aged; Positron-Emission Tomography; Treatment Outcome | 2014 |
The role of FDG-PET/CT in the evaluation of residual disease in paediatric non-Hodgkin lymphoma.
Topics: Adolescent; Biopsy; Child; Child, Preschool; Disease Progression; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Multimodal Imaging; Neoplasm, Residual; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2015 |
Comparison of (11)C-4'-thiothymidine, (11)C-methionine, and (18)F-FDG PET/CT for the detection of active lesions of multiple myeloma.
Topics: Adult; Aged; Aged, 80 and over; Bone Marrow; Carbon Radioisotopes; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Methionine; Middle Aged; Multimodal Imaging; Multiple Myeloma; Plasmacytoma; Positron-Emission Tomography; Radiopharmaceuticals; Thionucleosides; Thymidine; Tomography, X-Ray Computed; Whole Body Imaging | 2015 |
Longitudinal assessment of infarct progression, brain metabolism and behavior following anterior cerebral artery occlusion in rats.
Topics: Animals; Anterior Cerebral Artery; Antipyrine; Autoradiography; Brain; Brain Infarction; Cerebrovascular Circulation; Disease Models, Animal; Disease Progression; Endothelin-1; Fluorodeoxyglucose F18; Infarction, Middle Cerebral Artery; Isotopes; Longitudinal Studies; Magnetic Resonance Imaging; Male; Mental Disorders; Positron-Emission Tomography; Rats; Time Factors | 2015 |
Pre-treatment FDG-PET predicts the site of in-field progression following concurrent chemoradiotherapy for stage III non-small cell lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiotherapy Dosage; ROC Curve; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Degree of abnormality is associated with rate of change in measures of beta-amyloid, glucose metabolism and cognition in an autopsy-verified Alzheimer's disease case.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Brain; Cognition; Disease Progression; Fatal Outcome; Female; Fluorodeoxyglucose F18; Glucose; Humans; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Thiazoles | 2015 |
Early aortic valve inflammation precedes calcification: a longitudinal FDG-PET/CT study.
Topics: Aged; Aortic Valve; Aortic Valve Stenosis; Boston; Calcinosis; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Incidence; Inflammation; Longitudinal Studies; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Odds Ratio; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Time Factors; Tomography, X-Ray Computed | 2015 |
Deriving global quantitative tumor response parameters from 18F-FDG PET-CT scans in patients with non-Hodgkin's lymphoma.
Topics: Disease Progression; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphoma, Non-Hodgkin; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Splenic metabolic activity predicts risk of future cardiovascular events: demonstration of a cardiosplenic axis in humans.
Topics: Adult; Aged; Arteritis; C-Reactive Protein; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Radiopharmaceuticals; Risk Assessment; Risk Factors; Spleen; Time Factors; Vascular Calcification | 2015 |
A 66-year-old patient with progressive left hemiparesis: question.
Topics: Acute Disease; Aged; Brain Stem Neoplasms; Central Nervous System Infections; Cerebellar Neoplasms; Demyelinating Diseases; Diagnosis, Differential; Disease Progression; Encephalomyelitis; Fluorodeoxyglucose F18; Glioblastoma; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Paresis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Prediction of Outcomes in Mild Cognitive Impairment by Using 18F-FDG-PET: A Multicenter Study.
Topics: Aged; Alzheimer Disease; Brain; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Longitudinal Studies; Magnetic Resonance Imaging; Male; Mental Status Schedule; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity | 2015 |
Volume of interest-based [18F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
Brain metabolic maps in Mild Cognitive Impairment predict heterogeneity of progression to dementia.
Topics: Aged; Brain; Brain Mapping; Cognitive Dysfunction; Dementia; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals | 2015 |
Prediction of AD dementia by biomarkers following the NIA-AA and IWG diagnostic criteria in MCI patients from three European memory clinics.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Amyloidosis; Atrophy; Biomarkers; Disease Progression; Fluorodeoxyglucose F18; Hippocampus; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Sensitivity and Specificity; tau Proteins | 2015 |
Squamous cell carcinoma of the tongue with metastasis to the right ventricle.
Topics: Carcinoma, Squamous Cell; Disease Progression; Fluorodeoxyglucose F18; Heart Neoplasms; Heart Ventricles; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy; Tomography, X-Ray Computed; Tongue Neoplasms | 2015 |
Post-treatment surveillance of head and neck cancer: pitfalls in the interpretation of FDG PET-CT/MRI.
Topics: Adult; Aged; Aged, 80 and over; Disease Progression; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Population Surveillance; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Functional Neuroanatomical Correlates of The Frontal Assessment Battery Performance in Alzheimer Disease: A FDG-PET Study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Disease Progression; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Neuropsychological Tests; Positron-Emission Tomography | 2015 |
Irbesartan attenuates atherosclerosis in Watanabe heritable hyperlipidemic rabbits: noninvasive imaging of inflammation by 18F-fluorodeoxyglucose positron emission tomography.
Topics: Animals; Antihypertensive Agents; Atherosclerosis; Autoradiography; Biphenyl Compounds; Body Weight; Disease Progression; Fluorodeoxyglucose F18; Hyperlipidemias; Inflammation; Irbesartan; Male; Mice, Knockout; Positron-Emission Tomography; Rabbits; Renin-Angiotensin System; Tetrazoles | 2015 |
Connectivity analysis of normal and mild cognitive impairment patients based on FDG and PiB-PET images.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Brain; Case-Control Studies; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Thiazoles | 2015 |
Natural history of atherosclerotic disease progression as assessed by (18)F-FDG PET/CT.
Topics: Aged; Aged, 80 and over; Aorta; Aortic Diseases; Aortography; Arteries; Atherosclerosis; Carotid Arteries; Carotid Artery Diseases; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Iliac Artery; Linear Models; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Plaque, Atherosclerotic; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Time Factors; Tomography, X-Ray Computed; Vascular Calcification | 2016 |
[(18)]F FDG PET/CT imaging to monitor the therapeutic effect of liposome-encapsulated prednisolone in experimental rheumatoid arthritis.
Topics: Adjuvants, Immunologic; Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Bordetella pertussis; Disease Progression; Fluorodeoxyglucose F18; Freund's Adjuvant; Knee Joint; Liposomes; Male; Mice, Inbred C57BL; Positron-Emission Tomography; Prednisolone; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
[The role of PET in lung cancer staging].
Topics: Disease Progression; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Use of (18)F-FDG PET to predict tumor progression and survival in patients with intermediate hepatocellular carcinoma treated by transarterial chemoembolization.
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
[Multiple enlarged metabolically active lymph nodes in 18F-FDG PET/CT after anti-CTLA-4 antibody therapy in metastatic melanoma - disease progression or immunologically induced side effect?].
Topics: Aged; Antibodies, Monoclonal; Colon; CTLA-4 Antigen; Diagnosis, Differential; Disease Progression; Energy Metabolism; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Ipilimumab; Lymph Nodes; Lymphatic Metastasis; Male; Melanoma; Multimodal Imaging; Neoplasm Staging; Nose Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2015 |
PET/CT Improves the Definition of Complete Response and Allows to Detect Otherwise Unidentifiable Skeletal Progression in Multiple Myeloma.
Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; In Situ Hybridization, Fluorescence; Male; Middle Aged; Multiple Myeloma; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2015 |
Incidence of Internal Mammary Lymph Nodes with Silicone Breast Implants at MR Imaging after Oncoplastic Surgery.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Implants; Breast Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Incidence; Lymph Node Excision; Lymph Nodes; Magnetic Resonance Imaging; Mammaplasty; Mastectomy; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Silicones; Tomography, X-Ray Computed | 2015 |
(18)F-FDG and (18)F-NaF PET/CT demonstrate coupling of inflammation and accelerated bone turnover in rheumatoid arthritis.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Bone Remodeling; Disease Progression; Female; Fluorodeoxyglucose F18; Hand Joints; Humans; Inflammation; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Wrist Joint | 2016 |
Predicting pleural invasion using HRCT and 18F-FDG PET/CT in lung adenocarcinoma with pleural contact.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Pleura; Pleural Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
The relative importance of imaging markers for the prediction of Alzheimer's disease dementia in mild cognitive impairment - Beyond classical regression.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Biomarkers; Cognitive Dysfunction; Disease Progression; Ethylene Glycols; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Predictive Value of Tests; Prognosis | 2015 |
Prognostic value of (18)F-fluorodeoxyglucose PET-CT imaging in acute aortic syndromes: comparison with serological biomarkers of inflammation.
Topics: Acute Disease; Aged; Aged, 80 and over; Aortic Diseases; Biomarkers; C-Reactive Protein; Discriminant Analysis; Disease Progression; Female; Fibrin Fibrinogen Degradation Products; Fluorodeoxyglucose F18; Hospitalization; Humans; Inflammation Mediators; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retreatment; Retrospective Studies; Risk Factors; Serologic Tests; Syndrome; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Pancreatic Tumor Growth Prediction with Multiplicative Growth and Image-Derived Motion.
Topics: Algorithms; Artificial Intelligence; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Male; Middle Aged; Motion; Multimodal Imaging; Neuroendocrine Tumors; Pancreatic Neoplasms; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Tumor Burden | 2015 |
[18F]fluorodeoxyglucose uptake as a predictor of large joint destruction in patients with rheumatoid arthritis.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Disease Progression; Female; Fluorodeoxyglucose F18; Foot Joints; Hand Joints; Humans; Male; Methotrexate; Middle Aged; Prednisolone; Radiography; Radionuclide Imaging; Retrospective Studies | 2016 |
Response to chemotherapy estimates by FDG PET is an important prognostic factor in patients with Ewing sarcoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Sarcoma, Ewing; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2016 |
Role of FDG-PET/CT in Extramedullary Multiple Myeloma: Correlation of FDG-PET/CT Findings With Clinical Outcome.
Topics: Adult; Aged; Aged, 80 and over; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Multiple Myeloma; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2016 |
Multimodal Imaging of Orthotopic Mouse Model of Endometrial Carcinoma.
Topics: Aged; Animals; Carcinoma; Cell Line, Tumor; Contrast Media; Dideoxynucleosides; Disease Models, Animal; Disease Progression; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Transplantation; Positron-Emission Tomography; Tomography, X-Ray Computed | 2015 |
The Role of PET [18F]FDOPA in Evaluating Low-grade Glioma.
Topics: Adult; Aged; Brain Neoplasms; Demography; Dihydroxyphenylalanine; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; ROC Curve; Young Adult | 2015 |
Recurrent renal cell carcinoma: clinical and prognostic value of FDG PET/CT.
Topics: Aged; Carcinoma, Renal Cell; Decision Making; Decision Support Systems, Clinical; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Kidney Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2016 |
Brain glucose metabolism in diffuse large B-cell lymphoma patients as assessed with FDG-PET: impact on outcome and chemotherapy effects.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Brain; Cyclophosphamide; Disease Progression; Doxorubicin; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Prognosis; Radiopharmaceuticals; Retrospective Studies; Rituximab; Vincristine | 2016 |
Effects of imaging modalities, brain atlases and feature selection on prediction of Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Atlases as Topic; Brain; Cognitive Dysfunction; Cohort Studies; Datasets as Topic; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Support Vector Machine | 2015 |
FDG μPET Fails to Detect a Disease-Specific Phenotype in Rats Transgenic for Huntington's Disease – A 15 Months Follow-up Study.
Topics: Animals; Animals, Genetically Modified; Brain; Case-Control Studies; Disease Models, Animal; Disease Progression; Fluorodeoxyglucose F18; Huntington Disease; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Rats | 2015 |
Valvular (18)F-Fluoride and (18)F-Fluorodeoxyglucose Uptake Predict Disease Progression and Clinical Outcome in Patients With Aortic Stenosis.
Topics: Aged; Aged, 80 and over; Aortic Valve; Aortic Valve Stenosis; Case-Control Studies; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Longitudinal Studies; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Risk Assessment; Severity of Illness Index; Sodium Fluoride; Tomography, X-Ray Computed | 2015 |
Cross-validation of biomarkers for the early differential diagnosis and prognosis of dementia in a clinical setting.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cognitive Dysfunction; Diagnosis, Differential; Disease Progression; Female; Fluorodeoxyglucose F18; Frontotemporal Lobar Degeneration; Humans; Lewy Body Disease; Magnetic Resonance Imaging; Male; Middle Aged; Peptide Fragments; Positron-Emission Tomography; Predictive Value of Tests; Reproducibility of Results; tau Proteins | 2016 |
Association Between Choroidal Thickness and Metabolic Activity on Positron Emission Tomography in Eyes With Choroidal Melanoma.
Topics: Brachytherapy; Choroid; Choroid Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Melanoma; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, Optical Coherence | 2015 |
A simulation system for biomarker evolution in neurodegenerative disease.
Topics: Alzheimer Disease; Biomarkers; Brain; Computer Simulation; Disease Progression; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Longitudinal Studies; Models, Neurological; Nerve Tissue Proteins; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2015 |
Pseudoprogression after proton radiotherapy for pediatric low grade glioma.
Topics: Adolescent; Astrocytoma; Brain Neoplasms; Diagnosis, Differential; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Perfusion Imaging; Positron-Emission Tomography; Proton Therapy; Radiopharmaceuticals | 2015 |
Predictive value of (18)F-FDG PET/CT in restaging patients affected by ovarian carcinoma: a multicentre study.
Topics: Adult; Aged; Aged, 80 and over; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Odds Ratio; Ovarian Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Regression Analysis; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2016 |
The use of (18)F-FDG PET to differentiate progressive disease from treatment induced necrosis in high grade glioma.
Topics: Adult; Aged; Brain; Brain Neoplasms; Cohort Studies; Disease Progression; Drug Therapy; Female; Fluorodeoxyglucose F18; Glioma; Humans; Image Processing, Computer-Assisted; Karnofsky Performance Status; Magnetic Resonance Imaging; Male; Middle Aged; Necrosis; Outcome Assessment, Health Care; Positron-Emission Tomography; Radiotherapy; ROC Curve | 2015 |
Lateral Temporal Lobe: An Early Imaging Marker of the Presymptomatic GRN Disease?
Topics: Adult; Asymptomatic Diseases; Disease Progression; Female; Fluorodeoxyglucose F18; Frontal Lobe; Frontotemporal Lobar Degeneration; Humans; Intercellular Signaling Peptides and Proteins; Longitudinal Studies; Magnetic Resonance Imaging; Male; Mutation; Organ Size; Positron-Emission Tomography; Progranulins; Radiopharmaceuticals; Temporal Lobe | 2015 |
An 18F-FDG-PET maximum standardized uptake value > 10 represents a novel valid marker for discerning Richter's Syndrome.
Topics: Biomarkers; Biopsy; Disease Progression; Fluorodeoxyglucose F18; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; ROC Curve | 2016 |
Characteristics of FDG-PET findings in the diagnosis of systemic juvenile idiopathic arthritis.
Topics: Arthritis, Juvenile; Child; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Severity of Illness Index | 2016 |
Anticancer Activity of Atractylodes lancea (Thunb.) DC in a Hamster Model and Application of PET-CT for Early Detection and Monitoring Progression of Cholangiocarcinoma.
Topics: Animals; Atractylodes; Bile Duct Neoplasms; Cholangiocarcinoma; Cricetinae; Disease Progression; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Male; Mesocricetus; Multimodal Imaging; Phytotherapy; Plant Extracts; Positron-Emission Tomography; Tomography, X-Ray Computed | 2015 |
Role of β-Amyloidosis and Neurodegeneration in Subsequent Imaging Changes in Mild Cognitive Impairment.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloidosis; Aniline Compounds; Cognitive Dysfunction; Cohort Studies; Disease Progression; Female; Fluorodeoxyglucose F18; Gray Matter; Humans; Male; Neurodegenerative Diseases; Positron-Emission Tomography; Thiazoles | 2015 |
18F-FDG PET/CT in the Management of Aortitis.
Topics: Aged; Aorta; Aortitis; Aortography; Disease Progression; Early Diagnosis; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2016 |
Prognostic value of pretreatment FDG PET in pediatric neuroblastoma.
Topics: Child, Preschool; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Neuroblastoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate | 2015 |
18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease.
Topics: Aged; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Multiple Myeloma; Osteolysis; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
Longitudinal influence of microglial activation and amyloid on neuronal function in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Amyloid; Aniline Compounds; Brain; Case-Control Studies; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Functional Neuroimaging; Glucose; Humans; Isoquinolines; Male; Microglia; Middle Aged; Neurons; Positron-Emission Tomography; Thiazoles | 2015 |
Combining plasma Epstein-Barr virus DNA and nodal maximal standard uptake values of 18F-fluoro-2-deoxy-D-glucose positron emission tomography improved prognostic stratification to predict distant metastasis for locoregionally advanced nasopharyngeal carci
Topics: Carcinoma; Disease Progression; Disease-Free Survival; DNA, Viral; Female; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Kaplan-Meier Estimate; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Viral Load | 2015 |
Label-aligned multi-task feature learning for multimodal classification of Alzheimer's disease and mild cognitive impairment.
Topics: Aged; Alzheimer Disease; Brain; Cognitive Dysfunction; Databases, Factual; Disease Progression; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Machine Learning; Multimodal Imaging; Neuroimaging; Pattern Recognition, Automated; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; ROC Curve | 2016 |
Optimization of Statistical Single Subject Analysis of Brain FDG PET for the Prognosis of Mild Cognitive Impairment-to-Alzheimer's Disease Conversion.
Topics: Aged; Alzheimer Disease; Area Under Curve; Brain; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Image Interpretation, Computer-Assisted; Male; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; ROC Curve | 2016 |
Visual Versus Fully Automated Analyses of 18F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive Impairment.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Benzothiazoles; Cognitive Dysfunction; Dementia; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Observer Variation; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Thiazoles | 2016 |
Accurate Prediction of Conversion to Alzheimer's Disease using Imaging, Genetic, and Neuropsychological Biomarkers.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Apolipoproteins E; Area Under Curve; Brain; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity | 2016 |
Use of PERCIST for Prediction of Progression-Free and Overall Survival After Radioembolization for Liver Metastases from Pancreatic Cancer.
Topics: Aged; Aged, 80 and over; Algorithms; Disease Progression; Disease-Free Survival; Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Pancreatic Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Survival Analysis; Treatment Outcome; Yttrium Radioisotopes | 2016 |
Multimodal In Vivo Imaging of Tumorigenesis and Response to Chemotherapy in a Transgenic Mouse Model of Mammary Cancer.
Topics: Animals; Antineoplastic Agents; Carcinogenesis; Cell Proliferation; Disease Models, Animal; Disease Progression; Female; Fluorescence; Fluorodeoxyglucose F18; Ki-67 Antigen; Mammary Neoplasms, Animal; Mice; Mice, Transgenic; Multimodal Imaging; Technetium; Time Factors; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2016 |
A Population-Based Gaussian Mixture Model Incorporating 18F-FDG PET and Diffusion-Weighted MRI Quantifies Tumor Tissue Classes.
Topics: Animals; Diffusion Magnetic Resonance Imaging; Disease Progression; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Mice; Mitosis; Multimodal Imaging; Necrosis; Neoplasm Transplantation; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tumor Microenvironment | 2016 |
Significance of visual hallucinations and cerebral hypometabolism in the risk of dementia in Parkinson's disease patients with mild cognitive impairment.
Topics: Aged; Brain; Brain Mapping; Cognitive Dysfunction; Comorbidity; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hallucinations; Humans; Male; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Risk Factors | 2016 |
The Clinical Usefulness of (18)F-Fluorodeoxyglucose Positron Emission Tomography (PET) to Predict Oncologic Outcomes and PET-Based Radiotherapeutic Considerations in Locally Advanced Nasopharyngeal Carcinoma.
Topics: Adolescent; Adult; Aged; Carcinoma; Chemoradiotherapy; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Induction Chemotherapy; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Radiation Dosage; Radiopharmaceuticals; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Retrospective Studies; Treatment Failure; Tumor Burden; Young Adult | 2016 |
18 FDG-PET/CT: 21st century approach to leukemic tumors in 124 cases.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Infant; Leukemia; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasms, Unknown Primary; Positron-Emission Tomography; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2016 |
Prognostic value of negative interim 2-[¹⁸F]-fluoro-2-deoxy-d-glucose PET/CT in diffuse large B-cell lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
Early lesion-specific (18)F-FDG PET response to chemotherapy predicts time to lesion progression in locally advanced non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Proportional Hazards Models; Radiopharmaceuticals | 2016 |
Restaging oesophageal cancer after neoadjuvant therapy with (18)F-FDG PET-CT: identifying interval metastases and predicting incurable disease at surgery.
Topics: Adult; Aged; Chemotherapy, Adjuvant; Decision Theory; Disease Progression; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Tomography, X-Ray Computed | 2016 |
Prognostic value of diffusion-weighted magnetic resonance imaging and
Topics: Adult; Aged; Chemoradiotherapy; Diffusion Magnetic Resonance Imaging; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Uterine Cervical Neoplasms | 2016 |
Prediction of Progressive Mild Cognitive Impairment by Multi-Modal Neuroimaging Biomarkers.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Biomarkers; Brain; Cognitive Dysfunction; Disease Progression; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Predictive Value of Tests; Psychiatric Status Rating Scales; Sensitivity and Specificity | 2016 |
Positive (18)Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography Predicts Preinvasive Endobronchial Lesion Progression to Invasive Cancer.
Topics: Aged; Aged, 80 and over; Bronchial Neoplasms; Carcinoma in Situ; Carcinoma, Squamous Cell; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Precancerous Conditions; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
FDG-PET reveals coronary artery inflammation proceeding to cardiac allograft vasculopathy progression.
Topics: Allografts; Computed Tomography Angiography; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Disease Progression; Fluorodeoxyglucose F18; Heart Transplantation; Humans; Male; Middle Aged; Radiopharmaceuticals; Vasculitis | 2016 |
[(18)F]FDG PET Neuroimaging Predicts Pentylenetetrazole (PTZ) Kindling Outcome in Rats.
Topics: Animals; Disease Progression; Fluorodeoxyglucose F18; Kindling, Neurologic; Magnetic Resonance Imaging; Male; Neuroimaging; Pentylenetetrazole; Positron-Emission Tomography; Rats, Sprague-Dawley; Seizures | 2016 |
Prediction of Alzheimer's Disease in Amnestic Mild Cognitive Impairment Subtypes: Stratification Based on Imaging Biomarkers.
Topics: Aged; Alzheimer Disease; Biomarkers; Brain; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Glucose; Gray Matter; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Neuroimaging; Positron-Emission Tomography; Temporal Lobe | 2016 |
[Correlation analysis between 18F-FDG uptake features and the prognosis in patients with pathologic stage Ⅰ lung adenocarcinoma].
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sex Factors; Statistics, Nonparametric; Tomography, X-Ray Computed; Tumor Burden | 2016 |
High-resolution (18)F-FDG PET/CT for assessing disease activity in rheumatoid and psoriatic arthritis: findings of a prospective pilot study.
Topics: Arthritis, Psoriatic; Arthritis, Rheumatoid; Disease Progression; Female; Fluorodeoxyglucose F18; Hand Joints; Humans; Male; Middle Aged; Pilot Projects; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Wrist Joint | 2016 |
18F-fluorocholine versus 18F-fluorodeoxyglucose for PET/CT imaging in patients with suspected relapsing or progressive multiple myeloma: a pilot study.
Topics: Aged; Aged, 80 and over; Choline; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Pilot Projects; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Recurrence; Reproducibility of Results; Sensitivity and Specificity | 2016 |
Accelerating rates of cognitive decline and imaging markers associated with β-amyloid pathology.
Topics: Aged; Amyloid beta-Peptides; Aniline Compounds; Atrophy; Biomarkers; Brain; Cognition; Cognitive Dysfunction; Disease Progression; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Mental Status Schedule; Neuropsychological Tests; Peptide Fragments; Positron-Emission Tomography; Radiopharmaceuticals; Regression Analysis | 2016 |
Multiparametric [18F]Fluorodeoxyglucose/ [18F]Fluoromisonidazole Positron Emission Tomography/ Magnetic Resonance Imaging of Locally Advanced Cervical Cancer for the Non-Invasive Detection of Tumor Heterogeneity: A Pilot Study.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Middle Aged; Misonidazole; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Tumor Burden; Uterine Cervical Neoplasms | 2016 |
Multiple 18F-Fluorodeoxyglucose Positron Emission Tomography Scans Showing Progression of Abdominal Aortic Aneurysm: A Case Report.
Topics: Aged; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Aortitis; Disease Progression; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
Potential Clinical Value of Multiparametric PET in the Prediction of Alzheimer's Disease Progression.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Databases, Factual; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; ROC Curve | 2016 |
Malfunctioned cardiac resynchronization therapy attributed to acute exacerbation of cardiac sarcoidosis.
Topics: Adult; Cardiac Resynchronization Therapy; Cardiomyopathies; Disease Progression; Fluorodeoxyglucose F18; Glucocorticoids; Heart Failure; Humans; Male; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Sarcoidosis; Treatment Outcome | 2016 |
Fludeoxyglucose positron emission tomography-computed tomography scan showing polyarthritis in a patient with an atypical presentation of Henoch-Schönlein vasculitis without clinical signs of arthritis: a case report.
Topics: Arthritis; Child, Preschool; Disease Progression; Fluorodeoxyglucose F18; Glucocorticoids; Humans; IgA Vasculitis; Male; Positron Emission Tomography Computed Tomography; Prednisolone; Radiopharmaceuticals | 2016 |
Impact of (18)F-FDG PET/CT staging on management and prognostic stratification in head and neck squamous cell carcinoma: A prospective observational study.
Topics: Aged; Carcinoma, Squamous Cell; Disease Progression; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck | 2016 |
Predicting the transition from normal aging to Alzheimer's disease: A statistical mechanistic evaluation of FDG-PET data.
Topics: Aged; Aging; Alzheimer Disease; Biomarkers; Brain; Cognitive Dysfunction; Computer Simulation; Data Interpretation, Statistical; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Models, Statistical; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2016 |
Impact of Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose Uptake on Preoperative Positron Emission Tomography/Computed Tomography in the Lymph Nodes of Patients with Primary Colorectal Cancer.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Contrast Media; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Young Adult | 2017 |
The Added Prognostic Value of Metabolic Tumor Size on FDG-PET at First Suspected Recurrence of Glioblastoma Multiforme.
Topics: Disease Progression; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2017 |
18F-FDG PET/CT Demonstrating Malignant Degeneration of a Uterine Fibroid.
Topics: Adult; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Leiomyoma; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography | 2016 |
Characterization of progressive HIV-associated tuberculosis using 2-deoxy-2-[
Topics: Adult; Coinfection; Disease Progression; Female; Fluorodeoxyglucose F18; HIV Infections; Humans; Interferon-gamma Release Tests; Latent Tuberculosis; Male; Mycobacterium tuberculosis; Positron Emission Tomography Computed Tomography; Radiography, Thoracic; Radiopharmaceuticals; South Africa; Sputum; Tuberculosis; Tuberculosis, Pulmonary | 2016 |
A Lesion-Based Response Prediction Model Using Pretherapy PET/CT Image Features for Y90 Radioembolization to Hepatic Malignancies.
Topics: Adult; Aged; Disease Progression; Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Treatment Outcome; Yttrium Radioisotopes | 2017 |
Characteristics of mild cognitive impairment tending to convert into Alzheimer's disease or dementia with Lewy bodies: A follow-up study in a memory clinic.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Gyrus Cinguli; Humans; Lewy Body Disease; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Retrospective Studies; Visual Cortex | 2016 |
The Role of Single-Subject Brain Metabolic Patterns in the Early Differential Diagnosis of Primary Progressive Aphasias and in Prediction of Progression to Dementia.
Topics: Aged; Aphasia, Primary Progressive; Brain; Cognition; Dementia; Diagnosis, Differential; Disease Progression; Early Diagnosis; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Neuropsychological Tests; Positron-Emission Tomography; Precision Medicine; Radiopharmaceuticals; Retrospective Studies | 2017 |
Prediction of coronary artery calcium progression by FDG uptake of large arteries in asymptomatic individuals.
Topics: Algorithms; Asymptomatic Diseases; Computer Simulation; Coronary Artery Disease; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Models, Cardiovascular; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Vascular Calcification | 2017 |
Intratumoral Heterogeneity of Pretreatment 18F-FDG PET Images Predict Disease Progression in Patients With Nasal Type Extranodal Natural Killer/T-cell Lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, T-Cell; Male; Middle Aged; Multivariate Analysis; Nose Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Retrospective Studies; Risk Factors; ROC Curve | 2016 |
Role of 18F-fluorodeoxyglucose Positron Emission Tomography in the Monitoring of Inflammatory Activity in Crohn's Disease.
Topics: Adult; Crohn Disease; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Treatment Outcome; Young Adult | 2016 |
Predictive and Prognostic Value of Early Disease Progression by PET Evaluation in Advanced Non-Small Cell Lung Cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2017 |
Early Whole Blood Transcriptional Signatures Are Associated with Severity of Lung Inflammation in Cynomolgus Macaques with Mycobacterium tuberculosis Infection.
Topics: Adaptive Immunity; Animals; Blood Cells; Cells, Cultured; Disease Models, Animal; Disease Progression; Fluorodeoxyglucose F18; Gene Expression Profiling; Humans; Immunity, Innate; Lung; Macaca fascicularis; Mycobacterium tuberculosis; Pneumonia; Positron-Emission Tomography; Tomography, X-Ray Computed; Transcriptome; Tuberculosis, Pulmonary | 2016 |
Positron Emission Tomography/Computed Tomography Assessment After Immunochemotherapy and Irradiation Using the Lugano Classification Criteria in the IELSG-26 Study of Primary Mediastinal B-Cell Lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Immunotherapy; Leucovorin; Liver; Lymphoma, B-Cell; Male; Mediastinal Neoplasms; Methotrexate; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Prednisone; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Conformal; Recurrence; Rituximab; Statistics, Nonparametric; Vincristine; Young Adult | 2017 |
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Pilot Projects; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Thyroglobulin; Thyroid Neoplasms; Whole Body Imaging | 2017 |
Predictive factors associated with the progression of large-joint destruction in patients with rheumatoid arthritis after biologic therapy: A post-hoc analysis using FDG-PET/CT and the ARASHI (assessment of rheumatoid arthritis by scoring of large-joint d
Topics: Adult; Arthritis, Rheumatoid; Biological Therapy; Disease Progression; Female; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Joints; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prednisolone; Prognosis; Radiopharmaceuticals; Research Design; Tomography, X-Ray Computed | 2017 |
Primary mesenteric neuroendocrine tumor that changed its internal composition from cystic to solid: a case report.
Topics: Aged; Disease Progression; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Mesentery; Neuroendocrine Tumors; Peritoneal Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2017 |
Prognostic value of pre-treatment F-18-FDG PET-CT in patients with hepatocellular carcinoma undergoing radioembolization.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chi-Square Distribution; Disease Progression; Disease-Free Survival; Embolization, Therapeutic; Female; Florida; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Microspheres; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2016 |
Chemotherapy Response Assessment by FDG-PET-CT in Early-stage Classical Hodgkin Lymphoma: Moving Beyond the Five-Point Deauville Score.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Confidence Intervals; Dacarbazine; Disease Progression; Doxorubicin; Female; Fluorodeoxyglucose F18; Glycolysis; Hodgkin Disease; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Recurrence; Risk; Treatment Outcome; Tumor Burden; Vinblastine | 2017 |
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy Dosage; ROC Curve; Time Factors; Treatment Failure; Tumor Burden | 2017 |
In-vivo quantitative assessment of the therapeutic response in a mouse model of collagen-induced arthritis using
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Collagen; Disease Models, Animal; Disease Progression; Drug Evaluation, Preclinical; Fluorodeoxyglucose F18; Joints; Longitudinal Studies; Male; Mice; Mice, Inbred DBA; Positron-Emission Tomography; Radiopharmaceuticals; Tumor Necrosis Factor-alpha | 2017 |
The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer's disease: A European Alzheimer's Disease Consortium study.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Cognition Disorders; Diagnosis, Computer-Assisted; Diagnosis, Differential; Disease Progression; Europe; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Male; Neuropsychological Tests; Peptide Fragments; Positron-Emission Tomography; tau Proteins; Tomography, Emission-Computed, Single-Photon | 2017 |
Progressive Disintegration of Brain Networking from Normal Aging to Alzheimer Disease: Analysis of Independent Components of
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Brain; Cognitive Dysfunction; Connectome; Disease Progression; Fluorodeoxyglucose F18; Humans; Middle Aged; Nerve Net; Positron-Emission Tomography; Principal Component Analysis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index | 2017 |
FDG-PET to predict different patterns of progression in multicentric glioblastoma: a case report.
Topics: Adult; Antineoplastic Agents; Brain Neoplasms; Combined Modality Therapy; Disease Progression; Fluorodeoxyglucose F18; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Neurosurgical Procedures; Positron-Emission Tomography | 2008 |
New staging and response criteria for non-Hodgkin lymphoma and Hodgkin lymphoma.
Topics: Clinical Trials as Topic; Disease Progression; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Tomography, X-Ray Computed | 2008 |
Can FDG-PET be used to predict growth of stage I lung cancer?
Topics: Aged; Aged, 80 and over; Disease Progression; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2008 |
Relationship between primary tumor fluorodeoxyglucose uptake and nodal or distant metastases at presentation in T1 stage non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2009 |
Late-onset sporadic ataxia, pontine lesion, and retroperitoneal fibrosis: a case of Erdheim-Chester disease.
Topics: Afferent Pathways; Biomarkers; Bone and Bones; Brain Mapping; Cerebellar Ataxia; Cerebellum; Disease Progression; Erdheim-Chester Disease; Fluorodeoxyglucose F18; Hearing Loss, Central; Histiocytes; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Orbit; Pons; Positron-Emission Tomography; Retroperitoneal Fibrosis; Technetium | 2008 |
Effect of citalopram in treating hypersexuality in an Alzheimer's disease case.
Topics: Alzheimer Disease; Brain; Citalopram; Cognition Disorders; Disease Progression; Donepezil; Fluorodeoxyglucose F18; Humans; Indans; Male; Memory Disorders; Middle Aged; Mood Disorders; Nootropic Agents; Obsessive-Compulsive Disorder; Piperidines; Positron-Emission Tomography; Selective Serotonin Reuptake Inhibitors; Serotonin; Sexual Behavior; Sexual Dysfunctions, Psychological; Treatment Outcome | 2008 |
Fluorine 18-labeled fluorodeoxyglucose positron emission tomography in familial Creutzfeldt-Jakob disease.
Topics: 14-3-3 Proteins; Akinetic Mutism; Brain; Codon; Creutzfeldt-Jakob Syndrome; Dementia; Disease Progression; DNA Mutational Analysis; Electroencephalography; Fatal Outcome; Female; Fluorodeoxyglucose F18; Genetic Predisposition to Disease; Heterozygote; Humans; Magnetic Resonance Imaging; Middle Aged; Mutation, Missense; Neuropsychological Tests; Polymorphism, Genetic; Positron-Emission Tomography; Prions; Radiography; Radiopharmaceuticals | 2008 |
[18F]fluorodeoxyglucose positron emission tomography in the management of lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Diagnosis, Differential; Disease Progression; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Time Factors | 2008 |
In vivo non-invasive serial monitoring of FDG-PET progression and regression in a rabbit model of atherosclerosis.
Topics: Animals; Atherosclerosis; Diet, Atherogenic; Disease Models, Animal; Disease Progression; Fluorodeoxyglucose F18; Positron-Emission Tomography; Rabbits; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Random Allocation | 2009 |
Monitoring plaque composition: is it worthwile?
Topics: Animals; Atherosclerosis; Diet, Atherogenic; Disease Models, Animal; Disease Progression; Fluorodeoxyglucose F18; Positron-Emission Tomography; Rabbits; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals | 2009 |
Decreased cortical glucose metabolism in converters from CDR 0.5 to Alzheimer's disease in a community: the Osaki-Tajiri Project.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Blood Glucose; Brain; Cognition Disorders; Disease Progression; Dominance, Cerebral; Energy Metabolism; Female; Fluorodeoxyglucose F18; Gyrus Cinguli; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Japan; Magnetic Resonance Imaging; Male; Mental Status Schedule; Neuropsychological Tests; Parietal Lobe; Positron-Emission Tomography; Psychometrics; Reference Values; Temporal Lobe | 2009 |
Follow-up with 18FDG-PET-CT after radical radiotherapy with or without chemotherapy allows the detection of potentially curable progressive disease in non-small cell lung cancer patients: a prospective study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Long-Term Care; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Salvage Therapy; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
The role of FDG-PET imaging and involved field radiotherapy in relapsed or refractory diffuse large B-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Prognosis; Recurrence; Retrospective Studies; Salvage Therapy; Treatment Outcome | 2009 |
The neuropsychological and neuroradiological correlates of slowly progressive visual agnosia.
Topics: Agnosia; Aspartic Acid; Atrophy; Brain; Brain Mapping; Disease Progression; Energy Metabolism; Female; Fluorodeoxyglucose F18; Functional Laterality; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Middle Aged; Nerve Degeneration; Neuropsychological Tests; Occipital Lobe; Parietal Lobe; Positron-Emission Tomography; Temporal Lobe | 2009 |
[Merkel cell carcinoma: a rare tumor entity in an unusually young patient].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Merkel Cell; Combined Modality Therapy; Contrast Media; Disease Progression; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Knee; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Positron-Emission Tomography; Skin Neoplasms; Surgical Flaps; Whole Body Imaging | 2009 |
A follow-up study on 6-[18F]fluoro-L-dopa uptake in early Parkinson's disease shows nonlinear progression in the putamen.
Topics: Aged; Brain Mapping; Disease Progression; Female; Fluorodeoxyglucose F18; Functional Laterality; Humans; Levodopa; Longitudinal Studies; Male; Middle Aged; Nonlinear Dynamics; Parkinson Disease; Positron-Emission Tomography; Postmortem Changes; Putamen; Time Factors | 2009 |
Is FDG-PET/CT useful for managing malignant pleural mesothelioma?
Topics: Aged; Aged, 80 and over; Colonic Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mesothelioma; Middle Aged; Neoplasm Recurrence, Local; Pleural Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
Characterization of preclinical models of prostate cancer using PET-based molecular imaging.
Topics: Animals; Biological Transport; Carbon Radioisotopes; Cell Line, Tumor; Choline; Disease Models, Animal; Disease Progression; Fluorodeoxyglucose F18; Hormones; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neoplasm Staging; Positron-Emission Tomography; Prostatic Neoplasms; Reproducibility of Results | 2009 |
Dissecting molecular mechanisms in the living brain of dementia patients.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Brain; Disease Progression; Fluorodeoxyglucose F18; Humans; Nitriles; Positron-Emission Tomography; Radiopharmaceuticals; tau Proteins | 2009 |
Diffuse skeletal muscle F-18 fluorodeoxyglucose uptake in advanced primary muscle non-Hodgkin's lymphoma.
Topics: Aged; Disease Progression; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Muscle Neoplasms; Muscle, Skeletal; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
Positron emission tomography-computed tomography surveillance for the node-positive neck after chemoradiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Combined Modality Therapy; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Enhancement; Image Processing, Computer-Assisted; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Otorhinolaryngologic Neoplasms; Positron-Emission Tomography; Radiotherapy, Conformal; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
P-glycoprotein expression affects 18F-fluorodeoxyglucose accumulation in hepatocellular carcinoma in vivo and in vitro.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Calcium Channel Blockers; Carcinoma, Hepatocellular; Cell Differentiation; Disease Progression; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glucose Transporter Type 2; Glucose-6-Phosphatase; Hexokinase; Humans; Liver Neoplasms; Models, Biological; Radionuclide Imaging; Tumor Cells, Cultured; Verapamil | 2009 |
Clinical usefulness of 18F-FDG PET/CT in the restaging of esophageal cancer after surgical resection and radiotherapy.
Topics: Adult; Aged; Disease Progression; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Tomography, Emission-Computed | 2009 |
Widespread metastases from sarcomatoid renal cell carcinoma detected by (18)F-FDG positron emission tomography/computed tomography.
Topics: Carcinoma, Renal Cell; Disease Progression; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole Body Imaging | 2009 |
18F-FDG PET in sarcoidosis: an observational study in 12 patients treated with infliximab.
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Infliximab; Male; Positron-Emission Tomography; Respiratory Function Tests; Retrospective Studies; Sarcoidosis, Pulmonary; Treatment Outcome; Tumor Necrosis Factor-alpha | 2008 |
Preclinical evidence of Alzheimer changes: convergent cerebrospinal fluid biomarker and fluorodeoxyglucose positron emission tomography findings.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Brain; Cerebrospinal Fluid; Disease Progression; Early Diagnosis; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Neurofibrillary Tangles; Peptide Fragments; Plaque, Amyloid; Positron-Emission Tomography; Predictive Value of Tests; tau Proteins | 2009 |
Successive affection of bilateral temporomesial structures in a case of non-paraneoplastic limbic encephalitis demonstrated by serial MRI and FDG-PET.
Topics: Aged; Autoantibodies; Brain; Disease Progression; Fluorodeoxyglucose F18; Follow-Up Studies; Hippocampus; Humans; Limbic Encephalitis; Magnetic Resonance Imaging; Male; Memory Disorders; Positron-Emission Tomography; Potassium Channels, Voltage-Gated; Treatment Outcome | 2009 |
Predictive value of 18F-FDG PET and somatostatin receptor scintigraphy in patients with metastatic endocrine tumors.
Topics: Adult; Aged; Disease Progression; Endocrine Gland Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Indium Radioisotopes; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Receptors, Somatostatin; Somatostatin | 2009 |
Longitudinal brain metabolic changes from amnestic mild cognitive impairment to Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amnesia; Brain; Brain Mapping; Cognition Disorders; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography | 2009 |
Early prediction of response to first-line therapy using integrated 18F-FDG PET/CT for patients with advanced/metastatic non-small cell lung cancer.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cisplatin; Disease Progression; Female; Fluorodeoxyglucose F18; Gefitinib; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Predictive Value of Tests; Prospective Studies; Quinazolines; Radiopharmaceuticals; Survival Rate; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Occurrence of basal ganglia germ cell tumors without a mass.
Topics: Adolescent; Age Distribution; Age Factors; Antineoplastic Agents; Asian People; Atrophy; Basal Ganglia; Basal Ganglia Diseases; Brain Neoplasms; Brain Stem; Calcinosis; Child; Dementia; Disease Progression; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neoplasms, Germ Cell and Embryonal; Paresis; Positron-Emission Tomography; Radiotherapy | 2009 |
The value of positron emission tomography and proliferation index in predicting progression in low-grade astrocytomas of childhood.
Topics: Adolescent; Astrocytoma; Brain Neoplasms; Cell Proliferation; Child; Child, Preschool; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tissue Distribution | 2009 |
Micrometastasis of papillary thyroid carcinoma in a human immunodeficiency virus-infected patient: a case report and discussion.
Topics: Bone Neoplasms; Carcinoma, Papillary; Combined Modality Therapy; Disease Progression; Disease Susceptibility; Fluorine Radioisotopes; Fluorodeoxyglucose F18; HIV Infections; Humans; Iodine Radioisotopes; Lung Neoplasms; Male; Mediastinal Neoplasms; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Thyroid Neoplasms; Thyroidectomy | 2010 |
Progressive eyelid and facial swelling due to follicular lymphoma.
Topics: Adult; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Disease Progression; Edema; Eyelid Diseases; Facial Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Male; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
18F-fluorodeoxyglucose-PET/CT imaging of lungs in patients with cystic fibrosis.
Topics: Adolescent; Adult; Cystic Fibrosis; Disease Progression; Fluorodeoxyglucose F18; Forced Expiratory Volume; Humans; Lung; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult | 2009 |
[Positron emission tomography as a tool for early prediction of therapy outcome in soft tissue sarcoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Ifosfamide; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Sarcoma; Soft Tissue Neoplasms; Treatment Outcome; Young Adult | 2009 |
MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis: experience on seven patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Progression; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Histiocytosis, Langerhans-Cell; Humans; Leucovorin; Male; Methotrexate; Middle Aged; Positron-Emission Tomography; Prednisone; Remission Induction; Retrospective Studies; Vincristine; Young Adult | 2010 |
Multiple (18)F-FDG, PET-CT for postoperative monitoring of breast cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole Body Imaging | 2009 |
Fluorodeoxyglucose-positron-emission tomography imaging of head and neck squamous cell cancer.
Topics: Biopsy, Fine-Needle; Carcinoma, Squamous Cell; Disease Progression; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Neoplasms, Multiple Primary; Neoplasms, Unknown Primary; Otorhinolaryngologic Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden; Ultrasonography | 2010 |
Posterior cortical atrophy with [11C] Pittsburgh compound B accumulation in the primary visual cortex.
Topics: Aniline Compounds; Atrophy; Brain Mapping; Disease Progression; Energy Metabolism; Female; Fluorodeoxyglucose F18; Hemianopsia; Humans; Magnetic Resonance Imaging; Middle Aged; Neurofibrillary Tangles; Plaque, Amyloid; Positron-Emission Tomography; Predictive Value of Tests; Thiazoles; Vision Disorders; Visual Cortex | 2010 |
High levels of 18F-FDG uptake in aortic aneurysm wall are associated with high wall stress.
Topics: Aged; Aged, 80 and over; Aorta, Abdominal; Aorta, Thoracic; Aortic Aneurysm, Abdominal; Aortic Aneurysm, Thoracic; Aortic Rupture; Biomechanical Phenomena; Disease Progression; Female; Finite Element Analysis; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Pilot Projects; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Stress, Mechanical; Tensile Strength; Tomography, X-Ray Computed | 2010 |
MCI patients declining and not-declining at mid-term follow-up: FDG-PET findings.
Topics: Aged; Aged, 80 and over; Brain Mapping; Cognition Disorders; Dementia; Disease Progression; Fluorodeoxyglucose F18; Follow-Up Studies; Functional Laterality; Humans; Image Processing, Computer-Assisted; Male; Memory Disorders; Positron-Emission Tomography; Predictive Value of Tests; Prognosis | 2010 |
Relative value of magnetic resonance spectroscopy, magnetic resonance perfusion, and 2-(18F) fluoro-2-deoxy-D-glucose positron emission tomography for detection of recurrence or grade increase in gliomas.
Topics: Adolescent; Adult; Aged; Brain; Brain Neoplasms; Diagnosis, Differential; Disease Progression; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gadolinium; Glioma; Humans; Magnetic Resonance Angiography; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiotherapy; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2010 |
Serum amyloid A is a useful marker to evaluate the disease activity of Takayasu's arteritis.
Topics: Amyloidosis; Aorta, Thoracic; Biomarkers; Disease Progression; Drug Therapy, Combination; Female; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Positron-Emission Tomography; Prednisolone; Serum Amyloid A Protein; Takayasu Arteritis; Treatment Outcome; Young Adult | 2010 |
[Phlegmon of the palm of the hand as initial manifestation of the Lemierre syndrome].
Topics: Abscess; Acromioclavicular Joint; Anti-Bacterial Agents; Cellulitis; Combined Modality Therapy; Diagnosis, Differential; Disease Progression; Drainage; Fluorodeoxyglucose F18; Fusobacterium Infections; Fusobacterium necrophorum; Hand Dermatoses; Heparin, Low-Molecular-Weight; Humans; Image Processing, Computer-Assisted; Male; Mediastinal Diseases; Metronidazole; Positron-Emission Tomography; Pulmonary Embolism; Reoperation; Shock, Septic; Syndrome; Tomography, X-Ray Computed; Young Adult | 2010 |
Value of combined PET/CT for radiation planning in CT-guided percutaneous interstitial high-dose-rate single-fraction brachytherapy for colorectal liver metastases.
Topics: Aged; Aged, 80 and over; Brachytherapy; Colorectal Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2010 |
The stripe of primary lateral sclerosis: focal primary motor cortex hypometabolism seen on fluorodeoxyglucose F18 positron emission tomography.
Topics: Aged; Brain Mapping; Diagnosis, Differential; Disease Progression; Energy Metabolism; Female; Fluorodeoxyglucose F18; Gait Disorders, Neurologic; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Motor Cortex; Motor Neuron Disease; Paresis; Positron-Emission Tomography; Predictive Value of Tests; Pseudobulbar Palsy; Pyramidal Tracts; Retrospective Studies; Sensitivity and Specificity | 2010 |
Spindle cell sarcoma degeneration of giant cell tumor of the knee, imaged with F-18 FDG PET-CT and Tc-99m MDP bone scan.
Topics: Bone and Bones; Disease Progression; Fluorodeoxyglucose F18; Giant Cell Tumor of Bone; Humans; Knee; Male; Middle Aged; Positron-Emission Tomography; Sarcoma; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2010 |
Flourine-18 flourodeoxyglucose positron emission tomography as a non-invasive test of disease activity in Takayasu's arteritis--a report of four cases.
Topics: Adult; Anticoagulants; Asthma; Constriction, Pathologic; Diagnosis, Differential; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Immunosuppressive Agents; Middle Aged; Positron-Emission Tomography; Sensitivity and Specificity; Takayasu Arteritis; Tuberculosis, Pulmonary | 2010 |
Posterior glucose hypometabolism in Lafora disease: early and late FDG-PET assessment.
Topics: Adolescent; Biopsy; Blood Glucose; Brain; Carrier Proteins; Cerebral Cortex; Child, Preschool; Diagnosis, Differential; Disease Progression; DNA Mutational Analysis; Dominance, Cerebral; Electroencephalography; Energy Metabolism; Epilepsy, Tonic-Clonic; Female; Fluorodeoxyglucose F18; Genetic Carrier Screening; Humans; Image Processing, Computer-Assisted; Lafora Disease; Occipital Lobe; Positron-Emission Tomography; Signal Processing, Computer-Assisted; Skin; Tomography, X-Ray Computed; Ubiquitin-Protein Ligases | 2010 |
Positron emission tomography imaging of DMBA/TPA mouse skin multi-step tumorigenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogens; Disease Progression; Female; Fluorodeoxyglucose F18; Glucose; Mice; Papilloma; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Skin Neoplasms; Tetradecanoylphorbol Acetate; Tomography, X-Ray Computed | 2010 |
[18F]Fluorodeoxyglucose positron emission tomography for outcome prediction of mammalian target of rapamycin inhibitor therapy.
Topics: Antibiotics, Antineoplastic; Disease Progression; Disease-Free Survival; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Intracellular Signaling Peptides and Proteins; Neoplasms; Positron-Emission Tomography; Protein Serine-Threonine Kinases; Radiopharmaceuticals; Sirolimus; TOR Serine-Threonine Kinases; Treatment Outcome | 2010 |
Value of combined interpretation of computed tomography response and positron emission tomography response for prediction of prognosis after neoadjuvant chemotherapy in non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Combined Modality Therapy; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
FDG positron emission tomography/computed tomography studies of Wilms' tumor.
Topics: Adolescent; Child; Child, Preschool; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Infant; Male; Positron-Emission Tomography; Recurrence; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Wilms Tumor; Young Adult | 2010 |
Comparative analysis of brain structure, metabolism, and cognition in myotonic dystrophy 1 and 2.
Topics: Adult; Atrophy; Brain; Brain Mapping; Cognition Disorders; Disease Progression; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Myotonic Dystrophy; Nerve Fibers, Myelinated; Neuropsychological Tests; Positron-Emission Tomography; Predictive Value of Tests; Young Adult | 2010 |
Usefulness of dynamic contrast enhanced computed tomography in patients with non-small-cell lung cancer scheduled for radiation therapy.
Topics: Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free Survival; Drug Therapy; Feasibility Studies; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Radiographic Image Enhancement; Radiotherapy, Computer-Assisted; Tomography, X-Ray Computed | 2010 |
Uptake of 18F-FDG in acute aortic dissection: a determinant of unfavorable outcome.
Topics: Aged; Aged, 80 and over; Aorta, Thoracic; Aortic Aneurysm; Aortic Dissection; Blood Chemical Analysis; Cholesterol, HDL; Data Interpretation, Statistical; Disease Progression; Electrocardiography; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiography, Thoracic; Radiopharmaceuticals; Risk Assessment; Tomography, Emission-Computed; Treatment Outcome | 2010 |
Imaging of acute and chronic aortic dissection by 18F-FDG PET/CT.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Aorta, Thoracic; Aortic Aneurysm; Aortic Dissection; Chronic Disease; Diagnosis, Differential; Disease Progression; False Negative Reactions; False Positive Reactions; Female; Fibrin Fibrinogen Degradation Products; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed | 2010 |
Fluorodeoxyglucose positron emission tomography of mild cognitive impairment with clinical follow-up at 3 years.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cognition Disorders; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Lewy Body Disease; Male; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results | 2010 |
Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans.
Topics: Alzheimer Disease; Biomarkers; Cognition Disorders; Diagnostic Imaging; Disease Progression; Fluorodeoxyglucose F18; Gene Expression Regulation; Genetic Predisposition to Disease; Genome-Wide Association Study; Genotype; Humans; Image Interpretation, Computer-Assisted; MicroRNAs; Monomeric Clathrin Assembly Proteins; Mutation; Phenotype; Radiopharmaceuticals | 2010 |
Preliminary assessment of dynamic contrast-enhanced CT implementation in pretreatment FDG-PET/CT for outcome prediction in head and neck tumors.
Topics: Aged; Carcinoma, Squamous Cell; Contrast Media; Disease Progression; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Injections, Intravenous; Iohexol; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Statistics, Nonparametric; Survival Rate; Tomography, X-Ray Computed | 2010 |
Comparing predictors of conversion and decline in mild cognitive impairment.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Apolipoprotein E4; Cognition Disorders; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Memory Disorders; Middle Aged; Neuropsychological Tests; Peptide Fragments; Positron-Emission Tomography; Predictive Value of Tests; ROC Curve; Statistics, Nonparametric; tau Proteins; Time Factors | 2010 |
Progression of cerebral amyloid load is associated with the apolipoprotein E ε4 genotype in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Aniline Compounds; Apolipoprotein E4; Brain; Disease Progression; Female; Fluorodeoxyglucose F18; Genotype; Humans; Male; Middle Aged; Plaque, Amyloid; Positron-Emission Tomography; Radiopharmaceuticals; Thiazoles | 2010 |
High rates of tumor growth and disease progression detected on serial pretreatment fluorodeoxyglucose-positron emission tomography/computed tomography scans in radical radiotherapy candidates with nonsmall cell lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiography | 2010 |
Small-animal PET/CT for monitoring the development and response to chemotherapy of thymic lymphoma in Trp53-/- mice.
Topics: Aging; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Cell Proliferation; Deoxycytidine; Disease Progression; Fluorodeoxyglucose F18; Gemcitabine; Image Processing, Computer-Assisted; Lymphoma; Mice; Mice, Knockout; Mitotic Index; Positron-Emission Tomography; Radiopharmaceuticals; Thymus Neoplasms; Tomography, Emission-Computed; Tumor Suppressor Protein p53 | 2010 |
Dynamic changes in PET amyloid and FDG imaging at different stages of Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Benzothiazoles; Brain; Carbon Radioisotopes; Cognition; Cognitive Dysfunction; Disease Progression; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thiazoles; Time Factors | 2012 |
Standardized FDG uptake as a prognostic variable and as a predictor of incomplete cytoreduction in primary advanced ovarian cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Algorithms; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Ovarian Neoplasms; Ovariectomy; Positron-Emission Tomography; Prognosis; Survival Analysis | 2011 |
Predicting the clinical course of Hodgkin lymphoma.
Topics: Antigens, CD; Antigens, Differentiation, Myelomonocytic; Biomarkers, Tumor; Disease Progression; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Immunohistochemistry; Macrophages; Positron-Emission Tomography; Prognosis; Treatment Outcome | 2010 |
Sarcoidosis development during induction chemotherapy for lung cancer mimicked progressive disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Disease Progression; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Node Excision; Lymph Nodes; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Pneumonectomy; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis, Pulmonary; Tomography, X-Ray Computed | 2010 |
Parkinson's disease tremor-related metabolic network: characterization, progression, and treatment effects.
Topics: Aged; Brain; Deep Brain Stimulation; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Tremor | 2011 |
[The role of PET imaging in patients with lymphoma].
Topics: Antineoplastic Agents; Disease Progression; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphoma; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
Fatal hypoglycemia in malignant pheochromocytoma: direct glucose consumption as suggested by (18)F-2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography imaging.
Topics: Adrenal Gland Neoplasms; Bone Neoplasms; Disease Progression; Fatal Outcome; Fluorodeoxyglucose F18; Glucose; Humans; Hypoglycemia; Liver Neoplasms; Male; Pheochromocytoma; Positron-Emission Tomography; Tomography, Emission-Computed, Single-Photon; Tumor Burden; Young Adult | 2010 |
Should patient setup in lung cancer be based on the primary tumor? An analysis of tumor coverage and normal tissue dose using repeated positron emission tomography/computed tomography imaging.
Topics: Aged; Aged, 80 and over; Anatomic Landmarks; Bone and Bones; Carcinoma, Non-Small-Cell Lung; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Induction Chemotherapy; Lung; Lung Neoplasms; Lymph Nodes; Male; Mediastinum; Middle Aged; Multimodal Imaging; Organs at Risk; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Small Cell Lung Carcinoma; Spinal Cord; Tomography, X-Ray Computed; Tumor Burden | 2012 |
Sarcoid-like reaction mimics progression of disease after induction chemotherapy for lung cancer.
Topics: Antineoplastic Agents; Biopsy; Carcinoma, Squamous Cell; Diagnosis, Differential; Disease Progression; Endosonography; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis, Pulmonary; Tomography, X-Ray Computed | 2010 |
Niemann-Pick disease type C: unique 2-deoxy-2[¹⁸F] fluoro-D-glucose PET abnormality.
Topics: Brain; Cerebral Cortex; Disease Progression; Electroencephalography; Evoked Potentials, Auditory, Brain Stem; Female; Fluorodeoxyglucose F18; Humans; Infant; Niemann-Pick Disease, Type C; Radiopharmaceuticals; Tomography, Emission-Computed; Twins | 2011 |
Comparison of proton magnetic resonance spectroscopy with fluorine-18 2-fluoro-deoxyglucose positron emission tomography for assessment of brain tumor progression.
Topics: Adult; Aged; Brain; Brain Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Positron-Emission Tomography | 2012 |
Splenic infarction associated with rapidly progressive chronic lymphocytic leukemia with complex karyotype and ATM mutation.
Topics: Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; Chromosome Aberrations; Disease Progression; DNA-Binding Proteins; Fluorodeoxyglucose F18; Humans; Karyotyping; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Mutation; Positron-Emission Tomography; Protein Serine-Threonine Kinases; Splenic Infarction; Time Factors; Tumor Suppressor Proteins | 2011 |
Combining FDG-PET/CT with laboratory data yields superior results for prediction of relapse in multiple myeloma.
Topics: Adult; Aged; beta 2-Microglobulin; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multiple Myeloma; Myeloma Proteins; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2011 |
Evaluation of 18F-FDG PET and MRI associations in pediatric diffuse intrinsic brain stem glioma: a report from the Pediatric Brain Tumor Consortium.
Topics: Adolescent; Brain Stem Neoplasms; Child; Child, Preschool; Disease Progression; Female; Fluorodeoxyglucose F18; Glioma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Reproducibility of Results | 2011 |
Age-specific progression of nigrostriatal dysfunction in Parkinson's disease.
Topics: Adult; Aged; Aging; Carbon Isotopes; Corpus Striatum; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Male; Methylphenidate; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Protein Binding; Substantia Nigra; Tetrabenazine; Tritium; Young Adult | 2011 |
Fluorodeoxyglucose positron emission tomography fails to detect distant metastases at initial staging of melanoma patients with metastatic involvement of sentinel lymph node.
Topics: Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Melanoma; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Skin Neoplasms | 2011 |
Prognostic significance of interim ¹⁸F-FDG PET/CT after three or four cycles of R-CHOP chemotherapy in the treatment of diffuse large B-cell lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prednisolone; Prognosis; Rituximab; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2011 |
Parametric images via dynamic 18F-fluorodeoxyglucose positron emission tomographic data acquisition in predicting midterm outcome of liver metastases secondary to gastrointestinal stromal tumours.
Topics: Adult; Aged; Cohort Studies; Discriminant Analysis; Disease Progression; Female; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Image Interpretation, Computer-Assisted; Linear Models; Liver Neoplasms; Male; Middle Aged; Molecular Targeted Therapy; Positron-Emission Tomography; Prognosis; Retrospective Studies | 2011 |
Detection of precursor lesions of pancreatic adenocarcinoma in PET-CT in a genetically engineered mouse model of pancreatic cancer.
Topics: Adenocarcinoma; Animals; Carcinoma in Situ; Disease Models, Animal; Disease Progression; Fluorodeoxyglucose F18; Genetic Engineering; Glucose; Glucose Transporter Type 2; Humans; Mice; Mice, Transgenic; Pancreatic Neoplasms; Positron-Emission Tomography; Precancerous Conditions | 2011 |
(18)F-FDG PET/CT in a rare case of Stewart-Treves syndrome: future implications and diagnostic considerations.
Topics: Adult; Disease Progression; Female; Fluorodeoxyglucose F18; Hemangiosarcoma; Humans; Leg; Lymphangiosarcoma; Lymphedema; Positron-Emission Tomography; Skin; Tomography, X-Ray Computed | 2011 |
Recent progress in carcinogenesis, progression and therapy of breast cancer: the 20th Hiroshima Cancer Seminar--the 4th Three Universities' Consortium International Symposium, October 2010: 31 October 2010, International Conference Center Hiroshima.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Biomarkers, Tumor; Breast Neoplasms; Cell Transformation, Neoplastic; Cost-Benefit Analysis; Cyclin-Dependent Kinase 6; Cyclin-Dependent Kinase Inhibitor p16; Disease Progression; Drug Resistance, Neoplasm; Estrogens; Female; Fluorodeoxyglucose F18; Hexosyltransferases; Humans; Insurance Coverage; International Cooperation; Membrane Proteins; MicroRNAs; Molecular Targeted Therapy; Neoplasm Proteins; Positron-Emission Tomography; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Receptor, ErbB-2; Receptors, Immunologic; Signal Transduction; Sirtuin 1; Universities | 2011 |
Early CT and FDG-metabolic tumour volume changes show a significant correlation with survival in stage I-III small cell lung cancer: a hypothesis generating study.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bronchoscopy; Combined Modality Therapy; Contrast Media; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Small Cell Lung Carcinoma; Survival Analysis; Tomography, X-Ray Computed; Tumor Burden | 2011 |
Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study.
Topics: Adult; Aged; Brain Chemistry; Cerebral Cortex; Cognition; Cohort Studies; Dementia; Disease Progression; Female; Fluorodeoxyglucose F18; Glucose; Humans; Longitudinal Studies; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals | 2011 |
Prognostic value of fluorine-18 fluorodeoxyglucose positron-emission tomography imaging in patients with head and neck squamous cell carcinoma.
Topics: Aged; Analysis of Variance; Biopsy, Needle; Carcinoma, Squamous Cell; Cohort Studies; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Statistics, Nonparametric; Survival Analysis; Tomography, X-Ray Computed | 2012 |
[Positron emission tomography with 18F-FDG and cancer response to chemotherapy].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Disease Progression; Drug Monitoring; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Tumor Burden | 2011 |
Evaluation of a calibrated (18)F-FDG PET score as a biomarker for progression in Alzheimer disease and mild cognitive impairment.
Topics: Aged; Alzheimer Disease; Biomarkers; Calibration; Cognition; Cognition Disorders; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Mental Status Schedule; Middle Aged; Neurology; Neuropsychological Tests; Positron-Emission Tomography; Reproducibility of Results | 2011 |
Diagnostic and staging impact of radiotherapy planning FDG-PET-CT in non-small-cell lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Whole Body Imaging | 2011 |
Radiofrequency ablation of medically inoperable stage IA non-small cell lung cancer: are early posttreatment PET findings predictive of treatment outcome?
Topics: Aged; Aged, 80 and over; Biopsy; Carcinoma, Non-Small-Cell Lung; Catheter Ablation; Contrast Media; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiography; Radiopharmaceuticals; Treatment Outcome | 2011 |
Metabolism-perfusion imaging to predict disease activity in cardiac sarcoidosis.
Topics: Cardiomyopathies; Diagnosis, Differential; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Myocardium; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Sensitivity and Specificity; Severity of Illness Index | 2011 |
Clinical course of patients with familial early-onset Alzheimer's disease potentially lacking senile plaques bearing the E693Δ mutation in amyloid precursor protein.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Aniline Compounds; Apolipoproteins E; Atrophy; Benzothiazoles; Brain; Cerebellar Ataxia; Cognition; Disease Progression; Female; Fluorodeoxyglucose F18; Gait Disorders, Neurologic; Humans; Magnetic Resonance Imaging; Memory Disorders; Middle Aged; Mutation; Neuropsychological Tests; Pedigree; Plaque, Amyloid; Positron-Emission Tomography; Radiopharmaceuticals; Thiazoles | 2011 |
Seizures can precede cognitive symptoms in late-onset Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Amyloid beta-Protein Precursor; Apolipoprotein E3; Cognition Disorders; Disease Progression; Electroencephalography; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Seizures | 2011 |
Calcified metastases from ovarian carcinoma highlighted by F-18 FDG PET/CT: report of two cases.
Topics: Adult; Aged; Calcinosis; Carcinoma, Papillary; Combined Modality Therapy; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Metastasis; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
PET imaging may provide a novel biomarker and understanding of right ventricular dysfunction in patients with idiopathic pulmonary arterial hypertension.
Topics: Adolescent; Adult; Biomarkers; Cohort Studies; Contrast Media; Diagnostic Imaging; Disease Progression; Echocardiography, Doppler, Color; Electrocardiography; Familial Primary Pulmonary Hypertension; Female; Fluorodeoxyglucose F18; Humans; Hypertension, Pulmonary; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Retrospective Studies; Sensitivity and Specificity; Severity of Illness Index; Survival Rate; Ventricular Dysfunction, Right; Young Adult | 2011 |
Pioglitazone modulates vascular inflammation in atherosclerotic rabbits noninvasive assessment with FDG-PET-CT and dynamic contrast-enhanced MR imaging.
Topics: Animals; Anti-Inflammatory Agents; Aorta; Aortography; Atherosclerosis; Biomarkers; Contrast Media; Disease Models, Animal; Disease Progression; Fluorodeoxyglucose F18; Immunohistochemistry; Inflammation; Lipids; Macrophages; Magnetic Resonance Angiography; Multimodal Imaging; Neovascularization, Pathologic; Pioglitazone; Positron-Emission Tomography; PPAR gamma; Predictive Value of Tests; Rabbits; Radiopharmaceuticals; Thiazolidinediones; Time Factors; Tomography, X-Ray Computed | 2011 |
Evaluation of monkeypox disease progression by molecular imaging.
Topics: Animals; Axilla; Bronchi; Disease Models, Animal; Disease Progression; Female; Fluorodeoxyglucose F18; Injections, Intravenous; Lung; Lymph Nodes; Macaca fascicularis; Male; Monkeypox virus; Mpox (monkeypox); Multimodal Imaging; Necrosis; Pneumonia; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
PET-guided dose escalation tomotherapy in malignant pleural mesothelioma.
Topics: Adult; Aged; Chemoradiotherapy; Combined Modality Therapy; Disease Progression; Disease-Free Survival; Dose Fractionation, Radiation; Fatty Acids; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Mesothelioma; Middle Aged; Multimodal Imaging; Neoplasm Staging; Palliative Care; Pilot Projects; Pleural Neoplasms; Positron-Emission Tomography; Radiation Injuries; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Computer-Assisted; Radiotherapy, Image-Guided; Salvage Therapy; Tomography, Spiral Computed; Tomography, X-Ray Computed | 2011 |
Neuropathological investigation of the hypometabolic regions on positron emission tomography with [18F] fluorodeoxyglucose in patients with dementia with Lewy bodies.
Topics: Aged; Aged, 80 and over; alpha-Synuclein; Alzheimer Disease; Amyloid beta-Peptides; Autopsy; Brain; Cell Count; Data Interpretation, Statistical; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lewy Body Disease; Male; Middle Aged; Neurofibrillary Tangles; Neurons; Positron-Emission Tomography; Radiopharmaceuticals; tau Proteins | 2012 |
Evaluation of the role of tumor-associated macrophages in an experimental model of peritoneal carcinomatosis using (18)F-FDG PET.
Topics: Animals; Biological Transport; Diffusion; Disease Models, Animal; Disease Progression; Female; Fluorodeoxyglucose F18; Macrophages; Mice; Mice, Inbred BALB C; Peritoneal Neoplasms; Positron-Emission Tomography | 2011 |
Growth of a solitary pulmonary nodule after 6years diagnosed as oncocytic carcinoid tumour with a high 18-fluorodeoxyglucose (18F-FDG) uptake in positron emission tomography-computed tomography (PET-CT).
Topics: Carcinoid Tumor; Carcinoma, Non-Small-Cell Lung; Disease Progression; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Lung ¹⁸F-fluorodeoxyglucose positron emission tomography for diagnosis and monitoring of pulmonary arterial hypertension.
Topics: Animals; Disease Models, Animal; Disease Progression; Familial Primary Pulmonary Hypertension; Fluorodeoxyglucose F18; Hypertension, Pulmonary; Monitoring, Physiologic; Oxygen Consumption; Positron-Emission Tomography; Pulmonary Wedge Pressure; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Reproducibility of Results | 2012 |
Interim-treatment quantitative PET parameters predict progression and death among patients with Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Disease Progression; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Young Adult | 2012 |
Prognostic value of metabolic tumor volume and velocity in predicting head-and-neck cancer outcomes.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Karnofsky Performance Status; Lymph Nodes; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Proportional Hazards Models; Radiopharmaceuticals; Survival Analysis; Time Factors; Tomography, X-Ray Computed; Tumor Burden | 2012 |
Value of diagnostic tests to predict conversion to Alzheimer's disease in young and old patients with amnestic mild cognitive impairment.
Topics: Age Factors; Aged; Aged, 80 and over; Aging; Alzheimer Disease; Amyloid beta-Peptides; Canada; Cognitive Dysfunction; Databases, Bibliographic; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Peptide Fragments; Positron-Emission Tomography; Predictive Value of Tests; tau Proteins; United States | 2012 |
Characterizing a neurodegenerative syndrome: primary progressive apraxia of speech.
Topics: Aged; Aged, 80 and over; Aniline Compounds; Apraxias; Brain; Diffusion Magnetic Resonance Imaging; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Language Tests; Male; Middle Aged; Neurodegenerative Diseases; Neurologic Examination; Neuropsychological Tests; Positron-Emission Tomography; Speech Disorders; Thiazoles; Tomography, X-Ray Computed | 2012 |
Cost-effectiveness of positron emission tomography/computed tomography in the management of advanced head and neck cancer.
Topics: Aged; Alberta; Carcinoma, Squamous Cell; Cohort Studies; Contrast Media; Cost-Benefit Analysis; Disease Progression; Female; Fluorodeoxyglucose F18; Hospital Costs; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Otorhinolaryngologic Neoplasms; Palliative Care; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
Neoadjuvant chemotherapy in breast cancer: prediction of pathologic response with PET/CT and dynamic contrast-enhanced MR imaging--prospective assessment.
Topics: Adult; Aged; Analysis of Variance; Area Under Curve; Biopsy, Needle; Breast Neoplasms; Contrast Media; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Magnetic Resonance Imaging; Microcirculation; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Biomarkers; Brain; Cognition Disorders; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Male; Mental Status Schedule; National Institute on Aging (U.S.); Neuropsychological Tests; Positron-Emission Tomography; Thiazoles; United States | 2012 |
IgA NMDA receptor antibodies are markers of synaptic immunity in slow cognitive impairment.
Topics: Adrenal Cortex Hormones; Aged; Alzheimer Disease; Antibodies, Monoclonal, Murine-Derived; Atrophy; Autoimmunity; Biomarkers; Blotting, Western; Cognition Disorders; Cyclophosphamide; Disease Progression; Electrophysiology; Female; Fluorodeoxyglucose F18; Frontal Lobe; Hippocampus; Humans; Immunoglobulin A; Immunohistochemistry; Immunotherapy; Lewy Body Disease; Magnetic Resonance Imaging; Neurons; Plasma Exchange; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, N-Methyl-D-Aspartate; Rituximab; Synapses; Temporal Lobe; Treatment Outcome | 2012 |
Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Brain; Chi-Square Distribution; Cognition Disorders; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; National Institute on Aging (U.S.); Neuropsychological Tests; Positron-Emission Tomography; Psychiatric Status Rating Scales; Thiazoles; United States | 2012 |
Relationship between lymphocytopenia and circulating tumor cells as prognostic factors for overall survival in metastatic breast cancer.
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphopenia; Middle Aged; Neoplastic Cells, Circulating; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Survival Rate; Tomography, Emission-Computed; United States; Women's Health | 2012 |
Comparative study of the value of dual tracer PET/CT in evaluating breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Choline; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed; Young Adult | 2012 |
Bevacizumab as salvage therapy for progressive brain stem gliomas.
Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Astrocytoma; Bevacizumab; Brain Stem Neoplasms; Combined Modality Therapy; Databases, Factual; Disease Progression; Female; Fluorodeoxyglucose F18; Gait Disorders, Neurologic; Glioma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radiopharmaceuticals; Salvage Therapy | 2013 |
Hypometabolism precedes limbic atrophy and spontaneous recurrent seizures in a rat model of TLE.
Topics: Analysis of Variance; Animals; Atrophy; Brain Mapping; CA1 Region, Hippocampal; Disease Models, Animal; Disease Progression; Electroencephalography; Electron Transport Complex IV; Epilepsy, Temporal Lobe; Excitatory Amino Acid Agonists; Fluorodeoxyglucose F18; Glial Fibrillary Acidic Protein; Glucose Metabolism Disorders; Glucose Transporter Type 1; Kainic Acid; Limbic System; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Pyramidal Cells; Rats; Rats, Wistar; Synaptophysin; Time Factors | 2012 |
Analysis of the growth dynamics of angiogenesis-dependent and -independent experimental glioblastomas by multimodal small-animal PET and MRI.
Topics: Animals; Blood-Brain Barrier; Brain Neoplasms; Data Interpretation, Statistical; Dideoxynucleosides; Disease Progression; Fluorodeoxyglucose F18; Glioblastoma; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Ki-67 Antigen; Magnetic Resonance Imaging; Methionine; Neoplasm Transplantation; Neovascularization, Pathologic; Paraffin Embedding; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Nude; Xenograft Model Antitumor Assays | 2012 |
A multicenter prospective evaluation of the clinical utility of F-18 FDG-PET/CT in patients with AJCC stage IIIB or IIIC extremity melanoma.
Topics: Adult; Aged; Disease Progression; Disease-Free Survival; Extremities; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Multimodal Imaging; Neoplasm Staging; Population Surveillance; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Survival Analysis; Tomography, X-Ray Computed | 2012 |
Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Carcinoma, Non-Small-Cell Lung; Disease Progression; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Whole Body Imaging | 2012 |
Degenerative jargon aphasia: unusual progression of logopenic/phonological progressive aphasia?
Topics: Aged; Aphasia, Primary Progressive; Aphasia, Wernicke; Brain; Disease Progression; Female; Fluorodeoxyglucose F18; Functional Neuroimaging; Humans; Language Tests; Neuropsychological Tests; Positron-Emission Tomography | 2013 |
Nonfluent/agrammatic PPA with in-vivo cortical amyloidosis and Pick's disease pathology.
Topics: Aged; Alzheimer Disease; Amyloidosis; Aniline Compounds; Carbon Radioisotopes; Disease Progression; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Frontal Lobe; Functional Neuroimaging; Humans; Magnetic Resonance Imaging; Neuropsychological Tests; Pick Disease of the Brain; Positron-Emission Tomography; Primary Progressive Nonfluent Aphasia; Thiazoles | 2013 |
18F-FDG PET/CT useful for the early detection of rapidly progressive fatal interstitial lung disease in dermatomyositis.
Topics: Aged; Dermatomyositis; Disease Progression; Early Diagnosis; Fatal Outcome; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Diseases, Interstitial; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Positron emission tomography with computed tomography (PET-CT) to evaluate the response of bone metastases to non-surgical treatment.
Topics: Aromatase Inhibitors; Bone Density Conservation Agents; Breast Neoplasms; Diphosphonates; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Ibandronic Acid; Letrozole; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Nitriles; Positron-Emission Tomography; Radiopharmaceuticals; Spinal Neoplasms; Tomography, X-Ray Computed; Triazoles | 2010 |
Predicting brain activity using a Bayesian spatial model.
Topics: Algorithms; Alzheimer Disease; Bayes Theorem; Biostatistics; Brain; Case-Control Studies; Cognitive Dysfunction; Computer Simulation; Disease Progression; Fluorodeoxyglucose F18; Functional Neuroimaging; Humans; Magnetic Resonance Imaging; Models, Neurological; Normal Distribution; Positron-Emission Tomography; Radiopharmaceuticals | 2013 |
Molecular imaging of neuroblastoma progression in TH-MYCN transgenic mice.
Topics: Animals; Antineoplastic Agents; Disease Models, Animal; Disease Progression; Fluorodeoxyglucose F18; Histocytochemistry; Linear Models; Mice; Mice, Transgenic; Molecular Imaging; N-Myc Proto-Oncogene Protein; Neuroblastoma; Positron-Emission Tomography; Proto-Oncogene Proteins; Statistics, Nonparametric | 2013 |
Predictive value of ¹⁸F-fluorodeoxyglucose PET/CT for transarterial chemolipiodolization of hepatocellular carcinoma.
Topics: Aged; alpha-Fetoproteins; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Logistic Models; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Republic of Korea; Retrospective Studies; Risk Assessment; Risk Factors; Survival Analysis; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2012 |
PET/CT imaging of metastatic Merkel cell carcinoma to the adrenal glands.
Topics: Adrenal Gland Neoplasms; Aged; Carcinoma, Merkel Cell; Disease Progression; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Skin Neoplasms; Tomography, X-Ray Computed | 2010 |
Natural growth and disease progression of non-small cell lung cancer evaluated with 18F-fluorodeoxyglucose PET/CT.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2012 |
Early prediction of pathological response in locally advanced rectal cancer based on sequential 18F-FDG PET.
Topics: Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Combined Modality Therapy; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Period; Prognosis; Rectal Neoplasms; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Time Factors; Treatment Outcome | 2013 |
Regression of inflammation in atherosclerosis by the LXR agonist R211945: a noninvasive assessment and comparison with atorvastatin.
Topics: Animals; Apolipoproteins B; Atorvastatin; Disease Progression; Fluorodeoxyglucose F18; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; Liver X Receptors; Macrophages; Multimodal Imaging; Orphan Nuclear Receptors; Plaque, Atherosclerotic; Positron-Emission Tomography; Pyrroles; Rabbits; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Molecular imaging reveals a progressive pulmonary inflammation in lower airways in ferrets infected with 2009 H1N1 pandemic influenza virus.
Topics: Animals; Disease Progression; Female; Ferrets; Fluorodeoxyglucose F18; Influenza A Virus, H1N1 Subtype; Lung; Molecular Imaging; Multimodal Imaging; Nose; Orthomyxoviridae Infections; Pandemics; Pneumonia; Positron-Emission Tomography; Tomography, X-Ray Computed; Virus Replication; Virus Shedding | 2012 |
Contrast enhanced MRI and ¹⁸F-FDG PET-CT in the assessment of multiple myeloma: a comparison of results in different phases of the disease.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Disease Progression; Female; Fluorodeoxyglucose F18; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Multiple Myeloma; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Combination of 18F-FDG PET and cerebrospinal fluid biomarkers as a better predictor of the progression to Alzheimer's disease in mild cognitive impairment patients.
Topics: Aged; Alzheimer Disease; Biomarkers; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Longitudinal Studies; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Predictive Value of Tests | 2013 |
[Evaluation of efficacy and clinical impact of 18F-FDG-PET in the diagnosis of recurrent medullary thyroid cancer with increased calcitonin and negative imaging test].
Topics: Biomarkers, Tumor; Bone Neoplasms; Calcitonin; Carcinoma, Medullary; Disease Progression; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Multiple Endocrine Neoplasia Type 2b; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Thyroid Neoplasms; Thyroidectomy | 2012 |
Role of 18F-FDG PET in the diagnosis of Rasmussen's disease.
Topics: Anticonvulsants; Child, Preschool; Disease Progression; Electroencephalography; Encephalitis; Female; Fluorodeoxyglucose F18; Hemispherectomy; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Paresis; Positron-Emission Tomography; Radiopharmaceuticals; Status Epilepticus | 2012 |
Clinical relevance of 18F-FDG PET and 18F-DOPA PET in recurrent medullary thyroid carcinoma.
Topics: Adult; Aged; Carcinoembryonic Antigen; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Recurrence; Retrospective Studies; Survival Analysis; Thyroid Neoplasms; Young Adult | 2012 |
Amyloid deposition, hypometabolism, and longitudinal cognitive decline.
Topics: Aged; Amyloid; Aniline Compounds; Body Burden; Cognition Disorders; Cognitive Dysfunction; Cross-Sectional Studies; Disease Progression; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Longitudinal Studies; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography | 2012 |
Integrated peripheral boost in preoperative radiotherapy for the locally most advanced non-resectable rectal cancer patients.
Topics: Aged; Carcinoma; Chemoradiotherapy; Combined Modality Therapy; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Positron-Emission Tomography; Preoperative Period; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Adjuvant; Radiotherapy, Conformal; Rectal Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2013 |
Progressive changes in a recognition memory network in Parkinson's disease.
Topics: Aged; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Longitudinal Studies; Magnetic Resonance Imaging; Male; Memory Disorders; Middle Aged; Models, Neurological; Nerve Net; Neuropsychological Tests; Parkinson Disease; Principal Component Analysis; Psychomotor Performance; Radionuclide Imaging; Radiopharmaceuticals; Reaction Time; Recognition, Psychology; Socioeconomic Factors | 2013 |
Early interim FDG PET/CT prediction of treatment response and prognosis in pediatric Hodgkin disease-added value of low-dose CT.
Topics: Adolescent; Child; Child, Preschool; Disease Progression; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Radiation Dosage; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
The GGGGCC repeat expansion in C9ORF72 in a case with discordant clinical and FDG-PET findings: PET trumps syndrome.
Topics: Aged; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Brain; C9orf72 Protein; Chromosomes, Human, Pair 9; Disease Progression; DNA Repeat Expansion; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Longitudinal Studies; Male; Positron-Emission Tomography; Proteins; Radiopharmaceuticals | 2014 |
Oesophageal tumour progression between the diagnostic ¹⁸F-FDG-PET and the ¹⁸F-FDG-PET for radiotherapy treatment planning.
Topics: Adult; Aged; Aged, 80 and over; Disease Progression; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted | 2013 |
Usefulness of fluorine-18 fluorodeoxyglucose-positron emission tomography in management strategy for thymic epithelial tumors.
Topics: Adult; Aged; Aged, 80 and over; Disease Management; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Japan; Male; Middle Aged; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Positron-Emission Tomography; Practice Guidelines as Topic; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Thymus Neoplasms | 2013 |
Clinical staging of semantic dementia in an FDG-PET study using FTLD-CDR.
Topics: Age of Onset; Aged; Brain Chemistry; Brain Mapping; Dementia; Disease Progression; Female; Fluorodeoxyglucose F18; Frontotemporal Lobar Degeneration; Functional Laterality; Glucose; Humans; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; Regression Analysis | 2012 |
Interim PET/CT-based prognostic model for the treatment of diffuse large B cell lymphoma in the post-rituximab era.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Decision Support Techniques; Disease Progression; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Prognosis; Rituximab; Tomography, X-Ray Computed; Vincristine; Young Adult | 2013 |
Unresectable lung malignancy: combination therapy with segmental pulmonary arterial chemoembolization with drug-eluting microspheres and radiofrequency ablation in 17 patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Catheter Ablation; Chemoembolization, Therapeutic; Cisplatin; Combined Modality Therapy; Disease Progression; Doxorubicin; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Microspheres; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Monitoring the effects of bevacizumab beyond progression in a murine colorectal cancer model: a functional imaging approach.
Topics: Animals; Antibodies, Monoclonal, Humanized; Bevacizumab; Colorectal Neoplasms; Disease Models, Animal; Disease Progression; Female; Fluorodeoxyglucose F18; Ki-67 Antigen; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Positron-Emission Tomography; Tumor Burden | 2013 |
A Decision Support System for the assisted diagnosis of brain tumors: a feasibility study for ¹⁸F-FDG PET preclinical studies.
Topics: Algorithms; Brain Neoplasms; Decision Support Systems, Clinical; Disease Progression; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Principal Component Analysis; Sensitivity and Specificity | 2012 |
Flare response versus disease progression in patients with non-small cell lung cancer.
Topics: Acute Disease; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Disease Progression; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Diagnostic accuracy of markers for prodromal Alzheimer's disease in independent clinical series.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cognition Disorders; Databases, Factual; Disease Progression; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Peptide Fragments; Positron-Emission Tomography; Sensitivity and Specificity; Statistics, Nonparametric; Time Factors | 2013 |
In vivo imaging of region and cell type specific neocortical neurodegeneration in Alzheimer's disease. Perspectives of MRI derived corpus callosum measurement for mapping disease progression and effects of therapy. Evidence from studies with MRI, EEG and
Topics: Alzheimer Disease; Atrophy; Corpus Callosum; Disease Progression; Electroencephalography; Fluorodeoxyglucose F18; Hippocampus; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Neocortex; Nerve Degeneration; Neurons; Radiography; Radiopharmaceuticals; Severity of Illness Index; Tomography, Emission-Computed | 2002 |
Staging of regional nodes in AJCC stage I and II melanoma: 18FDG PET imaging versus sentinel node detection.
Topics: Adult; Aged; Disease Progression; Extremities; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Injections, Intravenous; Lymph Nodes; Male; Melanoma; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Recurrence; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, Emission-Computed | 2002 |
Sarcoma tumor FDG uptake measured by PET and patient outcome: a retrospective analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biological Transport; Bone Neoplasms; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Predictive Value of Tests; Prognosis; Regression Analysis; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Survival Analysis; Tissue Distribution; Tomography, Emission-Computed; Treatment Outcome | 2002 |
Whole-body (18)F-FDG PET identifies high-risk myeloma.
Topics: Adult; Aged; Aged, 80 and over; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Paraproteinemias; Plasmacytoma; Prognosis; Radiopharmaceuticals; Recurrence; Remission Induction; Retrospective Studies; Risk Factors; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2002 |
Posttherapy surveillance monitoring of cervical cancer by FDG-PET.
Topics: Adenocarcinoma; Carcinoma; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Multivariate Analysis; Neoplasm Recurrence, Local; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2003 |
Diagnostic imaging in 13 cases of Rasmussen's encephalitis: can early MRI suggest the diagnosis?
Topics: Atrophy; Brain; Child; Child, Preschool; Diagnosis, Differential; Disease Progression; Encephalitis; Female; Fluorodeoxyglucose F18; Humans; Infant; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Protons; Radiopharmaceuticals; Retrospective Studies; Technetium Tc 99m Exametazime; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2003 |
Quantitative analysis of gray- and white-matter volumes and glucose metabolism in Sturge-Weber syndrome.
Topics: Adolescent; Brain; Child; Child, Preschool; Disease Progression; Female; Fluorodeoxyglucose F18; Glucose; Hemangioma; Humans; Infant; Magnetic Resonance Imaging; Male; Radiography; Radiopharmaceuticals; Sturge-Weber Syndrome; Tomography, Emission-Computed | 2003 |
Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer's disease?
Topics: Alzheimer Disease; Brain; Disease Progression; Female; Fluorodeoxyglucose F18; Gyrus Cinguli; Humans; Male; Memory Disorders; Middle Aged; Neuropsychological Tests; Parietal Lobe; Prospective Studies; Radiopharmaceuticals; Risk Factors; Single-Blind Method; Temporal Lobe; Tomography, Emission-Computed | 2003 |
Indium-111-Octreotide scintigraphy in differentiated thyroid carcinoma metastases that do not respond to treatment with high-dose I-131.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Carcinoma, Papillary; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Indium Radioisotopes; Iodine Radioisotopes; Male; Middle Aged; Octreotide; Radiopharmaceuticals; Receptors, Somatostatin; Somatostatin; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Thyroid Neoplasms; Tomography, Emission-Computed; Treatment Failure | 2003 |
Rasmussen syndrome: multifocal spread of inflammation suggested from MRI and PET findings.
Topics: Autonomic Nervous System Diseases; Carbon Radioisotopes; Cerebral Cortex; Child; Disease Progression; Dominance, Cerebral; Encephalitis; Epilepsia Partialis Continua; Epilepsy; Epilepsy, Partial, Motor; Epilepsy, Temporal Lobe; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Enhancement; Magnetic Resonance Imaging; Methionine; Occipital Lobe; Temporal Lobe; Tomography, Emission-Computed | 2003 |
Rasmussen encephalitis associated with Parry-Romberg syndrome.
Topics: Child; Disease Progression; Encephalitis; Epilepsia Partialis Continua; Facial Hemiatrophy; Fluorodeoxyglucose F18; Frontal Lobe; Gliosis; Humans; Magnetic Resonance Imaging; Male; Parietal Lobe; Tomography, Emission-Computed | 2003 |
18FDG positron emission tomography versus 67Ga scintigraphy as prognostic test during chemotherapy for non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Prospective Studies; Radiopharmaceuticals; Remission Induction; Tomography, Emission-Computed; Tomography, X-Ray Computed; Vincristine | 2003 |
Evolution of diaschisis in a focal stroke model.
Topics: Animals; Antipyrine; Autoradiography; Blood Flow Velocity; Carbon Radioisotopes; Cerebrovascular Circulation; Disease Models, Animal; Disease Progression; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Male; Neostriatum; Rats; Rats, Sprague-Dawley; Somatosensory Cortex; Stroke; Thalamus; Tomography, Emission-Computed | 2004 |
[Metabolic imaging by positron emission tomography using [18F] fluorodeoxiglucose in developmental disorders].
Topics: Brain; Child; Developmental Disabilities; Disease Progression; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
3-Nitropropionic acid-induced neurotoxicity--assessed by ultra high resolution positron emission tomography with comparison to magnetic resonance spectroscopy.
Topics: Acute Disease; Animals; Behavior, Animal; Body Weight; Brain; Choline; Chronic Disease; Disease Models, Animal; Disease Progression; Energy Metabolism; Fluorodeoxyglucose F18; Glucose; Lactic Acid; Magnetic Resonance Spectroscopy; Male; Motor Activity; Neostriatum; Neurotoxicity Syndromes; Nitro Compounds; Propionates; Rats; Rats, Sprague-Dawley; Succinic Acid; Tomography, Emission-Computed | 2004 |
In vivo positron-emission tomography imaging of progression and transformation in a mouse model of mammary neoplasia.
Topics: Animals; Disease Models, Animal; Disease Progression; Fluorodeoxyglucose F18; Longitudinal Studies; Mammary Glands, Animal; Mammary Neoplasms, Animal; Mice; Tomography, Emission-Computed | 2004 |
[18F]FDG-PET in patients with Alzheimer's disease: marker of disease spread.
Topics: Aged; Alzheimer Disease; Amnesia; Blood Glucose; Brain; Disease Progression; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Image Processing, Computer-Assisted; Male; Memory, Short-Term; Mental Status Schedule; Middle Aged; Parietal Lobe; Positron-Emission Tomography; Statistics as Topic; Temporal Lobe | 2005 |
Assessment of disease progression in parkinsonism.
Topics: Aged; Brain; Carbon Radioisotopes; Disease Progression; Female; Fluorodeoxyglucose F18; Glucose; Humans; Iodine Radioisotopes; Longitudinal Studies; Male; Middle Aged; Movement; Parkinsonian Disorders; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tropanes | 2004 |
[PET/CT for colorectal and hepatic tumors].
Topics: Adult; Aged; Colon; Colorectal Neoplasms; Disease Progression; Equipment Design; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Processing, Computer-Assisted; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Rectum; Sensitivity and Specificity; Tomography, X-Ray Computed | 2004 |
Correlation of molecular genetics with molecular and morphological imaging in gliomas with an oligodendroglial component.
Topics: Adult; Aged; Alleles; Blood-Brain Barrier; Brain; Brain Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Glioma; Humans; Lasers; Magnetic Resonance Imaging; Male; Middle Aged; Oligodendroglioma; Prospective Studies; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2004 |
One-year change in cerebral glucose metabolism in patients with Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Brain Chemistry; Brain Mapping; Disease Progression; Donepezil; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Indans; Magnetic Resonance Imaging; Male; Nootropic Agents; Piperidines; Radionuclide Imaging; Radiopharmaceuticals | 2004 |
MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET.
Topics: Aged; Alleles; Alzheimer Disease; Apolipoprotein E4; Apolipoproteins E; Brain; Cognition Disorders; Disease Progression; Energy Metabolism; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Genetic Predisposition to Disease; Genotype; Humans; Male; Memory Disorders; Mental Recall; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Single-Blind Method | 2004 |
[18F]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Retrospective Studies; Survival Rate | 2005 |
Hypofrontality in men with first-episode psychosis.
Topics: Adult; Brain Mapping; Disease Progression; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Prefrontal Cortex; Psychiatric Status Rating Scales; Psychotic Disorders; Radiopharmaceuticals; Schizophrenia | 2005 |
Does increased 18FDG uptake reflect malignant transformation of a low-grade glioma? A diagnostic dilemma.
Topics: Adult; Brain Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Glioma; Humans; Positron-Emission Tomography; Severity of Illness Index | 2005 |
Fluorodeoxyglucose positron emission tomography as an outcome measure for castrate metastatic prostate cancer treated with antimicrotubule chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Fluorodeoxyglucose F18; Humans; Male; Microtubules; Neoplasm Metastasis; Orchiectomy; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Sensitivity and Specificity; Treatment Outcome | 2005 |
Positron emission tomography use in the diagnosis and follow up of Takayasu's arteritis.
Topics: Adult; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunosuppressive Agents; Positron-Emission Tomography; Radiopharmaceuticals; Takayasu Arteritis | 2005 |
Striatal dopamine D2 receptors, metabolism, and volume in preclinical Huntington disease.
Topics: Adult; Binding, Competitive; Biomarkers; Corpus Striatum; Disease Progression; DNA Mutational Analysis; Dopamine; Dopamine Antagonists; Female; Fluorodeoxyglucose F18; Glucose; Humans; Huntingtin Protein; Huntington Disease; Magnetic Resonance Imaging; Male; Middle Aged; Mutation; Nerve Degeneration; Nerve Tissue Proteins; Nuclear Proteins; Positron-Emission Tomography; Predictive Value of Tests; Raclopride; Receptors, Dopamine D2; Trinucleotide Repeat Expansion | 2005 |
Variable problems in lymphomas: CASE 2. Sarcoidosis mimicking progressive lymphoma.
Topics: Diagnosis, Differential; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis, Pulmonary; Tomography, X-Ray Computed | 2005 |
PET is better than perfusion SPECT for early diagnosis of Alzheimer's disease -- for.
Topics: Alzheimer Disease; Disease Progression; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technology Assessment, Biomedical; Tomography, Emission-Computed, Single-Photon | 2005 |
PET is better than perfusion SPECT for early diagnosis of Alzheimer's disease -- against.
Topics: Alzheimer Disease; Disease Progression; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technology Assessment, Biomedical; Tomography, Emission-Computed, Single-Photon | 2005 |
Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease.
Topics: Aged; Alzheimer Disease; Brain Mapping; Case-Control Studies; Cognition Disorders; Demography; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Psychological Tests; ROC Curve | 2005 |
Distinct different intra-tumor distribution of FDG between early phase and late phase in mouse fibrosarcoma.
Topics: Animals; Disease Progression; Fibrosarcoma; Fluorodeoxyglucose F18; Male; Metabolic Clearance Rate; Mice; Mice, Inbred C3H; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution | 2005 |
[The value of integrated PET-CT images in 2 lymphoma patients with skeletal localisations].
Topics: Adult; Diagnosis, Differential; Disease Progression; Fatal Outcome; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image Processing, Computer-Assisted; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2006 |
[Comparison of diagnostic accuracy of (18)F-FDG PET, (123)I-IMT- and (99m)Tc-MIBI SPECT: evaluation of tumour progression in irradiated low grade astrocytomas].
Topics: Adult; Astrocytoma; Brain Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Methyltyrosines; Middle Aged; Radioisotopes; Reproducibility of Results; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2006 |
Primary progressive aphasia accompanied by environmental sound agnosia: a neuropsychological, MRI and PET study.
Topics: Aged; Aphasia; Auditory Perceptual Disorders; Brain; Dementia; Disease Progression; Environment; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; Recognition, Psychology; Severity of Illness Index | 2006 |
Clinical insights into paraneoplastic cerebellar degeneration.
Topics: Adult; Ataxia; Atrophy; Biopsy; Bone Marrow; Breast Neoplasms; Carcinoma, Ductal; Cerebellar Neoplasms; Cerebellum; Diagnosis, Differential; Disease Progression; Dysarthria; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Migraine Disorders; Ovarian Cysts; Paraneoplastic Cerebellar Degeneration; Positron-Emission Tomography; Purkinje Cells; Radiopharmaceuticals; Tomography, X-Ray Computed | 2006 |
Progression to dementia in clinical subtypes of mild cognitive impairment.
Topics: Aged; Amnesia; Brain Chemistry; Cognition Disorders; Dementia; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Logistic Models; Male; Middle Aged; Neurodegenerative Diseases; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2006 |
Brain metabolic changes associated with predispotion to onset of major depressive disorder and adjustment disorder in cancer patients--a preliminary PET study.
Topics: Adjustment Disorders; Adolescent; Adult; Aged; Blood Glucose; Brain; Cerebral Cortex; Depressive Disorder, Major; Disease Progression; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Male; Middle Aged; Neoplasms; Nerve Net; Personality Inventory; Positron-Emission Tomography; Sensitivity and Specificity | 2007 |
Thyroid cancer presenting as a PET incidentaloma in a patient with concomitant breast cancer metastases to the thyroid.
Topics: Adrenal Gland Neoplasms; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Papillary; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease Progression; Estrogens; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Iodine Radioisotopes; Lung Neoplasms; Mastectomy, Segmental; Mediastinal Neoplasms; Middle Aged; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Adjuvant; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography | 2006 |
Level of fluorodeoxyglucose uptake predicts risk for recurrence in melanoma patients presenting with lymph node metastases.
Topics: Adult; Aged; Aged, 80 and over; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Skin Neoplasms; Survival Rate | 2006 |
Discordant response to chemotherapy: an unusual pattern of fluoro-deoxy-D-glucose uptake in heavily pre-treated lymphoma patients.
Topics: Adult; Aged; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Time Factors | 2006 |
Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Brain; Cholinesterase Inhibitors; Cognition Disorders; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Psychiatric Status Rating Scales; Radiopharmaceuticals; Thiazoles | 2006 |
Long-term prognostic value of 18F-FDG PET in patients with locally advanced rectal cancer previously treated with neoadjuvant radiochemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Chemotherapy, Adjuvant; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy, Adjuvant; Rectal Neoplasms; Time Factors | 2006 |
Paraneoplastic cerebellar degeneration: Yo-expressing tumor revealed after a 5-year follow-up with FDG-PET.
Topics: Biomarkers, Tumor; Breast Neoplasms; Carcinoma; Cerebellum; Disease Progression; Early Diagnosis; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Forecasting; Humans; Immunohistochemistry; Lymph Nodes; Middle Aged; Neoplasm Metastasis; Nerve Tissue Proteins; Paraneoplastic Cerebellar Degeneration; Positron-Emission Tomography; Sentinel Lymph Node Biopsy; Time Factors | 2006 |
Genetic and metabolic predictors of chemosensitivity in oligodendroglial neoplasms.
Topics: Adult; Aged; Alleles; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Disease Progression; Female; Fluorodeoxyglucose F18; Genetic Predisposition to Disease; Genotype; Humans; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Oligodendroglioma; Procarbazine; Prospective Studies; Survival Rate; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2006 |
Correlation of GLUT-1 overexpression, tumor size, and depth of invasion with 18F-2-fluoro-2-deoxy-D-glucose uptake by positron emission tomography in colorectal cancer.
Topics: Adenocarcinoma; Aged; Biomarkers, Tumor; Colorectal Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity | 2006 |
FDG PET/CT demonstrated rapid progression of mediastinal lymphadenopathy in sarcoidosis.
Topics: Aged; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Diseases; Mediastinal Diseases; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed | 2007 |
Serial 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) to monitor treatment of bone-dominant metastatic breast cancer predicts time to progression (TTP).
Topics: Adult; Aged; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies | 2007 |
PET/CT characterization and monitoring of disease activity in lymphomatoid granulomatosis.
Topics: Adult; Diagnosis, Differential; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lymphomatoid Granulomatosis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
Changes in network activity with the progression of Parkinson's disease.
Topics: Aged; Blood Glucose; Brain; Brain Mapping; Corpus Striatum; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Male; Middle Aged; Nerve Net; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Severity of Illness Index | 2007 |
Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria.
Topics: Antineoplastic Agents; Benzamides; Disease Progression; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Multivariate Analysis; Neoplasm Metastasis; Piperazines; Positron-Emission Tomography; Protein-Tyrosine Kinases; Pyrimidines; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
PET imaging of amyloid deposition in patients with mild cognitive impairment.
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Benzothiazoles; Cerebral Cortex; Cognition Disorders; Disease Progression; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Neuropsychological Tests; Plaque, Amyloid; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Thiazoles | 2008 |
Impact of PET/CT in comparison with same day contrast enhanced CT in breast cancer management.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Evaluation of tumor growth in vivo in a rat model of liver metastasis, using a newly devised index obtained by positron emission tomography with [18F] FDG.
Topics: Adenocarcinoma; Animals; Cell Line, Tumor; Colonic Neoplasms; Disease Progression; Fluorodeoxyglucose F18; Immunohistochemistry; Liver Neoplasms, Experimental; Male; Positron-Emission Tomography; Proliferating Cell Nuclear Antigen; Radiopharmaceuticals; Rats; Rats, Inbred F344 | 2007 |
Reduced cerebral glucose metabolism in patients at risk for Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Brain; Brain Mapping; Cerebral Cortex; Cognition Disorders; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Frontal Lobe; Functional Laterality; Glucose; Gyrus Cinguli; Humans; Image Processing, Computer-Assisted; Male; Positron-Emission Tomography; Severity of Illness Index; Temporal Lobe; Tissue Distribution | 2007 |
Cerebral metabolic correlates of the clinical dementia rating scale in mild cognitive impairment.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Blood Glucose; Brain; Cognition Disorders; Disease Progression; Dominance, Cerebral; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gyrus Cinguli; Humans; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Parietal Lobe; Positron-Emission Tomography; Statistics as Topic; Temporal Lobe | 2007 |
FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease.
Topics: Adult; Aged; Alzheimer Disease; Brain; Dementia; Diagnosis, Differential; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2007 |
Positron Emission Tomography in basic epilepsy research: a view of the epileptic brain.
Topics: Animals; Biomarkers; Brain; Disease Models, Animal; Disease Progression; Epilepsy; Epilepsy, Temporal Lobe; Fluorodeoxyglucose F18; Mice; Positron-Emission Tomography; Radiopharmaceuticals; Research Design | 2007 |
Neuroimaging follow-up in a case of Rasmussen's encephalitis with dyskinesias.
Topics: Adult; Cerebral Cortex; Disease Progression; Dyskinesias; Encephalitis; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Functional Laterality; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography | 2007 |
Metabolic tumor burden predicts for disease progression and death in lung cancer.
Topics: Aged; Aged, 80 and over; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Regression Analysis; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2007 |
Thalamic metabolism and symptom onset in preclinical Huntington's disease.
Topics: Adult; Analysis of Variance; Case-Control Studies; Corpus Striatum; Disease Progression; Fluorodeoxyglucose F18; Gyrus Cinguli; Heterozygote; Humans; Huntington Disease; Longitudinal Studies; Male; Middle Aged; Motor Cortex; Neuropsychological Tests; Occipital Lobe; Positron-Emission Tomography; Protein Binding; Raclopride; Radiopharmaceuticals; Receptors, Dopamine D2; Thalamus | 2007 |
Usefulness of FDG-PET for early prediction of the response to gefitinib in non-small cell lung cancer.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free Survival; ErbB Receptors; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gefitinib; Humans; Lung Neoplasms; Middle Aged; Neoplasm Staging; Prognosis; Quinazolines; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed | 2008 |
Assessment of local control after laser-induced thermotherapy of liver metastases from colorectal cancer: contribution of FDG-PET in patients with clinical suspicion of progressive disease.
Topics: Adult; Aged; Catheter Ablation; Colorectal Neoplasms; Diagnostic Errors; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Hyperthermia, Induced; Laser Therapy; Liver Neoplasms; Male; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; ROC Curve; Sensitivity and Specificity | 2007 |
Prognostic value of different metabolic measurements with fluorine-18 fluorodeoxyglucose positron emission tomography in resectable non-small cell lung cancer: a two-center study.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate | 2007 |
[The outcome of whole-body FDG-PET examination predicts the future of patients with diffuse large-cell lymphoma in the use of both intermediary staging and at the end of standard chemotherapy].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Whole Body Imaging | 2007 |
[Comparison of 18F-FDG coincidence SPECT imaging and computed tomography in the initial staging and therapeutic evaluation of lymphomas].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Diagnosis, Differential; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Radiopharmaceuticals; Remission Induction; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2007 |
Detection of inflammation in patients with acute aortic syndrome: comparison of FDG-PET/CT imaging and serological markers of inflammation.
Topics: Adult; Aged; Aged, 80 and over; Aortic Aneurysm, Thoracic; Aortic Diseases; Aortic Dissection; Aortitis; Biomarkers; Chest Pain; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Syndrome; Tomography, X-Ray Computed | 2008 |
The role of [18F]-fluorodeoxyglucose positron emission tomography in predicting plexiform neurofibroma progression.
Topics: Adolescent; Adult; Child; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Neurofibroma, Plexiform; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2008 |
Thymic 18F-fluorodeoxyglucose uptake on positron emission tomography scanning after doxorubicin, bleomycin, vincristin and dacarbazine chemotherapy and highly-active antiretroviral therapy in HIV-associated Hodgkin's disease in an adult.
Topics: Adult; Anti-HIV Agents; Antibiotics, Antineoplastic; Antiretroviral Therapy, Highly Active; Bleomycin; Dacarbazine; Disease Progression; Doxorubicin; Fluorodeoxyglucose F18; HIV Infections; Hodgkin Disease; Humans; Male; Positron-Emission Tomography; Thymus Gland; Treatment Outcome; Vincristine | 2008 |
Multivoxel proton MRS for differentiation of radiation-induced necrosis and tumor recurrence after gamma knife radiosurgery for brain metastases.
Topics: Adult; Aged; Aged, 80 and over; Brain Chemistry; Brain Neoplasms; Diagnosis, Differential; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Spectroscopy; Male; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiation Injuries; Radiopharmaceuticals; Radiosurgery; Treatment Outcome | 2006 |
18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer.
Topics: Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Cholecystectomy; Diagnosis, Differential; Disease Progression; Female; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2008 |
Amyloid and tau imaging, neuronal losses and function in mild cognitive impairment.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Brain; Diagnosis, Differential; Disease Progression; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Nitriles; Positron-Emission Tomography; tau Proteins | 2008 |
Natural history and management of brainstem gliomas in adults. A retrospective Italian study.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Brain; Brain Stem Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Glioma; Humans; Image Processing, Computer-Assisted; Italy; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Spinal Cord; Survival Analysis; Treatment Outcome | 2008 |
Lung cancer screening with low-dose computed tomography: a non-invasive diagnostic protocol for baseline lung nodules.
Topics: Aged; Chi-Square Distribution; Contrast Media; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Incidence; Lung Neoplasms; Male; Mass Screening; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiation Dosage; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Sensitivity and Specificity; Statistics, Nonparametric; Tomography, X-Ray Computed | 2008 |
Bone metastases in patients with metastatic breast cancer: morphologic and metabolic monitoring of response to systemic therapy with integrated PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
The role of 18F-FDOPA and 18F-FDG-PET in the management of malignant and multifocal phaeochromocytomas.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Aged; Dihydroxyphenylalanine; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Multiple Primary; Pheochromocytoma; Positron-Emission Tomography; Retrospective Studies; Tomography, Emission-Computed, Single-Photon | 2008 |
CSF phosporylated TAU protein levels correlate with cerebral glucose metabolism assessed with PET in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Biomarkers; Cerebrum; Disease Progression; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Positron-Emission Tomography; Statistics as Topic; tau Proteins | 2008 |
Preliminary retrospective investigation of FDG-PET/CT timing in follow-up of ablated lung tumor.
Topics: Catheter Ablation; Clinical Protocols; Contrast Media; Disease Progression; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
The metabolic topography of idiopathic torsion dystonia.
Topics: Adult; Aged; Aged, 80 and over; Brain; Deoxyglucose; Disease Progression; Dystonia Musculorum Deformans; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Reference Values; Tissue Distribution; Tomography, Emission-Computed | 1995 |
Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study.
Topics: Adult; Aged; Aspartic Acid; Biomarkers, Tumor; Biopsy; Brain Neoplasms; Cell Transformation, Neoplastic; Choline; Creatine; Deoxyglucose; Disease Progression; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Glioma; Humans; Hydrogen; Lactic Acid; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neoplasm Recurrence, Local; Phosphocreatine; Prognosis; Protons; Radiopharmaceuticals; Tomography, Emission-Computed | 1997 |
Quantitative [F-18]fluorodeoxyglucose positron emission tomography in pretreatment and grading of sarcoma.
Topics: Adult; Aged; Aged, 80 and over; Disease Progression; Fluorodeoxyglucose F18; Humans; Middle Aged; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed | 1998 |
A longitudinal study of cerebral glucose metabolism, MRI, and disability in patients with MS.
Topics: Adult; Brain; Disability Evaluation; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
Prognostic value of FDG PET imaging in malignant pleural mesothelioma.
Topics: Aged; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Mesothelioma; Middle Aged; Prognosis; Radiopharmaceuticals; Survival Rate; Tomography, Emission-Computed | 1999 |
Magnetic resonance and positron emission tomography changes during the clinical progression of Rasmussen encephalitis.
Topics: Brain; Child; Disease Progression; Encephalitis; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Oxygen Radioisotopes; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
Persistent tumor 18F-FDG uptake after a few cycles of polychemotherapy is predictive of treatment failure in non-Hodgkin's lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Survival Rate; Tomography, Emission-Computed; Treatment Outcome | 2000 |
Evaluation of early response to SU101 target-based therapy in patients with recurrent supratentorial malignant gliomas using FDG PET and Gd-DTPA MRI.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Biological Transport, Active; Carmustine; Chemotherapy, Adjuvant; Combined Modality Therapy; Cranial Irradiation; Disease Progression; Disease-Free Survival; Energy Metabolism; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Glioblastoma; Glucose; Humans; Isoxazoles; Leflunomide; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Platelet-Derived Growth Factor; Prognosis; Signal Transduction; Supratentorial Neoplasms; Tomography, Emission-Computed; Treatment Outcome | 2000 |
Whole body positron emission tomography imaging of activated lymphoid tissues during acute simian-human immunodeficiency virus 89.6PD infection in rhesus macaques.
Topics: Acute Disease; Animals; Biological Factors; CD4-Positive T-Lymphocytes; Diffusion; Disease Progression; Female; Fluorodeoxyglucose F18; HIV Infections; HIV-1; In Situ Hybridization; Lymph Nodes; Lymphocyte Activation; Lymphoid Tissue; Macaca mulatta; Rectum; RNA, Viral; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Tomography, Emission-Computed; Vagina; Virus Replication | 2000 |
Lung cancer proliferation correlates with [F-18]fluorodeoxyglucose uptake by positron emission tomography.
Topics: Disease Progression; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Ki-67 Antigen; Lung Neoplasms; Prognosis; Tomography, Emission-Computed | 2000 |
Role of repeated F-18 fluorodeoxyglucose imaging in management of patients with bone and soft tissue sarcoma.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Posture; Radiopharmaceuticals; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2001 |
In vivo evaluation of 5-[(18)F]fluoro-2'-deoxyuridine as tracer for positron emission tomography in a murine pancreatic cancer model.
Topics: Animals; Cell Division; Disease Models, Animal; Disease Progression; Floxuridine; Fluorodeoxyglucose F18; Genes, p53; Mice; Mice, Transgenic; Pancreatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; RNA, Messenger; Thymidine Kinase; Thymidylate Synthase; Transforming Growth Factor alpha; Up-Regulation | 2001 |
FDG-PET in the detection of gastrointestinal metastases in melanoma.
Topics: Adult; Aged; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
(18)F-fluorodeoxyglucose positron emission tomography and MR imaging findings in Rasmussen encephalitis.
Topics: Adolescent; Adult; Atrophy; Biopsy; Blood Glucose; Brain; Child; Child, Preschool; Disease Progression; Dominance, Cerebral; Encephalitis; Energy Metabolism; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Infant; Male; Retrospective Studies; Tomography, Emission-Computed | 2001 |
Lymph node staging by positron emission tomography in patients with carcinoma of the cervix.
Topics: Actuarial Analysis; Adult; Aged; Aged, 80 and over; Carcinoma; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multivariate Analysis; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed; United States; Uterine Cervical Neoplasms | 2001 |
Functional decline in Parkinson disease.
Topics: Adolescent; Adult; Age of Onset; Aged; Aged, 80 and over; Autonomic Nervous System Diseases; Demography; Dihydroxyphenylalanine; Disease Progression; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Multiple System Atrophy; Multivariate Analysis; Neurologic Examination; Parkinson Disease; Radiopharmaceuticals; Time Factors | 2001 |
Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome.
Topics: Aged; Brain; Dementia; Disease Progression; Female; Fluorodeoxyglucose F18; Glucose; Humans; Likelihood Functions; Male; Middle Aged; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
Can positron emission tomography with [(18)F]-fluorodeoxyglucose after first-line treatment distinguish Hodgkin's disease patients who need additional therapy from others in whom additional therapy would mean avoidable toxicity?
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm, Residual; Patient Selection; Prognosis; Radiopharmaceuticals; Recurrence; Retrospective Studies; Tomography, Emission-Computed; Treatment Outcome | 2001 |
The neural substrates of episodic memory impairment in Alzheimer's disease as revealed by FDG-PET: relationship to degree of deterioration.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Linear Models; Male; Memory Disorders; Mental Recall; Tomography, Emission-Computed | 2002 |
Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
Topics: Aged; Alzheimer Disease; Brain; Cerebral Cortex; Clinical Trials as Topic; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Longitudinal Studies; Male; Middle Aged; Neuropsychological Tests; Outcome Assessment, Health Care; Placebos; Psychiatric Status Rating Scales; Research Design; Severity of Illness Index; Tomography, Emission-Computed; Treatment Outcome | 2002 |